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ABSTRACT 
The genome of the soil bacterium Pseudomonas putida KT2440 encodes orthologs of genes 
crp (cAMP receptor protein), cyaA (adenylate cyclase) and cpdA (cAMP phosphodiesterase) 
of Escherichia coli. The crpP.putida gene restored the lack of maltose consumption of a crp 
mutant of E. coli, but not in a double crp/cyaA strain, suggesting that the ability to regulate 
such functions required cAMP. On the other hand, the cyaAP. putida gene was transcribed in 
vivo but failed to complement the metabolic capacities of an equivalent cyaA mutant of E. 
coli. Yet, generation of cAMP by CyaAP. putida could be verified by expressing the cyaAP. putida 
gene in a hypersensitive E. coli strain, thereby indicating that cAMP was poorly synthetized 
by the adenylate cyclase of P. putida. The low levels of cAMP formed by P. putida cells 
were further confirmed either chemically or with a Dictyostelium biosensor in vivo. Using 
transcriptional and translational fusions of cyaAP. putida promoter with lacZ, we demonstrated 
that such a low cAMP levels stem from the fact that the adenylate cyclase is transcribed but 
it is not efficiently translated. Also, the Crp regulator of P. putida was purified and 
subjected to a battery of in vitro assays aimed at determining its principal physicochemical 
properties. Analytical ultracentrifugation indicated effector-free CrpP. putida to be a dimer in 
solution that undergoes a significant change in the presence of cAMP. Such a 
conformational transition was confirmed by limited proteolysis of the protein in the 
absence or presence of the effector. Thermodynamic parameters calculated by isothermal 
titration calorimetry revealed a tight 1:1 cAMP:CrpP. putida dimer association with an 
apparent KD of 45.0 ± 3.4 nM, i.e. much greater affinity than that reported for the E. coli’s 
counterpart. The regulator also bound cGMP, but with a KD ~100 fold lower. An in vitro 
transcription system was then set up with purified P. putida’s RNA polymerase for 
examining the preservation of the correct protein–protein architecture that makes Crp to 
activate target promoters. These results, along with cognate gel shift assays indicated that all 
basic features of the reference CrpE. coli are kept in P. putida. Finally, RNA-seq transcriptome 
analysis demonstrated that cAMP-CrpP. putida is not related with the regulation of metabolic 
functions, but it rather controls factors for the cellular response to environmental stress and 
the expression of components of the bacterial membrane to shape the cell envelope in 
response to harmful conditions. This poor metabolic profile of the cAMP-Crp system of P. 
putida when compared with E. coli exposes a case of regulatory exaptation i.e. the process 
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RESUMEN 
El genoma de la bacteria del suelo Pseudomonas putida KT2440 codifica ortólogos de los genes 
crp (proteína receptora de cAMP), cyaA (adenilato ciclasa) y cpdA (fosfodiesterasa de cAMP) 
presentes en Escherichia coli. En este trabajo demostramos que el gene crpP.putida logra restaurar la 
incapacidad para consumir maltosa en un mutante crp de E. coli, pero no así en un doble 
mutante crp/cyaA de esta bacteria, sugiriendo que la habilidad para regular las funciones 
dependientes de CrpP.putida requieren cAMP. Por otra parte, mostramos que el gene cyaAP. putida se 
transcribe in vivo, pero es incapaz de complementar estas capacidades metabólicas en un 
mutante equivalente del gene cyaA en E. coli. No obstante, la producción de cAMP por la 
proteína CyaAP.putida se pudo verificar posteriormente al expresar el gene cyaAP. putida en una cepa 
de E. coli hipersensible a bajas concentraciones de cAMP, indicando que la síntesis de cAMP en 
P. putida es muy baja. Estos niveles tan bajos del cAMP fueron confirmados posteriormente 
tanto de forma química como por un biosensor in vivo basado en Dictyostelium. Mediante 
fusiones transcripcionales y traduccionales del promotor del gene cyaAP. putida con lacZ, 
demostramos que la baja producción de cAMP en P. putida radica en que el gen de la adenilato 
ciclasa se transcribe eficientemente, pero su nivel de traducción es muy bajo. Adicionalmente, la 
proteína Crp de P. putida se purificó y se sometió a un conjunto de ensayos in vitro para 
determinar sus principales propiedades físico-químicas. Mediante ultracentrifugación analítica, 
mostramos que la proteína CrpP. putida forma dímeros en solución, los cuales sufren un 
importante cambio conformacional al interaccionar con el cAMP. Este cambio se demostró 
asimismo utilizando ensayos de proteólisis parcial en ausencia o presencia de este efector. Por 
medio de ensayos de microcalorimetría, se calcularon los parámetros termodinámicos de la 
unión de con el cAMP. Esta interacción resultó llevarse a cabo con una estequiometría de 1 
molécula cAMP: 1 dímero CrpP.putida y se reveló que la unión es especialmente fuerte, 
presentando un valor aparente de la KD de 45.0 ± 3.4 nM, es decir, una afinidad mucho mayor 
que la conocida para la proteína homóloga de E. coli. CrpP.putida también unió cGMP pero con 
una KD cerca de 100 veces menor. Posteriormente utilizamos un sistema de transcripción in 
vitro empleando la ARN polimerasa purificada de P. putida para examinar la conservación de 
las interacciones proteína-proteína que permiten la activación de los promotores dependientes 
de Crp. Estos experimentos, junto con sus respectivos ensayos de retardo de la movilidad 
electroforética, indicaron que todas las características básicas de la CrpE.coli también se 
encuentran presentes en la Crp de P. putida. Finalmente, análisis transcriptómicos utilizando 
ultra-secuenciación profunda (ARN-seq) demostraron que el sistema cAMP-Crp no regula 
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funciones metabólicas en P. putida, sino que por el contrario parece controlar factores 
relacionados con la respuesta celular a estrés ambiental y la expresión de componentes de la 
envuelta celular en tales condiciones estresantes. Este pobre perfil metabólico del sistema 
cAMP-Crp en P. putida en comparación con E. coli expone un claro caso de exaptación 
reguladora. Este es el proceso por el que un componente biológico que emerge por primera vez 
para cumplir una función particular es reclutado para desempeñar un nuevo uso sin cambiar su 
estructura. 


















1 Global regulation of gene expression 
The wide diversity of microorganisms in nature live in a variety of environments subject to 
rapid changes in the availability of the carbon and nitrogen compounds necessary to 
provide energy and building blocks for the synthesis of cell material. Their survival depends 
on their ability to adapt to these changes by regulating the expression of genes coding for 
enzymes and transport proteins required for growth in the altered environment (Magasanik, 
2000). This gene expression is a highly complex process that comprises many steps, each 
with elaborate regulation. In bacteria, transcription initiation is the major step of regulation, 
although mRNA abundance is also controlled at the step of transcription elongation and 
termination. Degradation of mRNA is also subject to control and, furthermore, increasing 
data indicate the involvement of translational control of mRNA through various 
mechanisms, including the interference of mRNA translation by regulatory RNAs and 
proteins (Ishihama, 2010). 
The promoters of bacterial genes for such environmental signals are controlled by 
numerous proteins through direct protein-DNA or protein-protein interactions that either 
up- or downregulate the transcription by the multi-subunit RNA polymerase (RNAP; 
Perez-Rueda & Collado-Vides, 2000; Browning & Busby, 2004; Ishihama, 2010). These 
proteins include sigma (σ) factors (and their anti-sigma-factor counterparts), which 
associate with the core of the RNAP to initiate the transcription, and the transcriptional 
factors (TFs) that target sequences frequently found near promoter regions (Cases & de 
Lorenzo, 2005; Wosten, 1998). Such factors also include nucleoid-associated proteins, 
typically the integration host factor (IHF), the factor for inversion stimulation (FIS) and 
the regulator for leucine LRP (Cases & de Lorenzo, 2005); as well as more generic events 
like changes in chromosomal supercoiling (Hatfield & Benham, 2002) or the intracellular 
concentration of osmolytes like potassium glutamate, glycine betaine, L-proline and 
trehalose (Lee & Gralla, 2004). Additionally, the promoter architecture and the 
conservation of the consensus recognition sequences by RNAP (-10 and -35 promoter 
elements for example), acts as a powerful regulator in the gene expression and in the 
distribution of RNA polymerase amongst the different transcription units (Browning & 
Busby, 2004). 
 4 
The genome of the model prokaryote Escherichia coli encodes for about 300 types of TFs 
(Perez-Rueda & Collado-Vides, 2000; Madan Babu & Teichmann, 2003). The regulatory 
function is not known at all for approximately a third of them (Ishihama, 2010). When 
bound to specific DNA target sites near promoters, these proteins recruit the RNAP to the 
promoter region by interacting directly with one or more subunits of the RNAP complex, 
in order to activate the transcription. However, some TFs bind to promoter sequences to 
repress the transcription by overlapping core promoter elements -steric hindrance-,           
by forming DNA loops that avoid the interaction of RNAP with the intervening promoter 
-repression by looping- and by interacting directly with an activator, preventing its function 
-modulation of an activator- (reviewed in Browning & Busby, 2004). Some of these 
transcriptional factors control only few genes (local regulators), whereas others control 
simultaneously a large number of genes and therefore, many metabolic conditions. The last 
set of factors are known as global regulators and include Crp, FNR, IHF, Fis, ArcA, NarL, 
Lrp, RutR, Cra and Dan (Martinez-Antonio & Collado-Vides, 2003; Browning & Busby, 
2004; Cases & de Lorenzo, 2005; Ishihama, 2010). In fact, the first seven TFs described 
above are sufficient to directly modulating the expression of 51% of genes in E. coli 
(Martinez-Antonio & Collado-Vides, 2003), thereby exhibiting pleiotropic phenotypes 
(Ishihama, 2010). 
To respond immediately to the environmental signals, the function of the TFs must be 
regulated either by controlling their activity or their expression. There are at least four 
different mechanisms to achieve this (reviewed by Browning & Busby, 2004): [i] the 
affinity of some regulators could be modulated by covalent modification like 
phosphorylation mediated by TF-cognate sensor kinases. This is the case of NarL, which 
activity is controlled in response to extracellular nitrate and nitrite by the sensor kinases 
NarX and NarQ (Stock et al., 2000); [ii] the intracellular concentration of some regulators 
also can control their activity, like the SoxS regulator of oxidative stress in E. coli, or the 
XylS regulator of the meta-cleavage pathway for m-xylene/toluene degradation encoded in 
the TOL plasmid of P. putida mt-2 (Gonzalez-Perez et al., 2004). In these cases the 
concentration of the TF is controlled either by regulation of expression or by proteolysis; 
[iii] a less common mechanism for regulating the effective concentration (and therefore, the 
activity) of a TF is sequestration by another regulatory protein to which it binds. This is the 
case of Mlc global repressor, which is sequestered by the IIBCGlc complex of the 
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phosphoenolpyruvate-carbohydrate phosphotransferase system (PTS; see below) in presence 
of glucose (Tanaka et al., 2000); [iv] finally, one frequent mechanism to modulate the 
DNA-binding affinity in TFs is by interaction with small ligands, the concentrations of 
which fluctuate in response to nutrient availability or stress. This is the case of the Lac 
repressor, which DNA-binding affinity is reduced by allolactose. Amongst these small 
signalling molecules, the cyclic nucleotides count among the most widespread throughout 
the entire Tree of Life (Gomelsky, 2011), the proteins whose biological activity is regulated 
upon their binding diversify enormously (Shabb & Corbin, 1992). Virtually all bacterial 
genomes have been found to encode proteins that bind and respond to 3'-5'-cyclic 
adenosine monophosphate (cAMP), the prototypical of these being the transcriptional 
regulator of E. coli, first designated as the catabolite activator protein (CAP) and later 
named with the more unbiased name of cAMP-receptor protein or Crp (Busby & Ebright, 
1999). 
 
2 The archetypal cAMP-Crp system of E. coli 
2.1 The cAMP-receptor protein (Crp) 
The cAMP-receptor protein of E. coli (Crp or CAP) was the first transcriptional activator 
ever identified because of its positive role in expression of the lac operon (Ullmann & 
Monod, 1968; Zubay et al., 1970). This protein belongs to the Crp-FNR superfamily of 
transcriptional regulators that include nearly 370 DNA-binding members, which 
predominantly function as positive transcription factors (Korner et al., 2003). Crp-FNR 
proteins are characterized by a C-terminally located helix-turn-helix (HTH) structural 
motif consisting of two α-helices joined by a turn, which fits into the major groove of DNA. 
In addition to the HTH motif, Crp-FNR regulators have a large nucleotide-binding do- 
main that extends from the N-terminus over roughly 170 residues (Korner et al., 2003). 
Early in the study of Crp, it became clear that this protein had the ability of occupying a 
target DNA sequence in the proximity of the RNAP binding site of Plac depending on the 
binding to cAMP as co-activator. Later work has shown that Crp is in fact a homodimeric 
protein, each 209 amino acids monomer folded into two distinct structural domains (Fig. 
1).  The larger amino-terminal cAMP-binding domain (CBD; comprising residues 1-136) 
is responsible for the interaction with the allosteric effector cyclic AMP. It also contains the 
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long C α-helix, which is instrumental in protein dimerization. The carboxy-terminal DNA-
binding domain is smaller (DBD; comprising residues 140-209) and mediates the 
interaction of Crp with DNA through a helix-turn-helix DNA-binding motif (McKay & 
Steitz, 1981; Kolb et al., 1993; Busby & Ebright, 1999). Both domains are separated by a 
short hinge region (residues 136-139), which is involved in the regulation of the allosteric 
conformational change that occurs upon cAMP binding to Crp, including subunit 
realignment and domain rearrangement (Gao et al., 2012). 
 
 
Fig. 1. Tridimensional structure of the cAMP-Crp complex of E. coli bound to DNA. 
The cAMP-bound Crp-dimer interacts with the major groves of a DNA sequence similar 
to consensus (5’-GCGAAAAGTGTGACATATGTCACTTTTCG-3’) by direct contact 
of the F-helices located in the C-terminal DNA-binding domain of both subunits. Note 
the localization of the cAMP allosteric effector in the nucleotide-binding pocket situated 
in the N-terminal domain of Crp-dimer. The crystallographic structure at 2.5 Å was 
obtained from PDB accession ID 1J59 DNA (Parkinson et al., 1996). 
 
The E. coli cAMP-Crp complex of E. coli seems to target sequences best containing 
5’TGTGA-6N-TCACA3’ (extended: 5’AAATGTGATCTAGATCACATTT3’) although 
this optimal configuration hardly appears as such because permanent occupation of the 
DNA site may not be biologically useful (Ishihama, 2010; Shimada et al., 2011). Target 
sequences are often located at varying distances upstream the transcription start site of the 
RNAP (Busby & Ebright, 1999). Depending on this distance, the mode of transcription 
activation by Crp is different (this issue will be revisited later). However, Crp can also 
repress the transcription of some promoters by either preventing the RNAP from binding 
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to the promoter DNA (usually the Crp-binding site overlaps the -10 or -35 sequences of 
the promoter), or by blocking transcription from another upstream promoter (Zheng et al., 
2004). 
Recently, the cAMP-mediated allosteric transition of Crp from the inactive to the active 
DNA-binding conformation was proposed by Won et al. (2009) and finally demonstrated 
by Popovych and colleagues (2009). The basic feature of this mechanism is a bistable 
coiled-coil structure formed in the intersubunit of the C-helix/C’-helix (where ’ denotes the 
second Crp subunit) determined by the interaction with cAMP (Fig. 2). The cyclic 
nucleotide adenine base directly interacts with residues Thr-127 and Ser-128, causing both 
residues to relocate and to reorientate. This generates a coil-to-helix transition from Val-
126 to Phe-136, resulting in the extension of the C-helix by three turns of helix in each 
Crp-subunit. The coil-to-helix transition results in the rotation of the DNA-binding 
domain by ~60° and its translation by ~7 Å. This rotation and translation places the DNA-
recognition helices (F-helices) of both subunits in the correct orientation and in the correct 
position to interact with the successive DNA major grooves, making extensive contacts 
with DNA base pairs and the sugar phosphate backbone (Parkinson et al., 1996; Popovych 
et al., 2009). Interaction of Crp F-helices with DNA leads to an extensive bend of the 
 
 
Fig. 2. Mechanism of allosteric control of E. coli Crp (CAP). Schematic models of Crp in 
the 3 structurally characterized states: apo-Crp, Crp-cAMP2, and Crp-cAMP2-DNA. 
The mechanism of allosteric control involves the binding of cAMP to the CBD of Crp, 
making contacts with Thr-127 and Ser-128. These contacts induce a coil-to-helix 
transition that extends the C-helix, and the intersubunit C-helix/C’-helix coiled coil by 3 
helical turns (represented in cyan in the Crp-cAMP2 model). This coil-to-helix transition 
results in rotation and translation of the DBD of the Crp dimer. This conformational 
change places the F-helices (DNA-recognition helices) of the Crp dimer in the correct 
orientation to interact with DNA. (Popovych et al., 2009). 
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DNA double helix by about ~80°. The orientation of this Crp-induced DNA bend is such 
that the DNA wraps towards and around both sides of the homodimer (Parkinson et al., 
1996; Chen et al., 2001; Busby & Ebright, 1999). Thus, DNA-bending facilitates the 
interaction between Crp and the RNAP to promote transcription activation in some Crp-
dependent promoters (see below). 
Although Crp is an abundant protein in E. coli (Anderson et al., 1971) it seems that its 
regulatory scope has specialized in controlling metabolic functions in this bacterium (Kolb 
et al., 1993). Up to the present, about 200 target promoters have been recorded in 
RegulonDB database (http://regulondb.ccg.unam.mx/) to be regulated in some extent by 
Crp, many of them encoding transporters and catabolic enzymes for the metabolization of 
carbon sources (Gama-Castro et al., 2011; Shimada et al., 2011). Moreover, genome-
SELEX screening of Crp-regulated promoters identify at least 183 novel operons in E. coli, 
which added to the near 200 hitherto known targets, encompass approximately 380 
promoters as the regulation targets for cAMP-CRP (Shimada et al., 2011). The novel target 
genes identified by Shimada and colleagues are involved in metabolic processes of the cell, 
such as selective transport of carbon sources, the glycolysis-gluconeogenesis switching to the 
metabolisms downstream of glycolysis, including tricarboxylic acid (TCA) cycle, pyruvate 
dehydrogenase (PDH) pathway and aerobic respiration (Shimada et al., 2011). The 
regulation of such metabolic traits, converts Crp in one of the major players in the global 
pathway of Carbon Catabolite Repression (CCR) in E. coli (Stulke & Hillen, 1999; 
Deutscher, 2008; Gorke & Stulke, 2008; Shimada et al., 2011). Apart of being one key 
mediator of CCR, this factor ultimately orchestrates the distribution of carbon fluxes into 
respiratory and fermentative metabolisms (Haverkorn van Rijsewijk et al., 2011). 
2.2 Carbon Catabolite Repression mediated by cAMP-Crp in E. coli 
Bacteria have developed sophisticated mechanisms to adapt to environmental changes, for 
example the carbon availability. These microorganisms are able to distinguish between a 
preferred (i.e. rapidly metabolizable or energetically favourable) carbon source when they are 
exposed to more than one of these nutrients. To achieve this, the bacteria synthetize only 
the enzymes necessary for utilizing the preferentially consumed source of carbon 
(Deutscher, 2008; Stulke & Hillen, 1999). This regulatory phenomenon is known as 
Carbon Catabolite Repression, and is defined as the mechanism by which the expression of 
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functions for the use of secondary carbon sources and the activities of the corresponding 
enzymes are reduced in the presence of the preferred carbon source (Cases & de Lorenzo, 
1998; Gorke & Stulke, 2008). CCR is widely distributed amongst bacteria, as it represents 
an important mechanism for competition in natural environments, where selection of the 
preferred carbon source represents an adaptive advantage for the organisms (Ullmann, 
1996; Gorke & Stulke, 2008). In some pathogenic bacteria, for example, CCR has a crucial 
role in the expression of virulence genes, which often enable bacteria to access new sources 
of nutrients (Gorke & Stulke, 2008). This phenomenon plays also a major role in the 
genetic manipulation of bacteria for biotechnological or environmental applications, 
because the main bottleneck in the expression of heterologous genes or factors for these 
purposes is the general downregulation of promoter activity caused by environmental and 
metabolic conditions (Cases & de Lorenzo, 1998). 
The first quantitative analysis of CCR was observed by Jacques Monod in 1942. He grew 
bacterial cultures in the presence of two carbohydrates instead of a single one, and 
depending on the nature of the two carbohydrates (i.e. one preferred carbon source as 
glucose and a secondary carbon source such as lactose), the growth curve exhibited two 
successive growth cycles separated by a period of lag, describing a diauxic growth curve 
(Monod, 1942). However, it was not until 1965 that cAMP was identified as an antagonist 
of the repressing effect of glucose over alternative carbon sources in E. coli cells (Ullmann 
& Monod, 1968). Later, Zubay and colleagues (1970) discovered the protein factor which 
acts in conjunction with cAMP, called catabolite gene activator protein (CAP or Crp). 
In E. coli, the major players in the global pathway of CCR are the above-described Crp 
(together with its cognate signal cAMP) and the PTS system (Gorke & Stulke, 2008). The 
PTS is a multiprotein phosphorelay system that catalyses the uptake of numerous 
carbohydrates and their conversion in their respective phosphoesters during transport. Thus, 
it couples transport and phosphorylation of carbohydrates by the action of the protein 
complex formed by two general cytoplasmic components, Enzyme I (EI, encoded by ptsI 
gene) and HPr (encoded by ptsH gene), and the complex formed by the Enzyme II (EII; 




Fig. 3. Classical model of the Carbon Catabolite Repression (CCR) of carbohydrates in E. 
coli. (A) The glucose specific EIIA of the PTS-phosphotransferase system mediates the 
CCR mechanism in E. coli. When phosphorylated, EIIAGlc binds and activates the 
adenylate cyclase enzyme (AC) to produce cAMP. Activation of AC requires also 
the interaction of an unrecognized regulatory factor of the cell cytoplasm (RF). In 
the presence of a mixture of sugars, glucose (Glc) regulates the flow of the phosphate from 
PEP to the carbohydrate simultaneously with its transport by the EIIBC components. 
This prevents the EIIAGlc to become phosphorylated by the PTS. Nonphosphorylated 
EIIAGlc interacts with the transporters of non-preferred carbon sources such as 
lactose permease (LacY), impeding the uptake of alternative carbon sources by the 
mechanism known as inducer exclusion. (B) When glucose is consumed, the 
EIIAGlc becomes phosphorylated. Phospho-EIIAGlc activates the adenylate cyclase, 
increasing cellular cAMP concentrations. High concentrations of the cyclic 
nucleotide trigger the formation of cAMP-Crp complex, which binds and 












Carbohydrate specificity resides in EII, and hence, bacteria usually contain many different 
EII complexes, consisting in one or two integral membrane domains (C and D) and two 
hydrophilic domains (A and B; Deutscher et al., 2006). Regulation of CCR in E. coli is 
thus brought about by the IIA component of the glucose-specific PTS (EIIAGlc, encoded by 
ccr gene). In the classical model of CCR in enterobacteria (Fig. 3), when cells are faced with 
a mixture of carbohydrates, the uptake of the preferentially consumed PTS substrate like 
glucose increases the level of dephosphorylated EIIAGlc (Reviewed in Deutscher et al., 2006; 
Deutscher, 2008; Gorke & Stulke, 2008). This occurs because the phosphate group 
transferred from phosphoenolpyruvate (PEP) through PTS system is drained towards 
transport of the preferred carbon source (glucose-6-phosphate in Fig. 3A). Phosphorylated 
(but not unphosphorylated) EIIAGlc exerts its regulatory role by activating the cAMP-
producing enzyme adenylate cyclase (AC; Kolb et al., 1993). Recently, it was discovered 
that this activation is also dependent on an uncharacterized regulatory factor (RF) in the 
cell cytoplasm that interacts with the AC, with EIIAGlc~P or with both proteins (Park et al., 
2006). Therefore, the presence of glucose lowers the intracellular concentrations of this 
cyclic nucleotide. Also, unphosphorylated EIIAGlc can bind to a number of enzymes 
involved in the transport and metabolism of non-PTS carbon sources (e.g. lactose, 
melibiose, maltose and glycerol), and thereby inhibits the utilization of these carbon sources, 
a process called inducer exclusion (Deutscher et al., 2006; Deutscher, 2008; Gorke & 
Stulke, 2008). Once the preferred carbon source is exhausted, the adenylate cyclase is 
activated by EIIAGlc~P and the regulatory factor RF. This increases the synthesis of cAMP, 
that binds to Crp and therefore, the cAMP-Crp complex activates the promoters of many 
catabolic genes and operons (Fig. 3B). 
2.3 Transcription activation at simple Crp-dependent promoters 
The cAMP-Crp complex binds at a variety of distances upstream of the transcription start 
site of several promoters to activate transcription of thereby encoded genes. This spacing 
has a central role in determining the mechanism of protein-protein interaction between the 
TF and the RNAP (Gaston et al., 1990). Thus, transcription activation at simple Crp-
dependent promoters are divided in three classes (Fig. 4; reviewed by Busby & Ebright, 
1999).  
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[i] Transcription activation at class I Crp-dependent promoters require only one cAMP-
Crp complex interacting with the specific DNA-binding site of Crp centered near positions 
-93, position -83, position -72 or position -62 from transcription start point (Fig. 4A). 
Location at these positions affords the DNA site for Crp and the DNA site for the RNA 
polymerase to be on the same face of the DNA-helix (Gaston et al., 1990; Busby & Ebright, 
1999). Transcription activation in this type of promoters involves a direct protein-protein 
interaction between Crp and the C-terminal domain of RNAP-α subunit (αCTD) through 
a determinant consisting of residues 156-164 of Crp and known as activating region 1 
(AR1; Zhou et al., 1993; Busby & Ebright, 1999). AR1 interacts directly with residue 287 
of αCTD and facilitates the binding of this RNAP subunit to DNA. Protein-DNA 
interaction is mediated by the residue 265 of αCTD. Finally, the residue 261 of αCTD 
(located on the face of αCTD opposite from Crp) is proposed to interact with the σ factor 
(Benoff et al., 2002; Busby & Ebright, 1999). The interactions between Crp, RNAP and 
DNA, increase the affinity of RNAP for the promoter region, resulting in formation of the 
RNAP-promoter closed complex and, thus, in an increase of transcription initiation (Busby 
& Ebright, 1999).  
[ii] At class II Crp-dependent promoters, one DNA site for Crp is centered near position -
41.5 from transcription start point, thus overlapping the DNA site for RNAP (Fig. 4B; 
(Gaston et al., 1990; Busby & Ebright, 1999). In this kind of promoters, Crp activates 
transcription through two different set of interactions: the first interaction involves the 
previously described activating region 1 (Bell et al., 1990; Zhou et al., 1994; Busby & 
Ebright, 1999). AR1 interacts with the 287 determinant of one of the two copies of αCTD, 
facilitating the binding of this subunit to the DNA segment upstream Crp (Fig. 4B; Busby 
& Ebright, 1999) The second interaction requires a class II-specific determinant consisting 
in residues His 19, His 21, Glu 96 and Lys 101 located in the N-terminal CBD of Crp 
(activating region 2, AR2; Niu et al., 1996; Busby & Ebright, 1999). This AR2 interacts 
with the N-terminal domain of RNAP-α subunit (αNTD), specifically in the determinant 
formed by residues 162-165. Thus, interaction of Crp-AR1 with αCTD facilitates the 
formation of the RNAP-promoter DNA closed complex, while AR2 facilitates de transition 
of closed complex to open complex (Niu et al., 1996; Busby & Ebright, 1999). 
Additionally, there is a third non-native activating region at class-II Crp dependent 
promoters triggered by the mutation of the inhibitory determinant composed of residue 
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Lys52 mainly by a neutral or negative charged amino acid (activating region 3, AR3; Busby 
& Ebright, 1999; Rhodius & Busby, 2000b). This inhibitory effect is proposed to occur 
mainly due to an unfavourable interaction of Lys52 side chain that clashes with RNAP.  
 
 
Fig. 4. Mechanisms of transcription activation at Crp-dependent promoters. (A) Ternary complex 
of Crp, RNA polymerase (RNAP) and the DNA of class I-dependent promoter having the DNA 
site for Crp centered at position -61.5. Transcriptional activation requires direct protein-protein 
interaction between activating region 1 of Crp (AR1) and the 287 determinant of one copy of 
RNAP-αCTD. The AR1–αCTD interaction facilitates the binding of αCTD to the DNA segment 
immediately downstream of Crp and to σ70 region 4 bound at -35 element. (B) Ternary complex of 
Crp, DNA and RNAP at class II Crp-dependent promoters. Transcription activation requires the 
location of the Crp-site centered near position -41.5. Protein-protein interaction between Crp-
RNAP requires two activating regions at Crp. The AR1 of the upstream subunit of Crp interact 
with residue 287 of one copy of αCTD and facilitates the binding of αCTD to DNA. The 
activating region 2 (AR2) of the downstream subunit of Crp interacts with one copy of αNTD. (C) 
Quaternary complex of multiple Crp subunits, RNAP and a class III Crp-dependent promoter 
having an upstream Crp dimer operating by a class I mechanism, and the downstream Crp dimer 
functioning by a class II mechanism. For details see text. Adapted from Busby & Ebright (1999). 
 
In the putative model of transcription activation at AR3, substitution of inhibitory Lys52 
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E55 and E58 with the positively charged amino acids K593, K597, R599 and R596 located 
at the C-terminal region of σ70 subunit of RNAP (Rhodius & Busby, 2000b; Rhodius & 
Busby, 2000a). 
[iii] Finally, transcription activation at class III dependent promoters requires multiple 
activator molecules for full transcription activation (Fig. 4C). This synergistic transcription 
activation could be obtained by multiple Crp dimers placed at various class I positions (e.g. 
-103, -93 and/or -62 position from transcription star site). Similarly a Crp dimer located 
upstream could function by a class I mechanism, while another Crp dimer located 
downstream near -41.5 position functions by a class II mechanism (Busby & Ebright, 
1999). Also, synergistic transcription activation could be obtained by interaction of Crp 
and other activators (Busby & Ebright, 1999). Amongst this kind of class III Crp-
dependent promoters, a particular case is the coregulation exerted by Sxy and Crp over 
ppdA or yrfD genes. These promoters are regulated by Crp positioning at a non-canonical 
Crp site (called Crp-S sites) with the core half sequence 5’-TGCGANNN instead 
consensus 5’-TGTGANNN. Thus, binding of Crp to the non-canonical Crp-S site 
requires the interaction of the Sxy factor (Cameron & Redfield, 2006). 
 
3 Adenylate cyclase (CyaA) 
As stated above, cyclic nucleotides are found amongst the most important second 
messengers throughout the entire Tree of Life (Gomelsky, 2011). These signalling 
molecules are synthetized by nucleotide cyclase enzymes. While the adenylate cyclase (AC) 
catalyses the production of 3'-5'-cyclic adenosine monophosphate (cAMP) from ATP, the 
homologous guanylate cyclase (GC) catalyses the formation of 3'-5'-cyclic guanosine 
monophosphate (cGMP) from GTP (Danchin, 1993). At least, six classes of nucleotide 
cyclases have been described: The class I or enterobacterial cyclase is represented by the 
CyaA adenylate cyclase of E. coli (Danchin, 1993). These enzymes have only been found in 
γ- and δ-proteobacteria (Linder, 2008). Class II, or the Calmodulin activated toxic class of 
cyclases, includes a group of toxic adenylate cyclases of pathogens like Bacillus anthracis, 
Bordetella pertussis or P. aeruginosa (Danchin, 1993). The class III or the universal class of 
nucleotide cyclases is an ancestral group of purine cyclases that comprises adenylate and 
guanylate cyclases present in bacteria, archaea and eukaryotes (Danchin, 1993). The class 
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IV was initially identified in hyperthermophilic archaebacteria and is represented by the 
AC2 of Aeromonas hydrophila (Sismeiro et al., 1998). Little is know about class V and class 
VI nucleotide cyclases, which are represented by the adenylate cyclases of the anaerobic 
Prevotella runimicola and Rhizobium etli, respectively (Shenroy & Visweswariah, 2004).  
The CyaA of E. coli is probably the only class I AC that has been biochemically 
characterized to some extent (Linder, 2008). CyaA is a soluble monomeric protein of 848 
amino acids and ~95 kDa of molecular weight (Yang & Epstein, 1983). The modular 
enzyme is composed of two functional domains, an amino-terminal catalytic domain and a 
carboxy-terminal regulatory domain (Roy et al., 1983; Linder, 2008; Park et al., 2006). 
The catalytic activity of the N-terminal domain is elicited within the first 420 amino acids 
of CyaA, where 12 residues were identified to be essential for enzymatic activity (Linder, 
2008). The proposed mechanism for cAMP synthesis involves the binding of two metal 
ions (Mg2+) to two aspartate residues (Asp 114 and Asp 116) within the catalytic domain 
(Roy et al., 1983; Linder, 2008). These metal-cofactors catalyse the cyclization reaction. 
ATP is proposed to be discerned from ADP and AMP via Ser 103, which binds the γ 
phosphate and provides the substrate binding energy (Linder, 2008). On the other hand, 
the C-terminal regulatory domain is essential for metabolic activation of the adenylate 
cyclase by the phosphorylated-EIIAGlc and the RF factor of the cell cytoplasm (Park et al., 
2006). 
 
4 cAMP phosphodiesterase (cAMP PDE) 
The intracellular concentration of cAMP is determined by its synthesis through adenylyl 
cyclases (see above), degradation, and the efflux across the cell membrane. Conversely to 
the function of adenylate cyclase, the turnover of intracellular cAMP is carried through the 
specialized enzyme cyclic 3’,5’-AMP phosphodiesterase. The cyclic nucleotide 
phosphodiesterases (PDE) catalyzes the hydrolytic cleavage of the 3′-phosphodiester bond 
of the cyclic nucleotide, resulting in formation of the corresponding inactive 5′- 
monophosphate (Essayan, 2001; Richter, 2002). Like adenylate cyclases, cyclic nucleotide 
phosphodiesterases are found in all branches of life and encompass a family of enzymes that 
are grouped into three classes based on their primary amino acid sequence: Class I include 
all mammalian PDE described as well as several genes identified in Drosophila, 
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Caenorhabditis, Dictyostelium discoideum and yeast.  The phosphodiesterase class II is 
comprised of a few enzymes from Saccharomyces cerevisae, Dictyostelium discoideum, 
Schizosaccharomyzes pombe, Candida albicans, and a periplasmic PDE from Vibrio fischeri. 
Finally, the newly identified class III PDE includes most of the phosphodiesterases found 
in bacteria (Richter, 2002). This comprises the phosphodiesterases of E. coli (Imamura et 
al., 1996; Richter, 2002), Haemophilus influenzae (Macfadyen et al., 1998) , Mycobacterium 
tuberculosis (Shenoy et al., 2007), Anabaena sp. PCC 7120 (Fujisawa & Ohmori, 2005) 
and Pseudomonas aeruginosa (Fuchs et al., 2010b). Richter (2002) found that, despite high 
similarity between class III phosphodiesterases, only 13 amino acid residues could be 
identified as absolutely conserved in this class of enzymes (detail of this residues can be 
found in Fig. 6).  These residues appear to be organized in five sequence clusters that 
correspond very well to a sequence signature of the formula D-(X)n-GD-(X)n-GNH[E/D]-
(X)n-H-(X)n-GHXH (where X is any residue, and n is the number of repeats). This is 
known from purple acid phosphatases, which catalyse the hydrolysis of activated 
phosphoric acid esters and anhydrides. They contain a binuclear Fe3+-Me2+ catalytic center 
in their active site (where Me2+ can be occupied by Fe, Zn, or Mn). Imamura et al. (1996) 
identified that the addition of iron ions stimulated the activity of CpdA phosphodiesterase 
of E. coli. Furthermore, X-ray crystallography of M. tuberculosis dimeric phosphodiesterase 
revealed that this protein contain a Fe3+-Mn2+ coordinated in the core active site (Shenoy et 
al., 2007). Thus, although not fully understood, the mechanism of action of class III PDE 
could be similar to the catalytic activity of purple acid phosphodiesterases (Richter, 2002; 
Fuchs et al., 2010b). 
	  
5 Virulence factor regulator (Vfr) of Pseudomonas aeruginosa 
In view of the massive involvement of Crp in the control of metabolic functions in E. coli 
(see above), it has been generally assumed that bona fide orthologues found in many 
eubacterial genomes could fulfil the same role. This notion changed with the discovery in 
1994 of the so-called virulence factor regulator (Vfr), a protein of the opportunistic 
pathogen Pseudomonas aeruginosa that is virtually identical to Crp (67% identity and 91% 
similarity) but lacks functional similarity in respect to the metabolism of this bacterium 
(West et al., 1994; Suh et al., 2002). Moreover, whole transcriptome and proteome analysis 
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of vfr mutants demonstrate that Vfr is a global transcriptional regulator that controls the 
expression of more than 200 genes and at least 60 proteins (Wolfgang et al., 2003; Suh et 
al., 2002). Virtually none of the large list of genes controlled by Vfr is related with 
metabolic traits in this bacterium (Wolfgang et al., 2003). Instead, Vfr exerts a global 
regulatory effect on the production of multiple surface-exposed and secreted virulence 
factors. These include the production of exotoxin A (ETA or ToxA), type IV pili (Tfp), 
flagellar biosynthesis, type III secretion system (T3SS), and the las quorum sensing system 
(including lasR and lasB) which, in turn, controls the expression of hundreds of additional 
genes, including multiple virulence factors (West et al., 1994; Albus et al., 1997; Dasgupta 
et al., 2002; Wolfgang et al., 2003; Kanack et al., 2006). Vfr also exerts a positive 
autoregulation over its own expression and over the promoter of the cpdA gene, encoding a 
cyclic 3’,5’-AMP phosphodiesterase (Fuchs et al., 2010a; Fuchs et al., 2010b). This 
provides a feedback mechanism for controlling cAMP levels and a fine-tuning virulence 
factor expression.  
Vfr acts mainly in concert with cAMP as effector molecule. However, there is some 
evidence that Vfr also can operate though cAMP-independent mechanisms, since cAMP is 
not required for Vfr binding to the lasR promoter in vitro or for activation of the lasR 
promoter activity in vivo (Fuchs et al., 2010b). In P. aeruginosa, two different classes of 
adenylate cyclases produce cAMP (Wolfgang et al., 2003). Most of the cyclic nucleotide is 
produced via the membrane-bound CyaB, a class II adenylate cyclase. The rest of cAMP 
contribution is produced by the cytoplasmic class I CyaA (Danchin, 1993; Wolfgang et al., 
2003). Both ACs respond to environmental signals as calcium concentration and host cell 
contact. Thus, the cAMP-signalling pathway in P. aeruginosa seems to be responding to 
completely different signals in comparison with the metabolic regulation of cAMP observed 
in E. coli (Wolfgang et al., 2003).  
 
6 cAMP-Crp system in Pseudomonas putida 
Bacteria from the genus Pseudomonas were initially described in 1894 by W. Migula as 
Gram-negative, polarly flagellated strictly aerobic rods. Defined in this way, the genus was 
very heterogeneous and did not allow a clear distinction from other Gram-negative 
bacterial groups (Palleroni, 1984; Palleroni, 2008). Therefore, a more precise criteria for 
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classification was defined first with the inclusion of the morphological and phenotypical 
characteristics of the bacterium and later with the implementation of nucleic acid studies 
such as DNA-rRNA hybridization, rRNA oligonucleotide cataloguing, 5S rRNA 
sequencing and finally by 16S rRNA sequencing (Stanier et al., 1966; Moore et al., 1996; 
Palleroni, 2008). This later method, led to the clustering of Pseudomonas within the γ 
subclass of Proteobacteria, now recognized as the class Gammaproteobacteria (Palleroni & 
Moore, 2004). The genus Pseudomonas collectively exhibit a highly diverse range of 
activities: they are extremely versatile metabolically, physiologically and genetically and 
engage in many critically important environmental activities, such as element cycling, 
degradation and recycling of biogenic and xenobiotic organic compounds, food spoilage, 
growth promotion and protection from pathogens of plants (Timmis, 2002). They also 
include important human opportunistic pathogens as P. aeruginosa or plant pathogens as P. 
syringae (Klockgether et al., 2008; Rico et al., 2011).  
Pseudomonas putida is a non-pathogenic bacterium frequently isolated from most temperate 
soils (particularly polluted soils), waters or plant rhizosphere. It is a nutritional opportunist 
par excellence and a paradigm of metabolically versatile microorganisms that recycle organic 
wastes in aerobic compartments of the environment (Timmis, 2002; Martins dos Santos et 
al., 2004). P. putida strain KT2440 is probably the best characterized saprophytic 
Pseudomonad that has retained its ability to survive and function in the environment 
(Nelson et al., 2002; Martins dos Santos et al., 2004). This bacterium is a derivative of P. 
putida mt-2 (originally isolated in Japan by K. Hosokawa as P. arvilla mt-2) that has lost 
the TOL plasmid (Nakazawa, 2002), which encodes genetic pathways for degradation of 
toluene, m- and p-xylene in two catabolic operons (Assinder & Williams, 1990; Ramos et 
al., 1997). The wide metabolic versatility of this bacterium, joint with the capacity to 
degrade xenobiotic compounds, its robustness, rapid growth, the availability of genome 
sequence, ease of handling in the laboratory and its amenability to genetic analysis and 
manipulation, have resulted in P. putida becoming a laboratory workhorse for research on 
soil bacteria and for biotechnological applications such as bioremediation and biocatalysis 
(Jimenez et al., 2002; Timmis, 2002; Nelson et al., 2002; Wackett, 2003).  
Although E. coli Crp was the first transcriptional activator ever described, the information 
in the literature on the homologous protein of P. putida is scarce. Milanesio and colleagues 
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(2011) reported the presence in the genome of P. putida KT2440 of singular orthologues of 
cyaA and crp genes of E. coli, encoding a genuine Adenylate cyclase and cAMP receptor 
protein, respectively. Despite the high degree of identity between CrpP. putida and CyaAP. putida 
with the similar proteins of E. coli, deletion of crp or cyaA in the soil bacterium lead to 
virtually unnoticeable changes in the gross metabolic conditions of the cell, as consumption 
of a battery of carbon and nitrogen sources remained unaltered with respect to the wild-
type P. putida. Moreover, deletion of both genes leads the mutants to acquire a higher 
tolerance to pyrophosphate and protamine as well as a noticeable resistance to colistin. At 
the same time, they lost concurrently the ability to use a large number of dipeptides as the 
only N source and became more sensitive to some antibiotics and antimetabolites 
(Milanesio et al., 2011). Besides the regulatory role in the resistance to antibiotics and toxic 
compounds, crp and cyaA mutations seems to affects other cell surface-related functions as 
cell motility and biofilm formation (Milanesio, 2007). Similarly, Daniels et al. (2010) 
showed that deletion of crp in the solvent-tolerant strain P. putida DOT-T1E did not alter 
markedly the growth of the bacterium in 35 different carbon sources, except when cells 
were grown with L-valine, L-tyrosine, decanoate, propionate and 2-phenylethylamine as 
the only C source. Additionally, they demonstrate that the growth of the crp mutant was 
impaired in cells growing with L-arginine, L-serine and the dipeptides Ala-Thr, Gly-Gln, 
Gly-Gly, Gly-Ser as the only nitrogen source. Finally, Herrera et al. (2012) showed some 
evidences that Crp could be implicated in the co-activation of the phhAB operon (involved 
in the metabolism of phenylalanine and tyrosine) together with the regulator PhhR and 
IHF. 
 
7 The issue at stake 
Fully understanding of the gene regulatory network is essential not only to know how 
bacteria thrive to changing environments in nature, but also to manipulate the gene 
expression in order to take advantage of these organisms for biotechnological purposes. In 
this regard, the metabolic versatility, easy handling in the laboratory, growing availability of 
genetic tools and robustness of Pseudomonas putida, make this organism a powerful agent 
that can be exploited for applications as bioremediation, biocatalysis or as a cell factory. 
Despite the significant role played by Crp proteins in Gram-negative bacteria since its 
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discovery more than 40 years ago, the regulatory duties of cAMP-Crp system in P. putida 
are not understood. Some evidences point out that cAMP-Crp regulation is related with 
cell envelope functions and with the consumption of amino acids as carbon and nitrogen 
source. Notably, it seems that in P. putida this system does not have any relation with the 
generic regulation of carbon and energy metabolism with which this system has been linked 
in enterobacterial organisms. In order to clarify this picture, we have investigated the 
components of the cAMP-Crp system of gene regulation of P. putida from a phenotypic, 
biochemical and genetic point of view. To this end, in this work we have addressed the 
objectives spelled out next. 
  


















To investigate the regulatory mechanisms of the cAMP-Crp system of gene expression 
in Pseudomonas putida, as well as the functions that are subject to it. 
 
Specific objectives: 
1. To characterize genetically and phenotypically the crp, cyaA and cpdA genes of P. 
putida, as well as the protein products of each one of these genes. 
2. To survey the intracellular levels of the second metabolite cAMP in P. putida. 
3. To purify and characterize biochemically the CrpP. putida and its modulation by 
cAMP. 









































Materials and Methods 
 27 
1 Culture conditions and media 
Unless otherwise indicated, the E. coli and P. putida cells were respectively grown at 30°C 
and 37°C in either rich Luria-Bertani (LB) medium or in synthetic mineral M9 medium 
(Sambrook et al., 1989) supplemented with 0.2% of the C-sources indicated in each case 
and with 170 rpm orbital shaking. Additionally, 0.2% (w/v) glucose (Sigma-Aldrich) was 
supplemented to LB for cells grown for MBP-Crp protein purification, according to the 
pMALTM Protein Fusion and Purification System (New England Biolabs) as described 
below. Likewise, 0.0005% of thiamine was added in the specific minimal medium for 
growing the E. coli strains. For solid media preparation, LB and M9 medium were 
supplemented with 1.5% (w/v) of Bacto Agar (Pronadisa). For crp and cyaA 
complementation experiments, indicator plates were prepared by adding 1.0% (w/v) of 
maltose to MacConkey agar base (Miller, 1972). The growth of the bacterial strains on M9 
minimal medium was measured in microtiter plates by turbidometry at 600 nm using the 
Victor 2 multireader spectrophotometer (Perkin Elmer). Where required, isopropyl-β-D-
thiogalactopyranoside (IPTG) was added to the media as inducer of Plac-derived promoters. 
The following antibiotics were added to the cultures to retain plasmids and to select for 
plasmid cointegration, as indicated in each case: ampicillin (Ap) 150 µg/ml, 
chloramphenicol (Cm) 40 µg/ml, kanamycin (Km) 50 µg/ml and tetracycline (Tc) 8 µg/ml. 
 
2 Bacterial strains 
The bacteria used in this work are described in Table 1 with their corresponding genotype. 
All P. putida strains generated were derived from the reference strain KT2440 (Nelson et al., 
2002). The E. coli strains CC118, DH5α and JM109 were used for routine maintenance of 
plasmids. Similarly, the replication of plasmids with the oriR6K suicide origin of 
replication (see Table 2) was done in DH5αλpir and CC118λpir phage lysogen strains of E. 
coli. For crp and cyaA complementation assays, the E. coli strain of reference was W3110 on 
which various mutations were engineered, as will be described. 
  
 28 
Table 1. Description of the Bacterial strains used in this study 
Strain  Description Reference 
Pseudomonas putida strains  
KT2440 Prototrophic, wild-type strain derived of P. putida mt-2 
without pWWO plasmid 
Nelson et al., 
2002 
KT2440 Δcrp KT2440 derivative with a full deletion of crp This work 
KT2440 ΔcyaA KT2440 derivative with a full deletion of cyaA This work 
KT2440 cpdA KmR, RifR. KT2440 derivative carrying a chromosomal 
insertion of the mini-Tn5 Km in PP_4917 (cpdA)  
Duque et al., 
2007 
MAD-1 TelR, RifR KT2442 with a chromosomal insertion of 
mini-Tn5 carrying a xylR, Pu-lacZ fusion 
Fernandez et al., 
1995 
MAD-1 crp  MAD1 derivative, crp::xylE Milanesio et al., 
2011 
MAD-1 cyaA MAD1 derivative, cyaA::km Milanesio et al., 
2011 
Escherichia coli strains  
JM109 F´, traD36, proA+B+, lacIq, Δ(lacZ)M15/ Δ(lac-proAB), 
glnV44 e14-, gyrA96, recA1, relA1, endA1, thi, hsdR17 
Yanisch-Perron et 
al., 1985 
CC118 F-, Δ(ara-leu)7697, araD139, Δ(lac)X74, phoAΔ20, galE, 
galK, thi, rpsE, rpoB, argE(Am), recA1 
Manoil & 
Beckwith, 1985 
CC118λpir λpir phage lysogen of CC118 de Lorenzo & 
Timmis, 1994 
DH5α F-, supE44, ΔlacU169, (φ80 lacZDM15), hsdR17, (rk-
mk+), recA1, endA1, thi1, gyrA, relA 
Hanahan & 
Meselson, 1983 
HB101 Smr, hsdR-M+, pro, leu, thi, recA Sambrook et al., 
1989 
DH5αλpir λpir phage lysogen of DH5α Lab collection 
W3110 Prototrophic, F-, l-, IN (rrnD-rrnE)1, rph-1 Hayashi et al., 
2006 
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W3110 cyaA cyaA deletion derivative of W3110 strain This work 
W3110 crp  crp deletion derivative of W3110 strain This work 
W3110 crp cyaA Double crp cyaA deletion derivative of W3110 This work 
TP610A 
  
F-, thi-1, thr-1, leuB6, pro, lacY1, tonA2l, supE44, λ-hsdR 
hsdM recBC lop-11 lig+ cya-610, spontaneous mutant of 





A brief description of the plasmids employed in this work is listed in Table 2. The suicide 
vector pEMG and its derivatives with R6K origin of replication were used to construct full 
deletions of crp and cyaA genes both in E. coli and P. putida (Martinez-Garcia & de 
Lorenzo, 2011). The plasmid pRK600 was used in bacterial conjugations. The remaining 
plasmids were used as expression vectors. 
 
Table 2. Plasmids employed in this work  
Plasmid Description Reference 
pRK600 CmR; oriV ColE1, tra+mob+ of RK2, helper plasmid for 
mobilization in tripartite conjugations 
Kessler et al., 1992 
pEMG KmR, oriR6K, suicide plasmid with two I-SceI sites 
flanking the lacZα polylinker 
Martinez-Garcia & 
de Lorenzo, 2011 
pSW-1 ApR, oriRK2, xylS, bearing a Pm→I-sceI transcriptional 
fusion 
Wong & Mekalanos, 
2000 
pARCrp8 KmR, oriR6K, suicide pEMG carrying the upstream and 
downstream (TS1-TS2) flanking regions of E. coli crp gene 
This work 
pARCrp9 KmR, oriR6K, suicide pEMG carrying the upstream and 





pJΔcyaA KmR, oriR6K, suicide pEMG carrying the upstream and 
downstream (TS1-TS2) flanking regions of P. putida cyaA 
gene 
This work 
pACBSR CmR, I-SceI and λred recombinase expression plasmid with 
arabinose-inducible expression 
Herring et al., 2003 
pUC18Not ApR, oriV ColE1, cloning vector, polylinker flanked by 
NotI sites 
Herrero et al., 1990 
pVLT31 TcR, oriV RSF1010, broad-host range LacIq/IPTG 
inducible expression vector 
de Lorenzo et al., 
1993 
pGEM-T ApR, multicopy cloning vector Promega 
pVTR-A CmR, oriV PSC101, LacIq/IPTG inducible expression 
cassette inserted as a NotI segment 
Perez-Martin & de 
Lorenzo, 1996 
pCA24N CmR, oriV ColE1 cloning and IPTG-inducible expression 
vector 
Mori et al., 2000 
pCA24N crp CmR, pCA24N inserted with crp gene of E. coli Mori et al., 2000 
pMZC5 TcR, pVLT31 inserted with the P. putida cyaA gene 
sequence  
Milanesio et al., 
2011 
pMZC6 ApR, pUC18Not inserted in the EcoRI/HindIII sites with 
the P. putida cyaA gene cassette of pMZC5 
Milanesio et al., 
2011 
pARV1 ApR, pUC18Not inserted with the P. putida crp gene 
sequence. The encoded Crp is added with terminal 6xHis. 
This work 
pARV2 TcR, pVLT31 bearing with the P. putida crp gene sequence 
assembled in pARV1 
This work 
pARCrp10 TcR, pVLT31 cloned with the EcoRI/PstI fragment of 
pCA24Ncrp that encodes the crp gene of E. coli bearing 
the sequence of an N-terminal 6xHis 
This work 
pARC2 CmR. pVTR-A with its NotI insert altogether replaced by a 
segment bearing the cyaA gene of E. coli expressed through 
its native transcription and translation signals. 
 
This work 
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pDIA5240 ApR, oriV ColE1, expression plasmid for the catalytic 
subunit of the adenylate cyclase gene of Bordetella pertussis 
Ladant et al., 1992 
pARC3 TcR, pVLT31 inserted with the B. pertussis cyaA gene 
amplified from plasmid pDIA5240  
This work 
pARCrp4 ApR, pGEM-T cloned with PCR fragment of P. putida crp 
gene 
This work 
pMAL-C2T ApR, commercial pMAL-c2X (MBP gene fusion vector) 
with Factor Xa cleavage site modified for the thrombin 
protease recognition motif 
Arce-Rodriguez et 
al., 2012 
pARCrp5 ApR, pMAL-C2T harbouring the MBP-Crp fusion protein This work 
pJCD01 ApR, oriColE1, polylinker of pUC19 flanked by rpoC and 
rrnBT1T2 terminators 
Marschall et al., 
1998 
pJCD-Plac ApR, pJCD01 cloned with the lac promoter of E. coli This work 
pSEVA225 KmR, oriRK2, promoterless lacZ, vector for constructing 
transcriptional fusions 
Lab collection 
pSEVA225T KmR, oriRK2, promoterless lacZ, vector for cloning in-
frame translational fusions with lacZ 
Lab collection 
pARPcrp1 KmR, oriRK2, lacZ translational fusion to the crp promoter 
region plus 30 codons from its ATG 
This work 
pARPcyaA1 KmR, oriRK2, lacZ translational fusion to the cyaA 
promoter region plus 30 codons from its ATG 
This work 
pARPcyaA2 KmR, oriRK2, transcriptional fusion of the crp promoter 
region to lacZ 
This work 
 
4 Recombinant DNA techniques 
General methods for DNA manipulation were performed with standard protocols 
described previously (Sambrook et al., 1989). Specific chromosomal segments of P. putida 
and E. coli were amplified from genomic DNA by means of polymerase chain reactions 
(PCR) using 100 ng of genomic DNA or 10 ng of plasmid as templates in a buffer 
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containing 1.5 mM MgCl2, 0.2 mM of deoxynucleoside triphosphates (dNTP), 0.2 µM of 
oligonucleotides (indicated in each case) and 1 U of DNA polymerase. A list of the 
oligonucleotides used in this work is described in Table 3. PCR reactions were run by first 
setting an initial denaturalization 5 min at 94°C followed by 30 cycles of denaturalization 
(1 min, 94°C), annealing (1 min, 58°-64°C), extension (1-3 min at 72°C) and final 
extension (10 min, 72°C). Moreover, when PCR was carried out with high fidelity Pfu 
DNA Polymerase (Promega. Cat. Nº M774A), the extension temperature of reactions was 
increased to 75°C. In some cases, the same PCR reaction was directly run on a small 
amount of bacterial biomass picked from isolated colonies grown on agar plates. Where 
necessary, amplified DNA segments were purified from PCR or agarose gels using the 
QIAEX®II Gel extraction kit of QIAGEN (Cat. Nº 20021). 
Plasmid DNA was extracted from bacterial cells by means of the alkaline lysis protocol 
using the commercial Wizard® Plus SV Minipreps DNA Purification kit (Promega. Cat. 
Nº A1460). The restriction endonucleases for DNA digestion and cloning were purchased 
from New England Biolabs, and used according to the manufacturer indications. Digested 
DNA was ligated by overnight incubation with T4 DNA ligase (Roche. Cat Nº 
10481220001) at 16°C. All the DNA fragments amplified by PCR and cloned in each of 
the plasmids listed in Table 2 were verified by sequencing. 
The mobilization of plasmidic DNA into E. coli cells was carried out by preparation of 
competent cells using the CaCl2 method (Sambrook et al., 1989), or by electroporation as 
described by Wirth et al. (1989). In the case of P. putida, plasmids were incorporated by 
conjugative triparental mating using the E. coli HB101 (pRK600) as helper strain (de 
Lorenzo & Timmis, 1994) or by electroporation of cells previously washed and 
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Table 3. Oligonucleotides designed in this Thesis for PCR amplification. The restriction 
site sequence (in parenthesis) is underlined in each case. 
Name (restriction site) Sequence (5’-3’) 
aaPpucrpUp-F (EcoRI) TTAGGAATTCGCGCTTCTTTCAGCCCACGC 
aaPpucrpUp-R GCCGAGTTGCCCAAGGACTAGCACGAAATCCTGTTCGATATGAC 
aaPpucrpDown-F CTAGTCCTTGGGCAACTCGGC 
aaPpucrpDown-R (SalI) ATACTGTCGACTGCTGCTGCGAGAAACCGGC 
aaECcrpUP-F (EcoRI) TTAGGAATTCCTTCACAATCGACCACATCCTGAC 
aaECcrpUP-R AACGCGCCACTCCGACGGGAGCGCGGTTATCCTCTGTTATAAGC 
aaECcrpDown-F TCCCGTCGGAGTGGCGCGTTAC 
aaECcrpDown-R (SalI) TTAAGTCGACAACCAGTTAAACAATCCGTACCAGAG 
aaECcyaA-F (NotI) AAGGAAAAAAGCGGCCGCCAGTTCAACGACCAGGCCCG 
aaECcyaA-R (NotI) TAAGGAATTTGCGGCCGCGAGCCGCTGCACCAGGTATG 
aaBPcyaA-F (EcoRI) TTACGAATTCTCACACAGGAAACAGCTATGACC 





aaMBPVfr-F (EcoRI) TGTTGAATTCATGGTTGCCTCCGCCCTACC 
aaMBPVfr-R (HindIII) TTATAAGCTTCTAGCGGGTACCGTGGACC 
aaPlac-F AGTCAAAATGCAAGTACTAGCTGATACCGCTCGCCGCAG 
aaPlac-R CTTGCGGCCGCCCAGCTTGGATATC 
5’-PlacIVT (ScaI) AAAAGTACTTGATACCGCTCGCCGCAG 
3’-PlacIVT ATCCAAGCTGGGCGGCCG 
aaPcrp-F (EcoRI) CGAATTCGCAGCTTTCCACTGCCTGGCGCGAC 
aaPcrpTrad-R (BamHI) CGGGATCCATATTGCTTTTGGCGGTGTAGCGGC 
aaPcyaA-F (EcoRI) CGAATTCCAGCGGCACGTCACTGCAGATCACC 
aaPcyaATrad-R (BamHI) CGGGATCCTTCAGATGCAGGAAGCGCGCACGC 
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aaPcyaA-R (BamHI) CGGGATCCTGCGCGCTCGGGCAGGCCATTGAAG 
aaPpuCyaAUp1-F (EcoRI) CGAATTCAACGCCTGTTTCTCACGTTC 
aaPpuCyaAUp1-R GCAGTCTTGTGCTGCGAGTTCAGAAGCTGTGGCGAGTTTAGC 
aaPpuCyaATS2-F2 TGAACTCGCAGCACAAGACTGC 
aaPpuCyaATS2-R (BamHI) CGGGATCCCAGGAGTCTGACTGGATCATGAGC 
 
5 Protein techniques 
Protein extracts were analysed by denaturing-polyacrylamide gel electrophoresis (SDS-
PAGE) with 12-15% acrylamide/bisacrylamide (29:1) gel cast in a Mini-PROTEAN 3 Cell 
system (Bio-Rad), following standard protocols (Sambrook et al., 1989). Whole cells and 
proteins were resuspended in a denaturing buffer containing 60 mM Tris-HCl pH 6.8, 2% 
(w/v) sodium dodecyl sulphate (SDS), 5% (v/v) glycerol, 1% (v/v) β-mercaptoethanol and 
0.005% (w/v) bromophenol blue, and boiled for 5 min prior to loading. Gels were stained 
with a 0.05% (w/v) solution of Coomassie R-250 blue in methanol 50% (v/v) and acetic 
acid 10% (v/v), and de-stained in 10% (v/v) methanol with 7% (v/v) acetic acid. For 
immunodetection of Crp, protein samples were separated by electrophoresis and transferred 
to a polyvinylidene difluoride membrane (PVDF, inmobilon-P, Milipore) using a Trans-
Blot® SD Semi-Dry transfer apparatus (Bio-Rad). Blotted membranes were blocked for 1 h 
at 22 °C (or 16 h 4°C) with 3% (w/v) skimmed milk, 1% (w/v) BSA, in PBS buffer (137 
mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.76 mM KH2PO4, pH 7.4) containing 1% 
(v/v) Tween-20. The blots were subsequently incubated at room temperature in the same 
buffer (without milk) with anti-CRP rabbit serum (kindly provided by H. Aiba) diluted 
1:1000-1:5000 for 1 h. After washing with PBS-Tween buffer, the membrane was 
incubated with an anti-rabbit antibody conjugated with peroxidase, washed again and then 
soaked in a buffer 100 mM Tris-HCl pH 8.0 with 1.20 mM luminol (Sigma), 42 mM 
luciferin (Roche) and 0.0075% H2O2 (v/v). After a 1 min in the dark, the blots were 
exposed to an X-ray film (X-OMAT, Kodak). 
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6 Construction of ∆crp and ∆cyaA strains of P. putida 
The deletion of crp and cyaA genes in P. putida was obtained by the seamless genomic 
deletion system developed by Martínez-García and de Lorenzo (2011). In order to do so, 
the upstream (TS1, ~0.5 kb) and downstream (TS2, ~0.5 kb) flanking regions of P. putida 
crp and cyaA genes were amplified respectively by PCR with primer pairs aaPpucrpUp-
F/aaPpucrpUp-R and aaPpucrpDown-F/aaPpucrpDown-R (in the case of crp), and with 
primer pairs aaPpuCyaAUp1-F/aaPpuCyaAUp1-R and aaPpuCyaATS2-
F2/aaPpuCyaATS2-R (in the case of cyaA). The TS1 and TS2 products flanking each gene 
were then joined together by overlap extension (SOE)-PCR. The resulting ~1 kb TS1-TS2 
fragment was EcoRI/SalI digested and ligated within the same sites of pEMG, generating 
plasmids pARCrp9 for further deletion of crp, and pJΔcyaA for deletion of cyaA. The 
plasmids were mobilized by conjugation to P. putida KT2440 previously electroporated 
with pSW-1 (the latter plasmid codifies the expression of I-SceI endonuclease under the 
control of Pm promoter). The cointegration of pARCrp9 and pJΔcyaA into the KT2440 
chromosome was checked by Km and Ap (500 µg/ml) resistance, and by PCR 
amplification of the TS1-TS2 fragment (~1 kb). The cointegrated clones were grown 
overnight in 2 ml of LB medium with Ap (500 µg/ml) and 15 mM 3-methylbenzoate to 
drive the expression of      I-SceI. Induced cells were plated in LB-Agar and the elimination 
of cointegrated plasmids was confirmed by streak replicates of single colonies in LB and 
LB-Km plates. The KmS clones were selected and analysed by PCR of the TS1-TS2 
fragment (~1 kb) to identify the individual deletion of crp and cyaA genes. Finally, pSW-1 
was diluted by three consecutive subcultures of the cells in liquid LB. The loss of this 
plasmid was confirmed by sensitivity to ampicillin in LB-Ap (500 µg/ml) plates. 
 
7 crp and cyaA complementation assays 
7.1 Construction of single ∆crp and double ∆crp ∆cyaA strains of E. coli 
For construction of a reliable recipient of adenylate cyclases of various origins, we employed 
a cyaA mutant of E. coli K12 strain W3110 in which the AC gene was cleanly deleted from 
the genome with the λred recombinase method (Milanesio et al., 2011). By the same token, 
the crp counterpart of W3110 strain was removed using the scarless deletion system 
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described previously (Martinez-Garcia & de Lorenzo, 2011) with several modifications 
outlined below. The deletion was done initially by PCR amplifying of the ~500 bp 
upstream (TS1) and downstream (TS2) flanking regions of crpE. coli with primer pairs 
aaECcrpUP-F/ aaECcrpUP-R and aaECcrpDown-F/aaECcrpDown-R, respectively. The 
resulting products (TS1 and TS2) were then joined together in a single DNA fragment by 
overlap extension (SOE)-PCR. The resulting ~1 kb TS1-TS2 segment was purified, 
digested with enzymes EcoRI/SalI and ligated into the same sites of pEMG to generate the 
plasmid pARCrp8. This vector was isolated and mobilized by electroporation into E. coli 
W3110 cells, where pARCrp8 cointegration was selected by Km resistance and by PCR of 
TS1-TS2 segment with primers aaECcrpUP-F/ aaECcrpDown-R. 
A group of pARCrp8-cointegrated colonies (KmR) was pooled to prepare competent cells. 
These were transformed with pACBSR, which drives the expression of I-SceI under the 
control of an arabinose-dependent promoter (Herring et al., 2003). The KmR and CmR 
colonies were grown in 1ml of LB with 0.2% arabinose for one hour, whereupon the 
chloramphenicol was added to a final concentration of 40 µg/ml. The culture was grown 
another 7 hours and plated in LB-Agar. Replicates from individual colonies were patched 
in LB and LB-Km plates, to ascertain the loss of cointegrated plasmid. The KmS clones 
were analysed by colony PCR as described previously to check the deletion of entire crpE.coli 
gene. Finally, the pACBSR was eliminated by three consecutive subcultures in liquid LB 
and the loss of the plasmid was confirmed by sensitivity to chloramphenicol in LB-Cm 
plates. This procedure was also applied to the W3110 ∆cyaA strain for generating a double 
deletion host ∆crp ∆cyaA (Table 1). Both W3110 crp and W3110 crp cyaA strains of E. coli 
were proved to be Mal- (white colonies) in MacConkey-Maltose plates (not shown). 
7.2 Design of expression vectors for crp and cyaA genes of E. coli and P. putida 
The ∆crp and ∆cyaA strains of E. coli W3110 described above were employed along with 
the cAMP-hypersensitive strain E. coli TP610A (Hedegaard & Danchin, 1985) for 
complementation of the cAMP-Crp dependent maltose consumption phenotype of E. coli 
in MacConkey agar plates as explained in the text. The plasmids used in these experiments 
were constructed as follows. In order to create a control cyaA+ plasmid, the cyaA coding 
region of E. coli was amplified along with 500 bp upstream and 200 bp downstream with 
primers aaECcyaA-F and aaECcyaA-R to ensure inclusion of its own native promoter and 
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terminator sequences. The flanking NotI sites generated with the same primers were then 
employed to clone the corresponding DNA segment (~3,260 bp) in NotI-digested pVTR-A 
vector (Table 2), thereby originating plasmid pARC2, which expresses cyaAE.coli through its 
native transcription and translation signals. A second cyaA+ control plasmid was engineered 
to express the catalytic domain of the adenylate cyclase of Bordetella pertussis (i.e. residues 1 
to 399 of its AC protein). The corresponding DNA segment was amplified from plasmid 
pDIA5240 (Ladant et al., 1992) using primers aaBPcyaA-F and aaBPcyaA-R, which add 
terminal EcoRI and HindIII restriction sites to the amplified sequence. The resulting 
fragment of ~1.2 kb was then digested with these enzymes and cloned into the matching 
sites of IPTG-inducible expression vector pVLT31, giving rise to pARC3. To complete this 
set of expression vectors, the pMZC5 (low copy number) and pMZC6 (high copy number) 
were used as test plasmids encoding the adenylate cyclase of P. putida under the control of 
Ptac and Plac promoters, respectively (Milanesio et al., 2011).  
To complete the entire set of complementation experiments, a crpP.putida-expression plasmid 
was constructed as well. In this case, primers vfrMyc1 and vfrHis-C were used to amplify 
the promoterless crpP.putida coding region adding a 6xHis sequence at its 3’ end, being the 
whole segment flanked by EcoRI-HindIII sites. The corresponding segment was then 
ligated to pUC18Not as an EcoRI/HindIII insert (originating pARV1) and subsequently 
recloned in expression vector pVLT31, generating plasmid pARV2. Additionally, a broad 
host range plasmid expressing the crpE. coli was constructed anew by recloning the 731 bp 
EcoRI-PstI insert of pCA24Ncrp (Mori et al., 2000) in vector pVLT31 (de Lorenzo et al., 
1993). The resulting construct, named pARCrp10, expresses a 6xHis-tagged version of  
crpE. coli, which is functionally indistinguishable from the tag-less version. Other relevant 
plasmids used for complementation assays are listed in Table 2. 
 
8 Dictyostelium discoideum cAMP chemotaxis biosensor  
To examine whether E. coli or P. putida could secrete compounds able to elicit a 
chemotactic response in the slime mold Dictyostelium discoideum (Saran et al., 2002) 
cultures of E. coli W3110 and P. putida MAD1 were prepared in M9 minimal medium 
with 0.2% fructose as C source and let grow overnight to ensure complete consumption of 
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the C source.  Cells were then spun down, the supernatants filtered through a 0.45 µm 
pore membrane and the filtrates concentrated 5X in a Speed Vac. Additionally, starvation 
was induced in D. discoideum by first growing the mold in nutrient medium and then 
resuspending the cells for 16 hours in QQ2 phosphate buffer (KH2PO4 16.5 mM; K2HPO4 
3.9 mM; pH 6.2) devoid of nutrients. The suspension of D. discoideum was then adjusted 
to a concentration of 2.5 x 108 cells/ml, and 1 µl of the culture was placed in a QQ2-Agar 
plate. To induce chemotaxis, 1 µl of the concentrated supernatants of P. putida and E. coli 
were placed in the QQ2-Agar plate at 4 mm distance from the D. discoideum spot (1 µl of 
starvation-induced culture). The plates were then incubated in a humid chamber for 3 
hours at 22°C, after which formation of dendritic shapes towards the attractant at the rim 
of the D. discoideum population was considered an indication of chemotaxis and recorded 
with a Leica MZFLIII stereoscope. 
 
9 Quantification of cAMP produced by E. coli and P. putida 
In order to quantify the intracellular levels of cAMP in E. coli and P. putida and to measure 
the concentrations of this compound in the medium, the wild-type and cyaA strains 
indicated in each case were grown on M9 minimal medium with 1% glycerol as sole C 
source (excepting E. coli ∆cyaA, which was grown on glucose) until late exponential phase. 
The biomass of 10 ml of each of the samples was then collected by fast centrifugation 
(14000 rpm, 30 sec) and the pellets immediately frozen in liquid N2 to quench the cell 
metabolome (Hajjaj et al., 1998). cAMP was extracted from cells by vortexing the biomass 
with 25 mM ammonium acetate buffer (pH 7.2) in 60% ethanol at 70°C for 1 min, 
followed by incubation another 1 min at 70°C as described previously (Fuhrer & Sauer, 
2009). The supernatants were pooled, dried in the Speed Vac and resuspended in 100 µl of 
MilliQ water. For quantification of extracellular cAMP, the supernatants of 10 ml cultures, 
were likewise frozen, lyophilized and resuspended in 0.5 ml of water. cAMP standards were 
prepared ranging 0.1-10 µg/ml to 10 µg/ml, their concentrations being accurately 
determined with a Varian Prostar 210 high-performance liquid chromatography system 
coupled to a Varian 1200L Triple Quadrupole MS. cAMP analyses were made following 
the Klawitter method (Klawitter et al., 2007). To this end, samples were run on a Aqua 
C18 125A column  (250 mm × 4.6 mm × 5 µm; Phenomenex), using a 50% mixture of 
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methanol and an aqueous buffer containing 10 mM dibutylamine, 15 mM ammonium 
acetate and 5% methanol as the mobile phase at a flow-rate of 0.5 ml/min. The injection 
volume was 10 µl and the HPLC-ESI-MS analysis was performed in the negative-ion mode.  
 
10 Protein purification 
10.1 Production and purification of MBP-CrpP. putida fusion protein  
Preparation of CrpP. putida for detailed in vitro characterization required the implementation 
of a dedicated expression platform to produce it in large amounts, as an homogenous 
species and in a fully active form. To this end, the crp gene of P. putida KT2440 was 
amplified from genomic DNA with oligonucleotides aaMBPVfr-F and aaMBPVfr-R, 
which enter EcoRI and HindIII restriction sites to the 5’ and 3’ ends of the corresponding 
coding sequence, respectively. The resulting PCR fragment was cloned into pGEM-T 
cloning vector and the insert verified by DNA sequencing, thereby generating plasmid 
pARCrp4. In parallel, pMAL-C2T plasmid was then digested with EcoRI and HindIII to 
ligate the crpP. putida -bearing segment of pARCrp4 bound by the same sites, what resulted in 
plasmid pARCrp5. Owing to its pedigree, this construct bears an in-frame fusion of malE 
(encoding the maltose binding protein, MBP) and crpP. putida genes separated by 18 
nucleotides that encode the thrombin target sequence Leu-Val-Pro-Arg-Gly-Ser (Arce-
Rodriguez et al., 2012). To produce the MBP-Crp fusion protein, plasmid pARCrp5 was 
transformed into E. coli W3110 ∆crp. Transformants were inoculated in 800 ml of LB and 
the culture grown at 37°C to an OD600 = 0.5. At that point, 0.5 mM IPTG was added and 
the incubation continued for 2 hours for inducing expression of the plasmid-encoded 
protein. Cells were spun down and resuspended in 50 mM Na phosphate buffer pH 7.0, 
200 mM NaCl and 1X of a protease inhibitor cocktail (Roche Applied Science), followed 
by disruption in a French press (Thermo, Electron corporation). Soluble extract was 
separated from cellular debris by centrifugation and then passed through an amylose-resin 
column (New England Biolabs). After washing the resin with 15 volumes of the same 
buffer, the recombinant MBP-Crp fusion protein was eluted by with the same solution as 
above containing 10 mM maltose. The MBP-Crp eluted fractions were analysed by SDS-
PAGE (see below), and those which produced an apparently homogeneous protein band 
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were pooled, concentrated and its containing buffer was changed to 50 mM Na phosphate 
Buffer pH 7.0, 200 mM KCl, 20% (v/v) glycerol using a 50 kDa molecular weight-cutoff 
centrifugal filter device (Millipore). Final concentration of the thereby prepared MBP-CrpP. 
putida was 7.1 mg/ml, as determined by Bradford assay using BSA as standard (Sigma-
Aldrich).  
10.2 Cleavage of MBP-Crp and purification of CrpP. putida 
For purification of native-size CrpP. putida, 16 mg of the MBP-CrpP. putida fusion protein were 
first dialyzed against PBS for 8 hours at 4°C, followed by cleavage with 170 U of thrombin 
protease (Amersham Biosciences) for 15 hours at 22°C in a volume of 5 ml. The reaction 
mixture was then passed during 6 hours through 1.6 ml of P11 phosphocellulose resin 
column (Whatman) previously equilibrated with PBS, with a constant flux of 0.5 ml/min. 
The resin was extensively washed with 35 ml PBS for eluting the MBP moiety away of the 
column-bound MBP-less Crp product. After such an elution was complete, the CrpP. putida 
protein was recovered by washing with the same buffer with 500 mM KCl. The CrpP. putida –
containing fractions were pooled, concentrated in a 10,000 MWCO centricon device 
(Millipore) and dialyzed as before against 50 mM Na phosphate buffer pH 7.0, 250 mM 
KCl, 0.67 mM DTT, 25% (v/v) glycerol and finally stored at -80°C. Purified Crp protein 
was > 95% pure as determined by SDS-PAGE, and its concentration determined to be 1 
mg/ml by RC DC Protein Assay (Bio-Rad). To verify the integrity of the purified protein, 
the molecular mass of CrpP. putida was determined by mass spectrometry using a PCS-4000 
SELDI-TOF platform (BioRad). 
10.3 Production and purification of apo-CrpP. putida 
To purify large amounts of cAMP-less apo-CrpP. putida, we introduced several modifications 
to the protocol described above. First, the pARCrp5 was transformed in the E. coli W3110 
∆crp ∆cyaA double mutant (instead of the ∆crp strain) and this strain was grown in 800 ml 
of M9-glucose minimal medium to an OD600 = 0.5. This avoids the production cAMP by 
the cells and the presence of this metabolite in the culture media. Then, the cells were 
induced, collected and disrupted following the earlier protocol, and the cAMP-less MBP-
CrpP. putida was purified using the amylose-resin column like previously. Approximately 12 
mg of apo-MBP-Crp were extensively dialyzed against PBS during 8 hours at 4°C. Prior to 
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cleaving, 0.5 mM DTT was added to the fusion protein and then it was overnight digested 
with 240 U of thrombin at 22°C. Immediately after cleavage, the protein mixture was 
passed through 5 ml of PBS-equilibrated P11 phosphocellulose resin column (Whatman) 
and washed extensively with 80 ml of PBS. Elution of purified CrpP. putida was achieved by 
washing the resin with PBS + 500 mM KCl. The eluted fractions were pooled, 
concentrated and dialyzed against 50 mM Na phosphate buffer pH 7.0, 250 mM KCl, 
0.67 µM DTT and 20% (v/v) glycerol. The concentration of the protein was calculated to 
be 0.8 mg/ml as determined by absorbance at 280 nM, using a calculated extinction 
coefficient of 11.46 x 103 M-1 cm-1 (ProtParam tool, ExPASy server; Gasteiger et al., 2005). 
 
11 Analytical ultracentrifugation of CrpP. putida 
The effects of cAMP in the oligomerization state of Crp were examined in an XLI 
analytical ultracentrifuge (Beckman-Coulter Inc.) equipped with a UV-visible absorbance 
detection system. Sedimentation velocity experiments were performed in an An-50Ti rotor 
at 20°C and 48 krpm loaded with samples of CrpP. putida at a concentration of 49.6 µM 
prepared in 10 mM Na2HPO4, 1.76 mM KH2PO4, 137 mM NaCl and 102.7 mM KCl 
(pH 7.4), with or without 1 mM cAMP. Sedimentation profiles were recorded every 3 min 
at 285 nm. The corresponding sedimentation coefficient distributions c(s) were calculated 
by least squares boundary modelling of sedimentation velocity data using SEDFIT v12.1 
software (Schuck, 2000). From these analysis, the experimental sedimentation coefficients 
were corrected to standard solvent conditions (pure water, 20°C, and infinite dilution) 
using the SEDNTERP program (Laue et al., 1992) for generating the corresponding 
standard-values (S20,W). Sedimentation equilibrium experiments were made in the same 
instrument under identical Crp concentration and buffer conditions as the sedimentation 
velocity assays before, but at a lower temperature (10°C) in order to prevent formation of 
protein aggregates. In this case, measurements were taken at 11 and 14 krpm using short 
ultracentrifugation columns with 85 µl of protein sample. After the equilibrium scans, a 
high-speed centrifugation run (43 krpm) was done to estimate the corresponding base-line 
offsets. The corresponding buoyant signal average molecular weights of the samples were 
determined by fitting the experimental data to the equation that characterizes the 
equilibrium gradient of an ideally sedimenting solute using Hetero-Analysis software (Cole, 
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2004). The average molecular weight of Crp was determined from the experimental 
buoyant molecular weight values using the partial specific volume (0.733 ml/g) calculated 
from the amino acid composition using SEDNTERP (Laue et al., 1992). 
 
12 Partial proteolysis of CrpP. putida 
For partial proteolysis assay, 3.8 µg of the pure Crp were incubated in a 20 µl reaction 
mixture containing 50 mM Na phosphate buffer pH 7.0, 250 mM KCl and (where 
indicated) 1 mM cAMP for 10 minutes at 22 °C. Digestion reactions were started by 
addition of 30 ng of proteomics grade trypsin (Sigma-Aldrich), followed by incubation for 
0-45 min at 37°C. Proteolysis was stopped by addition of 5 µl of 5X protein loading dye 
[300 mM Tris-HCl pH 6.8, 5% (w/v) SDS, 5% (v/v) β-mercaptoethanol, 50% (v/v) 
glycerol, 0.025% (w/v) bromophenol blue]. Samples were boiled 5 min at 100°C, 
electrophoresed in a 15% SDS-polyacrylamide gel and the products stained with Coomasie 
blue as described before. 
 
13 Isothermal titration calorimetry (ITC) 
Initially, the isothermal titration calorimetry experiments were performed with the MBP-
CrpP. putida fusion protein as follows. Prior to experiments, the MBP-CrpP. putida solution was 
exhaustively dialyzed in 50 mM K phosphate buffer pH 7.0, 150 mM KCl and 20% (v/v) 
glycerol. Next, the protein was passed through a 0.22 µm pore size filter and its 
concentration was accurately determined by UV absorption spectroscopy using a calculated 
extinction coefficient of 7.8 x 104 M-1 cm-1 at 280 nm (ProtParam tool, ExPASy server; 
Gasteiger et al., 2005). Putative effector molecules were prepared by dissolving pure 
compounds (cAMP, cGMP and AMP) in filtered dialysis buffer described above to 
homogenize ligand and protein solvent. MBP-CrpP. putida was diluted to 10 µM and 1.4 ml 
of protein was titrated in a VP microcalorimeter (MicroCal, Northampton, MA, USA) at 
25°C. First titration was carried out with a single 1.6 µl injection of diluted ligands at 350 
µM, followed by subsequent injections with 4.8 µl of the same compounds. The mean 
enthalpies measured from injection of the ligands into the protein-less buffer were 
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subtracted from raw titration data. The mean enthalpies measured from the injection of 
ligand into buffer were subtracted from the raw titration data, prior to curve fitting using 
the One Binding Site model of the MicroCal (Northampton, MA, USA) version of 
ORIGIN. From the values obtained for KA and enthalpy (ΔH), the dissociation constant 
KD was determined (KD = 1/KA) as well as the changes in the free energy (ΔG) and entropy 
(ΔS) using the equation (ΔG = -RTlnKA = ΔH - TΔS, where R is the universal molar gas 
constant and T the absolute temperature. 
Additionally, ITC experiments with purified CrpP. putida devoid of cAMP (apo-CrpP. putida) 
and the cyclic nucleotides (cAMP and cGMP) were carried out on the basis of the previous 
procedures, but changing the salt concentration of the reaction buffer to 250 mM KCl (in 
the case of the interaction with cAMP) and incorporating 1 mM DTT to the reactions. 
This modification was incorporated in order to stabilize the protein in solution and provide 
a reduced environment for its Cys residues. The titrations were conducted with 8-7 µM of 
apo-CrpP. putida and 200 µM of cyclic nucleotides, following the same protocol described 
above. 
 
14 Electrophoretic mobility shift assays (EMSA) 
To prepare a DNA fragment suitable for gel retardation experiments a 330 bp sequence 
containing the lac promoter (Plac) of E. coli was amplified from plasmid pUC18Not 
(Herrero et al., 1990) with primers aaPlac-F and aaPlac-R. The resulting DNA product, 
that retains the EcoRI site of pUC18Not polylinker, was digested with this restriction 
enzyme and 3’-end labelled by filling the overhanging end of the cleaved site with [α-32P] 
dATP and Klenow DNA polymerase (Sambrook et al., 1989). Binding reactions were 
performed in 10 µl of TRRG buffer [20 mM Tris-HCl pH 7.5, 50 mM KCl, 2 mM β-
mercaptoethanol, 10% (v/v) glycerol] containing 0.5 ng end-labelled Plac probe, 5 µg BSA, 
5 ng poly deoxyinosinic-deoxycytidylic acid (poly dI-dC) and increasing amounts of Crp 
ranging 10-250 nM. Where indicated, 100 µM of cAMP or 100 µM cGMP were added to 
the reactions. Samples where incubated 20 minutes at 30°C and electrophoresed in a 4% 
non-denaturing polyacrylamide gel prepared in 0.5X TBE buffer (Sambrook et al., 1989). 
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DNA band shifts were observed by autoradiography of the dried gels on X-ray film (Konica 
Minolta). 
 
15 In vitro transcription assays (IVT) 
For preparation of a supercoiled DNA template for the in vitro transcription (IVT) 
experiments, the lac promoter (which has the CrpE. coli binding site 
5’TAATGTGAGTTAGCTCACTCAT3’ centered around position -61.5) was amplified as 
a 391 bp fragment from pUC18Not (Herrero et al., 1990) with primers 5’-PlacIVT and 3’-
PlacIVT, leaving the region of interest flanked by an upstream ScaI blunt restriction site 
and a downstream EcoRI (this latter restriction site is within the pUC18Not polylinker). 
This was then cloned into vector pJCD01 previously digested with SmaI and EcoRI, 
resulting in plasmid pJCD-Plac (Table 2), which was employed as DNA template in all 
subsequent in vitro transcription experiments. IVT cocktails were set in 50 µl volumes 
containing 50 mM Tris-HCl pH 7.5, 50 mM KCl, 10 mM MgCl2, 1 mM BSA, 10 mM 
DTT, 1 mM EDTA, 30 nM of purified Pseudomonas putida RNA polymerase holoenzyme 
prepared as described in Johansson et al. (2008); the kind gift of C. Alvarez), 5 nM of 
pJCD-Plac and Crp ranging 10-100 nM as specified. Where indicated, such a mixture was 
pre-incubated at 30°C for 10 minutes with 0.5 mM cAMP or cGMP prior to transcription 
start. Transcription was initiated by adding a cold ATP, CTP, and GTP 500 µM (each) 
and UTP 50 µM premixed with 2.5 µCi of [α-32P]UTP (3,000 mCi/mmol). Following a 
15 min incubation of the samples at 30°C, transcription reactions were stopped with 50 µl 
of a STOP mixture 50 mM EDTA, 350 mM NaCl, and 0.5 mg/ml of carrier tRNA. 
mRNA was precipitated with absolute ethanol at -20°C and resuspended in loading buffer 
containing 7 M urea, 1 mM EDTA, 0.6 M glycerol, 0.9 mM bromophenol blue and 1.1 
mM xylene cyanol. The resulting samples were electrophoresed on a denaturing 7 M urea–
4% polyacrylamide gel, and visualized by autoradiography. 
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16 β-galactosidase assays 
16.1 Construction of plasmids encoding lacZ transcriptional and translational fusions 
To measure the activity of crpP. putida promoter (Pcrp), a lacZ translational fusion was 
generated by PCR amplification of the 400 bp upstream the start codon (ATG) of crp plus 
the DNA sequence codifying its 30 first amino acids. PCR was conducted with 
oligonucleotides aaPcrp-F and aaPcrpTrad-R, which enter EcoRI and BamHI restriction 
sites. The corresponding 492 bp fragment was digested and cloned into the same sites of 
pSEVA225T, thereby generating the in-frame fusion of Crp (30 first aa) with LacZ. The 
resulting plasmid was named pARPcrp1. Following this line, a translational fusion of cyaAP. 
putida promoter (PcyaA) was created by PCR amplification of a 492 bp DNA fragment that 
includes the 400 bp upstream the ATG of cyaA gene plus the sequence of its 30 first 
codons. The reaction was carried out with oligonucleotides aaPcyaA-F and aaPcyaATrad-R, 
which enter EcoRI and BamHI sites respectively. The resulting fragment was EcoRI/BamHI 
digested, and cloned in the same sites of pSEVA225T to create pARPcyaA1. Finally, in 
order to compare the transcription and translation of cyaA P. putida promoter, a transcriptional 
fusion of this gene was constructed by PCR amplifying the 400 bp upstream the cyaA start 
codon, using oligonucleotides aaPcyaA-F (EcoRI) and aaPcyaA-R (BamHI). The resulting 
~0.4 kb fragment was EcoRI/BamHI digested and subsequently cloned in the pSEVA225T 
previously cleaved with the same restriction nucleases, generating pARPcyaA2. All these 
plasmids were transformed in the P. putida strains KT2440 wt, KT2440 ∆crp and KT2440 
∆cyaA. 
16.2 Measurements of the β-galactosidase activity 
The LacZ activity of the Pcrp translational fusion was analysed as follows. First, a single 
colony of the different P. putida strains transformed with pARPcrp1 was grown in 10 ml of 
M9 minimal medium supplemented with Km and 0.2% (w/v) of the carbon source 
indicated in each case (glucose, fructose or succinate). The cells were cultured until 
exponential growth phase and then, a small aliquot was obtained to measure the β-
galactosidase activity according to the classical method described by Miller (1972).  The 
same protocol described above was initially employed to measure the β-galactosidase 
activity of the PcyaA translational fusion, however the enzymatic values obtained were too 
low. Thus, we decided to measure the LacZ activity of PcyaA translational and 
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transcriptional fusions with the ultra-sensitive Galacto-Light PlusTM commercial system 
(Applied Biosystems). According with manufacturer specifications, this method 
incorporates a chemiluminiscent substrate for β-galactosidase and luminescence enhancers 
that make the system more sensitive to low amounts of enzyme. The methodology 
employed was as follows: one single colony of the different P. putida strains (transformed 
either with pARPcyaA1 or pARPcyaA2) was cultured in 10 ml of M9 minimal medium 
supplemented with Km and 0.2% (w/v) of carbon source. When the cultures reach 
exponential phase, 500 µl of cells were taken into an Eppendorf tube and pelleted by 
centrifugation 2 min at 14,000 rpm. The bacteria were then resuspended in 200 µl of lysis 
buffer [100 mM potassium phosphate pH 7.8, 0.2% (v/v) Triton X-100], subjected to two 
freeze-thaw cycles and centrifuged 1 min at 14.000 rpm to separate the cell debris. 20 µl of 
lysed supernatant were incubated with 80 µl of reaction buffer (100 mM sodium phosphate 
pH 8.0, 1 mM MgCl2 and 1X Galacto-Plus® chemiluminiscent substrate) previously 
distributed in 96-well plates. The reaction was incubated in the dark for 30 minutes, after 
which 125 µl of Sapphire-IITM light emission accelerator were added. The reactions were 
incubated 1 min in the dark and finally the luminescence was recorded in the Victor 2 
multireader spectrophotometer (Perkin Elmer). 
 
17 RNA-seq transcriptome analysis of crp and cyaA mutants in P. putida  
17.1 Culture conditions, RNA isolation and rRNA removal 
An overnight culture of P. putida strains KT2440 and its crp and cyaA mutants were grown 
in M9 medium supplemented with 0.2% glucose as carbon source. A 1/100 dilution of this 
pre-culture was used to inoculate 10 ml of the same medium with each strain. Bacteria were 
grown to mid-exponential phase (OD600~0,4-0,5) and then, transcription was halted by 
adding 1.25 ml of Stop solution [5% (v/v) saturated phenol dissolved in pure ethanol]. The 
samples were transferred to a Falcon tube and after vortexing, cells were spun down by 
centrifugation 20 min at 4000 and 4°C. Next, the cell pellets were resuspended in 300 µl 
of TE buffer (10 mM Tris-HCl, 1 mM EDTA; pH8) containing 2 mg/ml lysozyme, 
followed by incubation at 37°C for 10 min. 100 µl of cell lysates were transferred to an 
Eppendorf tube and RNA isolation was carried out using the miRNeasy kit from QIAGEN 
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(Cat. Nº 217004) according to manufacturer specifications. RNA concentration was 
checked in the NanoVue spectrophotometer (GE Healthcare) and the quality of the RNA 
samples was assessed by running a small aliquot on the 2100 Bioanalyzer (Agilent 
Technologies). Further removal of 23S, 16S and 5S ribosomal RNA (rRNA) was 
performed with Ribo-Zero™ rRNA Removal Kit (Epicentre; Cat. Nº RZNB1056), 
following manufacturer protocols. 
17.2 RNA-Seq using the Illumina Genome Analyzer 
Samples were prepared in accordance with the Illumina RNA preparation protocol (Part # 
1004898 Rev. A from September 2008) by the sequencing company BGI (Hong-Kong, 
China; http://www.bgisequence.com/eu/). The experimental pipeline of the RNA 
sequencing protocol is shown in Fig. 5. Briefly, the rRNA-free mRNA was chemically 
disrupted in shorter fragments by adding Fragmentation Buffer. Taking these cleaved RNA 
fragments as templates, random hexamer-primers and reverse transcriptase were used to 
synthesize the first-strand of cDNA. Following, the second-strand of cDNA was 
synthesized using GEX Second Strand Buffer, dNTPs, RNase H and DNA polymerase I. 
Short cDNA fragments were purified with QiaQuick PCR extraction kit and resolved  
 
 
Fig. 5. Pipeline of the RNA-seq protocol for transcriptome analysis using the Illumina 
sequencing platform. BGI company (Hong-Kong). 
 48 
with EB buffer to perform the end-repair protocol. This method converts the overhangs 
into blunt ends using T4 DNA polymerase, Klenow DNA polymerase and dNTP mix. The 
3' to 5' exonuclease activity of these enzymes removes 3' overhangs and the polymerase 
activity fills in the 5' overhangs. Next, addition of  ‘A’ bases to the 3’ end of the blunt 
phosphorylated DNA fragments was achieved using the polymerase activity of Klenow 
enzyme. ‘A’-tailing prepares the DNA fragments for ligation to the adapters (using T4 
ligase), which have a single ‘T’ base overhang at their 3' end. After adapters adhesion, total 
DNA was run on an agarose gel to select a size range of fragments. DNA of suitable size 
(approximately 200 bp) was purified and used as template for downstream enrichment, 
carried out by PCR reaction with two primers that anneal to the ends of the adapters. 
Finally, after validation of the DNA size with Bioanalyzer (Agilent Technologies), the 
library was sequenced using the Illumina HiSeq™ 2000 apparatus. 
17.3 Bioinformatic analysis 
Images generated by sequencers were converted into nucleotide sequences by base calling, 
thereby generating the raw data (stored in FASTQ format). Nevertheless, the information 
contains reads from the adapters, unknown nucleotides or low quality reads that could 
negatively affect the following bioinformatics analysis. Therefore, these dirty reads were 
discarded to generate the clean data.  Once filtered, the clean reads were mapped to P. 
putida KT2440 reference genome and to reference gene sequences using SOAP2 (Li et al., 
2009). Proportions of clean reads mapped to the genome and to individual genes provided 
an overall assessment of the sequencing. The expression of annotated genes was evaluated 
with two parameters. First, the percentage of each gene covered by reads (or gene coverage) 
was calculated. This value equals the ratio of the number of bases in a gene covered by 
unique mapping reads to number of total bases in that gene. Second, the expression of 
individual genes was calculated as RPKM (Reads Per kb per Million mapped reads; 
Mortazavi et al., 2008) using the following formula: 
 
The RPKM value measures the expression of a gene as a function of the number of reads 
that uniquely align to that gene (C), divided by the total number of reads that align to all 
RPKM =  10
6C     
NL/103 
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genes (N) and the number of bases in the CDS of the evaluated gene (L). The RPKM 
method eliminates the influence of gene length and sequencing discrepancy over the 
calculation of gene expression. Therefore, the calculated gene expression can be directly 
used for comparing the difference of gene expression among samples. 
17.4 Estimation of Differential Expression 
The identification of differentially expressed genes between two samples was carried out 
with a rigorous algorithm that calculates the p-value on the basis of reference The 
significance of digital gene expression profiles (Audic S, Genome Research). Additionally, the 
FDR (False Discovery Rate) was calculated as a statistical method to test and correct the 
results obtained with the p-value. In practical terms, FDR is the expected false discovery 
rate between the differential expression of every gene (Benjamini & Hochberg, 1995). The 
smaller the FDR value and the larger the fold change ratio between two samples, the greater 
the difference in the gene expression between them will be. In our analysis, we filtered the 
differentially expressed genes with FDR ≤ 0.001 and fold change ratio larger than 2.8, 
using the FIESTA v1.0 viewer (Oliveros, 2007). Positive fold change values represent the 
upregulated genes in the Δcrp and ΔcyaA strains with respect to the wild-type P. putida 
KT2440 reference, while negative values represent the downregulated genes of the mutants 
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1 The cAMP-Crp system of Pseudomonas putida and its components. 
The genome of P. putida KT2440 encodes singular orthologues of the cyaA and crp genes 
of E. coli, which are respectively annotated with the gene loci PP_5222 and PP_0424 
(Nelson et al., 2002), http://cmr.jcvi.org). By looking on its genome context, it is 
noteworthy that both crpP. putida and cyaAP. putida occur as stand-alone genes, and therefore, it is 
likely that they are expressed as a single cistron and thus unrelated to the adjacent ORFs 
(Fig. 6A and Fig. 6B). To complete this picture, a third partner of the system was recently 
characterized in Pseudomonas aeruginosa. This is the CpdA protein, a class III 
phosphodiesterase encoded by the cpdA gene that catalyses the hydrolysis of cAMP to 5’-
AMP (Fuchs et al., 2010b). In order to find a similar gene (or genes) codifying a putative 
phosphodiesterase in P. putida strain KT2440, we searched in the genome of this 
bacterium for genes whose protein products were similar to the CpdA of P. aeruginosa 
(PA4969) using the protein BLAST tool of the NCBI (http://blast.ncbi.nlm.nih.gov). Only 
one protein of 266 aa residues results to be highly similar to CpdAP. aeruginosa, with 54% 
identity and 69% similarity. This positive match was previously annotated as the Icc 
protein, encoded by the gene locus PP_4917 (Fig. 6C; Nelson et al., 2002). Unlike crp and 
cyaA, that are transcribed as stand-alone genes, cpdA is co-transcribed in a large operon that 
include the parC and parE genes, encoding respectively the A and B subunits of a type IV 
DNA topoisomerase. We aligned the amino acid sequence of the Icc protein with the 
homologous phosphodiesterases of E. coli and P. aeruginosa and we find that the 13 
residues that are absolutely conserved in all the class III phosphodiesterases are also present 
in the protein encoded by PP_4917 (Figure 6D). Yet, given to the sequence analysis, we 
decided to rename this protein as CpdAP. putida that stands for cAMP-phosphodiesterase. 
Despite the similarity of crpP. putida and cyaAP. putida with the respective orthologues of E. coli, 
these genes have not been related with any catabolite repression phenomena (Rojo, 2010). 
Therefore, we decided to construct full deletion mutants of crp and cyaA in the P. putida 
strain KT2440 to decipher whether the loss of these genes causes a perturbation in the 
metabolism of carbon sources in this bacterium. In addition, a mini-Tn5 insertion mutant 
in the cpdA phosphodiesterase was obtained from the P. putida KT2440 collection (Duque 
et al., 2007). These strains, together with wild-type KT2440, were grown on M9 minimal 




      
Fig. 6. Components of the cAMP-Crp system of P. putida KT2440. The upper panel 
shows the genome context of (A) crp (PP_0424), (B) cyaA (PP_5222) and (C) cpdA 
(PP_4917). Note that crp, cyaA and cpdA map in very different locations of the P. putida 
chromosome. While crp and cyaA are transcribed as stand-alone genes, cpdA is co-
transcribed with other genes in a large operon. (D) Alignment of CpdA proteins from E. 
coli W3110, P. aeruginosa PAO1 and P. putida KT2440. The symbols below each 
alignment indicate fully conserved (*), strongly similar (:) and weakly similar (.) amino 
acids. The 13 residues framed in blue correspond to conserved aa between all the class III 
phosphodiesterases (Richter, 2002), all of which were conserved in the CpdAP. putida 
counterpart. The alignment was generated with the online ClustalW2 software (Larkin et 
al., 2007). 
 
conditions: on the one hand, succinate is a gluconeogenic substrate, while glucose is 
consumed through the Entner–Doudoroff (ED) pathway (del Castillo et al., 2007). 

















E. coli          MESLLTLPLAGEARVRILQITDTHLFAQKHEALLGVNTWESYQAVLEAIRPHQHEFDLIV 60 
P. aeruginosa    -MSRHSNTPATDASVLLVQLSDSHLFAEDGARLLGMDTAHSLEKVVERVAREQPRIDLIL 59 
P. putida        -MS----PPDQSRPVHVVQLTDAHLFADPAGSMLGLKTRDSLRHVLAQVRREQPLVDLLL 55 
                   *    .   .  * ::*::*:****:    :**:.* .* . *:  :  .*  .**:: 
 
E. coli          ATGDLAQDQSSAAYQHFAEGIASFRAPCVWLPGNHDFQPAMYSALQDAGISPAKRVFIGE 120 
P. aeruginosa    ATGDVSQDGSLDSYTRFRRLSAPLDAPLRWFAGNHDEREPMQRATEGS--DLLEQVVDVG 117 
P. putida        CTGDLSQDASVASYEAFRELTAPFAVPTRWLPGNHDEAQVMAQVAP----ELVQAVTDIG 111 
                 .***::** *  :*  * .  *.: .*  *:.****    *  .      .  : *     
 
E. coli          QWQILLLDSQVFGVPHGELSEFQLEWLERKLADAPERHTLLLLHHHPLPAGCSWLDQHSL 180 
P. aeruginosa    NWRVVLLDSSIPGAVPGYLEEDQLELLRRAIDSAGERFLLVSFHHHPVPIGSDWMDPIGL 177 
P. putida        AWRVVMLNTAVQGATHGFLQDDQLAVLEAALKEAGERHCLVCFHHQPVDIGCAWIAPIGL 171 
                  *::::*:: : *.  * *.: **  *.  : .* **. *: :**:*:  *. *:   .* 
 
E. coli          RNAGELDTVLAKFPHVKYLLCGHIHQELDLDWNGRRLLATPSTCVQFKPHCSNFTLDTIA 240 
P. aeruginosa    RNPQALFDLLAPYPQVRCLLWGHIHQEFDRQRGPLRLLASPSTCVQFAPGSSDFTLDRLA 237 
P. putida        RNAQALFDIVEGYPQVRALLWGHVHQEWDEVREGRRLLATPSTCIQFAARSEDFQVSEEH 231 
                 **.  *  ::  :*:*: ** **:*** *      ****:****:** . ..:* :.    
 
E. coli          PGWRTLELHADGTLTTEVHRLADTRFQPDTASEGY 275 
P. aeruginosa    PGYRWLRLHDDGRLETGISRVDDVVFEVDYDTAGY 272 
P. putida        PGYRWLRLHADGRLETGVERALDFEVQLDFDSPGY 266 
                 **:* *.** ** * * : *  *  .: *  : ** 
(D) 
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pathway, and then it can continue through glycolysis or be metabolized though the ED 
pathway (Velazquez et al., 2004; Chavarria et al., 2012).  
By surveying the results shown in Fig. 7, the first noticeable feature is that there is virtually 
no difference in the growth rate between the wild-type strain and the ∆crp or ∆cyaA 
mutants in the three carbon sources tested. This is, however, in accordance with similar 
results obtained by Daniels et al. (2010) and also with the phenotypic microarray developed 
by Milanesio et al. (2011), in which the mutation of both genes have no effect on the 
catabolism of carbon sources employed. Therefore, it seems that crp and cyaA mutations 
have little, if any, influence in the general utilization of carbon sources in this bacterium. In 
contrast, the cpdA mutant shows a considerable growth rate decrease when it is grown on 
succinate. This was also evident, though a lesser extent, in the presence of glucose.  
 
 
Fig. 7. Growth curves of cAMP-Crp system mutants on three different carbon sources. 
Triplicate cultures of P. putida KT2440 wild-type, ∆crp, ∆cyaA and cpdA- strains were 
grown at 30°C in M9 medium supplemented with 0.2% (w/v) of the carbon substrate 
specified in each case: (A) Succinate; (B) Glucose and (C) Fructose. The OD600 was 
recorded each hour in microtiter plates with the Victor 2 multireader spectrophotometer 




































































































No effects were observed when the mutant grew on fructose. A similar behaviour was 
detected in a cpdA mutant of P. aeruginosa when grown on rich LB medium, but not on 
succinate or glucose. However, this phenomenon is not related with the increase of 
intracellular cAMP due to cpdA mutation and in contrast, it is attributed to another 
unknown function (Fuchs et al., 2010b). 
 
2 Functional characterization of P. putida crp and cyaA gene products. 
2.1 The crp gene of P. putida and its encoded transcriptional regulator 
Fig. 6A shows the genomic context of the unique crp ortholog that can be found in the 
genome of P. putida KT2440 with the gene locus PP_0424 (http://cmr.jcvi.org). It is 
worth to mention that despite 62% of identity and 80% of similarity of the encoded 
product with the Crp protein of E. coli (Fig. 8), PP_0424 was not annotated as such in the 
primary analysis, but as the cyclic nucleotide-binding transcriptional regulator Vfr, due to 
the similarity with the Virulence Factor Regulator of P. aeruginosa. Moreover, as  indicated 
in Fig. 8, CrpP.putida bears a considerable conservation of the functional traits of the E. coli 
counterpart. These include the helix-turn-helix (HTH) domain for DNA binding as well as 
a suite of residues needed for cyclic nucleotide monophosphate binding. Despite the 
conservation of amino acids, the differences in the residues observed in the HTH motif of 
the three different Crp orthologues, suggest that the DNA sequences bound by each of the 
proteins are likely to be similar, but not necessarily identical. It is also noteworthy that the 
only change observed in the cNMP interaction pocket of the CrpP.putida is a substitution of 
the Ser residue in position 128 of CrpE.coli for a Thr in the equivalent 133 amino acid of P. 
putida. This change is important, because a S128T exchange in CrpE.coli is known to make 
the mutant responsive to both cAMP and cGMP (Lee et al., 1994; Youn et al., 2008), 
raising the possibility that CrpP.putida uses both cAMP and cGMP as effectors. Additionally, 
the CrpP.putida sequence maintains the 3 regions identified in the E. coli protein responsible 
for interacting with various sites in the surface of the RNAP: AR1, necessary for activation 
of class I and class II promoters through direct contacts with the α-CTD; AR2, required for 
class II promoters via interactions with the α-NTD and the optional surface AR3, which 
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seems to interact with residues 590-600 of the region 4 of σ70 (Busby & Ebright, 1999; 
Zhou et al., 1993; Zhou et al., 1994; Parkinson et al., 1996; Niu et al., 1996; Rhodius & 
Busby, 2000a) . Taken together, all these similarities indicate that this protein is equivalent 
to the reference CrpE.coli transcription factor.  
 
 
Fig. 8. Comparison between the Crp homologues in E. coli, P. aeruginosa and P. putida. 
The image shows the corresponding amino acid sequences along with an indication of the 
key functional ingredients as follows.  :  residues involved in cAMP binding (West et al., 
1994). : stabilization of cAMP binding (West et al., 1994).  : residues involved in 
Crp-RNAP interactions: AR1, AR2 and AR3 (activating regions; Niu et al., 1996; Busby 
& Ebright, 1999; Zhou et al., 1993).  : Helix-turn-helix, DNA binding motif 
(Parkinson et al., 1996; West et al., 1994). : Residues that make direct contact with the 
DNA base edges (Parkinson et al., 1996; West et al., 1994).  : Residues that make 
contact with the phosphates of DNA (Parkinson et al., 1996). AR1 consist of the residues 
156-164 of Crp. The side chain of Thr158 seems to be the most important for its 
function (it is conserved in P. putida and P. aeruginosa). AR1 is necessary for activation of 
class I and class II promoters through direct interaction with the α-CTD (Zhou et al., 
1993; Busby & Ebright, 1999). AR2 is a specific determinant consisting of residues 
His19, His21, Glu96 and Lys101, which are necessary for the activation of class II 
promoters. In both P. putida and P. aeruginosa, the His21 is substituted for an Arg. 
Moreover, His19 is substituted in P. putida by a Glu residue. AR2 is proposed to interact 
with the α-NTD after initial binding of the RNAP to promoter DNA (Niu et al., 1996; 
Busby & Ebright, 1999). AR3 is the product of a non-native Crp-RNAP interaction at 
class II promoter and it is created by substitution of Lys52 by a neutral or negatively 
charged residue. Interestingly, both in P. putida and P. aeruginosa there is a Glu at 
position 52 that probably makes functional the AR3 determinant as well (Niu et al., 
1996; Busby & Ebright, 1999; Rhodius & Busby, 2000b) 
Results 
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2.2 In vivo functional complementation of CrpE. coli by CrpP.putida  
The comparison of the different Crp homologues described before suggests that CrpP.putida 
could operate in a similar fashion than its counterpart in E. coli. To verify this hypothesis, 
we examined the ability of crpP.putida, expressed at various levels, to restore the Crp-
dependent maltose utilization in E. coli strains with relevant genotypes (Fig. 9). The 
reference condition is that of row 1, in which E. coli W3110 ∆crp was transformed with a 
high-copy number plasmid (pCA24Ncrp, Table 2) which expressed crpE.coli under the 
control of a heterologous IPTG-inducible promoter. This strain was streaked along with 
the corresponding insert-less vector on the fermentation-indicative MacConkey medium 
supplemented with 1.0% (w/v) maltose. As shown in Fig. 9a (row 1), crpE.coli restored the 
Mal+ phenotype even when expressed through the escape of the vector promoter in the 
absence of induction. Fig. 9a (row 1) also shows that IPTG addition was toxic to the host 
∆crp E. coli strain. The situation was similar, but not identical, when crpE.coli was replaced by 
crpP.putida in the same test system (Fig. 9a, row 2). When cloned in a multicopy plasmid 
(pARV1), the gene from P. putida complemented the lack of crp in the host E. coli strain. 
Finally, when expressed from a low copy inducible vector (pARV2), IPTG addition was 
required to attain the same effect (Fig. 9a, row 3). These simple experiments revealed 2 
important facts. First, the CrpP.putida maintains the same RNAP-activating abilities of the E. 
coli protein; second, the P. putida Crp recognizes its same target DNA sequence. Yet, the 
affinity for the target could be lower (or expression of CrpP.putida lesser in the heterologous 
host), since overproduction of CrpP.putida was required to fully complement the phenotype 
under examination (compare rows 1 and 3 of Fig. 3). In any case, the function of the 
adenylate cyclase was necessary to bring about complementation, because crpP.putida failed to 
restore maltose metabolism in a double ∆crp ∆cyaA strain of E. coli, even when 
overexpressed (Fig. 3b; see below). This is an important detail, because other members of 
the same Crp-FNR family of proteins have been claimed to work independently of cAMP 
(e.g. Clp from Xanthomonas campestris complements an E. coli crp cyaA double mutant; de 
Crecy-Lagard et al., 1990). Furthermore, Vfr of P. aeruginosa seems able to operate in some 




Fig. 9. Complementation analysis of P. putida crp and cyaA genes in E. coli. (a) 
Expression of crp genes in E. coli ∆crp. The host strain was transformed with plasmids 
bearing either the crp genes from E. coli (EC) or P. putida (PP) or their corresponding 
insert-less vectors as indicated. Each transformant was then patched onto MacConkey-
maltose agar plates with or without 1 mM IPTG and incubated at 37°C. The red colour 
of colonies indicates maltose consumption and thus complementation of the crp-less 
phenotype. Note the toxicity exerted by crpE.coli when over-expressed from pCA24Ncrp. 
(b) Expression of crpP.putida in a double ∆cyaA ∆crp E. coli mutant. High-copy number 
crpP.putida-encoding plasmid pARV1 was transformed by itself in the host indicated or                  
co-transformed with cyaAE.coli+ plasmid pARC2 in the same strain. Rescue of the Mal+ 
phenotype is observed only when the ∆cyaA ∆crp strain contains the two compatible 
plasmids (pARV1 + pARC2). 
 
2.3 In vivo functional complementation of CyaAE. coli by CyaAP. putida  
As mentioned above, there is only one recognizable cyaA gene in P. putida. It corresponds 
to PP_5222 (Fig. 6B), which encodes a putative protein of 951 amino acids belonging to 
the class I of soluble adenylate cyclases (http://www.uniprot.org/uniprot/Q88CF9; 
Danchin, 1993). As it was the case with crpP.putida, the cyaAP. putida gene stands alone in the 
chromosome, apparently encoding a mono-cistronic RNA. Thus, we implemented the 
same complementation assay as before to test production of cAMP borne by its cognate AC. 
First, the cyaAP. putida-borne plasmid pMZC5 (Table 2) was transformed and induced in the 
∆cyaA mutant of E. coli. As controls we employed cyaAE. coli (pARC2) as well as the gene 
encoding the catalytic subunit of the adenylate cyclase of Bordetella pertussis (pARC3), 
which belongs to a different class of AC (Ladant et al., 1992). The results of these 
experiments are shown in Fig. 10, rows 1-3. While the controls cyaAE.coli and cyaAB. pertussis 
were able to complement the lack of cyaA in the maltose metabolism test in E. coli,       
cyaAP. putida failed to do so. This indicates that cAMP was not produced in E. coli, at least to 
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the levels needed to bring about complementation. On the other hand, crpP.putida had no 
effect on the lack of maltose consumption of a ∆cyaA ∆crp strain of E. coli, even when 
overproduced with IPTG (Fig. 9B; see above). These results established that CrpP.putida does 
not function separately from cAMP, at least in this type of essays.  
 
 
Fig. 10. Detection of cAMP production mediated by the CyaA product of P. putida. The 
∆cyaA strain of E. coli W3110 (rows 1-3) and the cAMP-hypersensitive host E. coli 
TP610A (rows 4-7) were transformed with plasmids bearing the cyaA genes from E. coli 
(EC), P. putida (PP) and B. pertussis (BP) along with their corresponding insert-less 
vectors as specified. Transformants were patched onto MacConkey-maltose plates with or 
without 1 mM IPTG and incubated as in Fig. 9. Note that plasmid pMZC5 expressing 
cyaAP. putida failed to restore the Mal+ phenotype in the conventional ∆cyaA host (row 2) 
but it complemented the phenotype in the specialized strain TP610A (row 5). In the 
same conditions, the cyaAB. pertussis variant is toxic for the same hypersensitive host (row 6). 
Observe also that overproduction of crpP.putida (pARV1) cannot complement E. coli 
TP610A, even if overproduced (row 7), indicating that in no case CrpP.putida can work 
independently of cAMP for activation of the maltose operon.  
 
Taken together, these data led to a paradox. On one hand, CrpP.putida needs cAMP to work 
in vivo. On the other hand, we were unable to detect the production of cAMP by the 
complementation of the cyaA strain of E. coli W3110 with a plasmid expressing the 
orthologous gene of P. putida (Fig. 10; rows 1-3). One possibility is that a small molecule 
different from cAMP is the one that actually elicits the regulatory ability of the protein. As 
mentioned above, cGMP could be a candidate to this, but no recognizable guanidyl 
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reactions is probably insignificant (Linder, 2010). A simpler explanation could be that 
CrpP.putida has a higher affinity for cAMP in a way that allows the active cAMP-Crp complex 
to form with lower intracellular concentrations of the effector. Thus, the levels of the cyclic 
nucleotide produced by the CyaAP. putida could be significantly lower. To examine this 
possibility, we resorted to the use of a specialized strain of E. coli (named TP610A; 
Hedegaard & Danchin, 1985), which is hyper-sensitive to cAMP. This means that a lower 
intracellular concentration of cAMP is sufficient to restore the phenotypes derived from the 
loss of cyaA. As before, this strain was separately transformed with expression plasmids 
bearing cyaAE.coli and cyaAB. pertusis as controls, and cyaA P. putida as test case (Fig. 10, rows 4-6). 
Using this experimental setup we were finally able to observe that overexpression of      
cyaAP. putida in this E. coli strain restored maltose metabolism, suggesting that cAMP was 
indeed produced albeit in very small amounts. On the other hand, overproduction of 
crpP.putida in the same strain had no effect (Fig. 10, row 7), thereby confirming the absolute 
requirement of cAMP for the protein to exert its regulatory role. An interesting sidelight of 
the results shown in Fig. 5 is what appears to be a strong threshold effect of intracellular 
cAMP concentrations. For instance, comparison of rows 3 and 6 (cells transformed with a 
cyaAB. pertusis expression plasmid) revealed that residual production of the protein in the non-
induced cells complemented the lack of cyaA in cAMP-hypersensitive strain E. coli TP610A 
but not in the ordinary counterpart E. coli W3110 cyaA. We did not find intermediate 
phenotypes on MacConkey-maltose plates as judged by colony coloration, thereby pointing 
out that complementation of cAMP deficit was an all-on or all-off occurrence. This could 
explain that a lesser level of expression of cyaAP. putida in a standard ∆cyaA E. coli strain 
completely fails to complement the mutation (Fig. 10, row 2), whereas the same construct 
fully reinstates the phenotype in a cAMP hypersensitive strain (Fig. 10, row 5).  
2.4 In vivo complementation with both Crp and CyaA of P. putida and E. coli 
The complementation experiments described above, suggest that the adenylate cyclase of P. 
putida may have a very low activity, unable to provide enough intracellular concentrations 
of cAMP for activation of the indigenous Crp of E. coli in the W3110 cyaA strain, but still 
capable to produce sufficient cyclic nucleotide to complement the same loss in the cAMP 
hypersensitive TP610A strain. However, it remains unclear whether the level of the cyclic 
nucleotide produced by its cognate CyaA is enough to activate CrpP. putida. To test this 
Results 
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important detail, we co-transformed a double ∆cyaA ∆crp mutant of E. coli with 
compatible plasmids expressing al possible combinations of crp and cyaA genes from either 
E. coli or P. putida and examined the restoration of the Mal+ phenotype in MacConkey-
maltose plates as shown in Fig. 11. The complementation assays indicated that the only 
combinations that produced red colonies in MacConkey plates were those expressing 
CyaAE. coli  / CrpP. putida  and  CyaAP. putida  / CrpP. putida. This indicated that the levels of cAMP 
generated by CyaAP. putida were too low for activation of the protein in E. coli, but sufficient 
enough to turn on that of P. putida.  
 
 
Fig. 11. Complementation of the ∆cyaA ∆crp double mutant of E. coli with combinations 
of plasmids encoding crp and cyaA genes of E. coli and P. putida. Each of the pairs of 
constructs indicated or their insert-less vectors were transformed in strain E. coli W3110 
∆crp ∆cyaA and plated onto maltose-MacConkey medium with or without 1 mM IPTG, 
as shown. The right panel corresponds to wild-type E. coli W3110 co-transformed with 
empty pVLT31/pVTR-A (top) or pVLT31/pUC18Not (bottom) as controls. The red 
colour of the colonies (maltose consumption) indicates complementation of both ∆cyaA 
and ∆crp. Note the toxicity of overexpressing the crp gene of E. coli, which reduces or 
even inhibits growth of the corresponding host cells. 
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Taken together, the whole set of complementation experiments shown in this section 
indicate two important things: [i] CrpP. putida is an active transcriptional regulator which acts 
in concert with cAMP, and [ii] CyaA P. putida produces low levels of cAMP, insufficient to 
activate the Crp of E. coli but enough to promote the activation in CrpP.putida, suggesting in 
turn that this protein could have a higher affinity for this cyclic nucleotide. These 
possibilities will be revisited later. 
 
3 Concentrations of cyclic AMP in P. putida 
3.1 Detection of cAMP by the slime mold Dictyostelium discoideum 
On the basis of the results above we set out several approaches to detect the concentrations 
of cAMP in P. putida. To first detect the release of this compound by bacterial cells, we  
 
 
Fig. 12. D. discoideum cAMP chemotaxis test in vivo. Overnight cultures of the sensor 
slime mold in either nutrient-rich (allowing vegetative state) or starvation media (QQ2 
buffer, see Materials and Methods), were plated in the presence of the compound 
specified in each case and observed with a stereoscope. Colonies previously grown in 
starvation media endowed D. discoideum with a chemotactic motion towards cAMP 
(panels 1-4). For the experiments, the same starved colonies were laid in the proximity of 
concentrated supernatants of either E. coli or P. putida cultures (panels 5 and 6). Note 
dendritic extensions towards the E. coli sample in contrast with the maintenance of the   
D. discoideum colony rim in the case of P. putida.  
starved vegetative 
buffer cAMP 
Buffer QQ2                               cAMP 









set up an in vivo biosensor based on the chemotaxis of Dictyostelium discoideum towards 
cAMP, which is a differentiation signal for starved cells of this slime mold at concentrations 
in the nM-µM range (Saran et al., 2002). The corresponding experiment is shown in Fig. 
12.  As a control, the upper panels 1 and 2 of Fig. 12 display how the rims of starved and 
vegetative colonies of D. discoideum were affected differently by cAMP: starved cells 
presented a dendritic growth towards the compound that was not apparent in vegetative 
cells. A closer view of such colonies (Fig. 12, panels 3 and 4) allowed differentiating the 
presence or absence of cAMP in the neighbourhood. These conditions were used for testing 
the release of compounds from E. coli and P. putida cells that are able to elicit the same 
chemotactic response. The panels 5 and 6 of Fig. 4 indicated that this was the case for E. 
coli but not for P. putida, thereby confirming that the production and/or excretion of 
cAMP was negligible under these conditions. 
3.2 Quantification of the intracellular and extracellular levels of cAMP 
In order to corroborate the qualitative cAMP detection results obtained with the D. 
discoideum biosensor, we developed a sensitive HPLC-ESI-MS analytical procedure to test 
and quantify the levels of cAMP both in the culture supernatant and the cytoplasm of 
bacteria grown on minimal-glycerol medium up to the late exponential phase of growth 
(see Materials and Methods). Note that the quenching method was adapted for full 
recovery of the analyte at the moment of cell harvest. As a control of sensitivity we 
processed equivalent samples from wild-type and cyaA strains of E. coli. It is noteworthy to 
point that E. coli wild-type cells were cultured in the conditions where they are expected to 
produce high amounts of cAMP (Joseph et al., 1982). Conversely, the ∆cyaA strain of E. 
coli was cultured in 0.2% (w/v) glucose due to its inability to grow on glycerol as carbon 
source. The results of these experiments are shown in Fig. 13. As anticipated, cAMP was 
found both intracellularly (~180 pmol/OD600/ml) and in the external medium (~1100 
pmol/OD600/ml) of the cultures of wild-type E. coli. In contrast, the cyaA strain gave cAMP 
signals below the calibration range of the method (> 43 pmol/OD600/ml). Unexpectedly, we 
were unable to detect any cAMP signal coming from P. putida cells collected and processed 
with the same protocol. This was somewhat surprising because -as mentioned above- the 
complementation experiments indicated that CrpP. putida needs cAMP for its regulatory 
function, at least in the heterologous test system employed. 
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Fig. 13. Analysis of cAMP production by E. coli and P. putida. Levels of cAMP were 
determined in both cells (IN) and supernatants (OUT) of wild-type E. coli W3110 and P. 
putida MAD-1 strains along with their cyaA counterparts by HPLC-ESI-MS as explained 
in Materials and Methods. The limit of quantification (LOQ) of the method employed 
was in the range of 43 pmol/OD600/ml as indicated. 
 
4 The cyaA gene is transcribed, but it is not efficiently translated in P. putida 
The complementation experiments with the cyaAP. putida in the TP610A cAMP-
hypersensitive strain of E. coli and the experiments for detection and quantification of 
cAMP in P. putida, confirm that the production of the cyclic nucleotide in this bacterium 
is lower compared to E. coli, at least in the conditions tested. This low intracellular cAMP 
production could be caused inter alia by low transcription/translation rates of the cyaA gene 
and/or by a deficient enzymatic activity of the adenylate cyclase itself. We know by 
genome-wide transcriptomic analysis of P. putida, that the adenylate cyclase mRNA is well 
transcribed (Yuste et al., 2006). However, the close examination of the 5’ UTR of P. putida 
cyaA mRNA in Fig. 14A reveals that the putative Shine-Dalgarno (SD) motif of this gene is 
suboptimal according to the GGAGG core that makes direct contact with the anti-SD 
sequence of the 16S rRNA (Ma et al., 2002). Then, the lack of a good quality SD sequence 
could prevent proper formation of the translation initiation complex and therefore, the 
cyaA mRNA will not be efficiently translated into the adenylate cyclase enzyme. To test this 
hypothesis, we constructed plasmid-borne translational (pARPcyaA1) and transcriptional 
(pARPcyaA2) fusions of the cyaAP. putida promoter (PcyaA) with lacZ. Initially we quantified 
the activity of cyaA’-‘lacZ translational fusion employing the classical β-galactosidase assay 
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described by Miller (1972). However, the values obtained were too low to be significant (i.e. 
<15 Miller Units, not shown). Therefore, we resorted to the ultra-sensitive Galacto-Light 
PlusTM commercial system. Fig. 14B shows the corresponding LacZ activity for both  
 
 
Fig. 14. Transcription and translation of the cyaA gene of P. putida. (A) Overview of the 
translation initiation region of P. putida and E. coli cyaA genes. The putative Shine-
Dalgarno (SD) sequence of each gene is underlined and base-paired with the 3’ anti-SD 
of the 16S rRNA. The start codons are annotated in red colour. Note the non-canonical 
TTG start codon of E. coli cyaA. (B) β-galactosidase activity of translational (green) and 
transcriptional (blue) fusions of PcyaA promoter with lacZ. Plasmids encoding the 
promoter fusions were transferred to the indicated P. putida strains and the enzymatic 
activity was measured by the Galacto-Light PlusTM method in cultures grown on 
succinate, glucose or fructose as carbon source. The basal level of promoterless 
plasmids (pSEVA225T and pSEVA225) was respectively subtracted from measured LacZ 
activity. The experiments were run in triplicates. (C) Zoom-in of the β-galactosidase 
activity of P. putida KT2440 with the translational fusion of PcyaA (pARPcyaA1) 
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translational and transcriptional fusions of PcyaA, measured in the P. putida strains of 
cAMP-Crp system (KT2440, ∆crp and ∆cyaA) grown on different carbon sources 
(succinate-glucose-fructose). The results reveal a remarkable difference amongst the 
transcription and the translation levels of the cyaAP. putida gene, the transcriptional activity of 
the promoter being between 10-30 fold-change higher than the translational activity in the 
conditions tested. As observed, the deletion of crp and cyaA did not affect the activity of the 
promoter, conversely to E. coli where the cAMP-Crp complex binds to the P2 promoter of 
cyaAE.coli and down-regulates its expression (Mori & Aiba, 1985; Aiba, 1985). This was later 
confirmed by an electrophoretic mobility shift assay (EMSA) of a ~200 bp end-labelled 
DNA fragment comprising the upstream region of cyaAP. putida gene and purified CrpP. putida. 
Even at protein concentrations as high as 5 µM, CrpP. putida was not able to retard noticeably 
the electrophoretic migration of the PcyaA DNA probe despite of the presence of cAMP 
(not shown).  
Interestingly, the growth on fructose seems to increase slightly the transcription of the 
PcyaA promoter (blue bars in Fig. 14B) compared to glucose or succinate. However, 
inspection of the translational fusion of this promoter in Fig. 14C reveal that the cyaA’-
‘lacZ β-galactosidase activity is higher in glucose than in the other carbon sources. As the 
translational fusion demonstrate better the real amounts of CyaA protein that cells are 
producing (in comparison with the transcriptional fusion that reveals the mRNA levels of 
cyaA), we can assume that the translational levels of CyaAP. putida are higher in glucose than 
in succinate or fructose, albeit this difference is slight. 
 
5 The production of CrpP. putida is slightly increased in cells growing on glucose. 
Following the same approach used for PcyaA analysis, a plasmid-encoded lacZ translational 
fusion including the crp promoter (Pcrp) and the sequence of its 30 first amino acids was 
constructed. This vector was mobilized to P. putida KT2440 and its crp/cyaA mutants, and 
the β-galactosidase activity was measured in three different carbon sources. The results 
depicted in Fig. 15, show that the β-galactosidase levels of the crp’-‘lacZ translational fusion 
are high (from ~250 to ~900 Miller Units) and slightly controlled by the carbon source in 
which the cells are growing. Although this difference is not striking, it seems that the 
translational activity of crp’-‘lacZ fusion is higher in cells growing on glucose than that for 
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the cells growing on succinate or fructose. Remarkably, expression of cyaA’-‘lacZ fusion is 
also higher when cells are growing on glucose as only carbon and energy source (Fig. 14C). 
Once again, the deletion of crp and cyaA genes in P. putida did not have effect in the 
transcription/translation of crp. This last observation result was corroborated also by EMSA 
with purified CrpP. putida and a DNA probe containing 200 bp of the promoter region of crp. 
Even at protein concentrations as high as 5 µM, CrpP. putida failed to bind and retard the 
electrophoretic migration of the promoter (not shown). 
 
 
Fig. 15. β-galactosidase activity of a translational crp’-‘lacZ gene fusion. Plasmid 
pARPcrp1 (upper panel) was transferred to the indicated P. putida strains and the 
enzymatic activity measured by the classical ONPG hydrolysis method (Miller, 
1972) in cultures grown on succinate, glucose or fructose as carbon source. The 
basal activity of promoterless pSEVA225T was subtracted from measured LacZ activity. 
The experiments were run in triplicates.  
 
In summary, the information collected until now demonstrates in first instance that cAMP 
is necessary for CrpP.putida activity in E. coli. Nevertheless, cAMP production in P. putida was 
neither detected by the D. discoideum biosensor or by the intracellular/extracellular 
quantification of the cyclic nucleotide. Moreover, complementation assays in the E. coli 




































































its cognate adenylate cyclase is very low (Fig. 10), in part because the cyaAP. putida mRNA is 
well transcribed, but hardly translated. This state of affairs raises the hypothesis that 
CrpP.putida has a high affinity for cAMP. Hence, lower intracellular concentrations of cAMP 
could be enough to activate Crp and promote transcription of Crp-controlled promoters in 















Part of this Chapter has been published as: 
Arce-Rodríguez, A., Durante-Rodríguez, G., Platero, R., Krell, T., Calles, B. and de 
Lorenzo, V. (2012), The Crp regulator of Pseudomonas putida: evidence of an unusually 
high affinity for its physiological effector, cAMP. Environ Microbiol 14: 702-713. 
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1 Purification of CrpP.putida as an MBP-fusion protein 
Initial attempts to purify Crp as an N-terminal His-tagged fusion were completely 
unsuccessful due to the low amounts of soluble protein expressed in the cells, which tended 
to precipitate and degrade rapidly (not shown). Hence, we considered an alternative 
method based in the maltose binding protein of E. coli (MalE or MBP), which has been 
shown to promote the correct folding of heterologous polypeptides added to its C-terminus 
in a large number of cases and to maintain the resulting fusion in a soluble and active form 
(Bach et al., 2001; Kapust & Waugh, 1999). We thus cloned the structural crpP.putida gene in 
the optimized vector pMAL-C2T as described in Materials and Methods. This vector is 
derived from pMAL-C2X (New England Biolabs), but it has been improved by exchanging 
the Xa protease-cleavage site (Ile–Glu–Gly–Arg) located at the boundary between the MBP 
domain and the protein of interest by that of thrombin (Leu–Val–Pro–Arg–Gly–Ser; Arce-
Rodriguez et al., 2012).  
 
 
Fig. 16. Expression and purification of MBP-CrpP.putida in E. coli. (A) Rescue of Mal+ 
phenotype in MacConkey-maltose agar was tested in W3110 Δcrp strain of E. coli 
transformed with empty pMAL-C2T and with plasmids encoding Crp (pARV1) and 
MBP-Crp fusion protein (pARCrp5). Utilization of maltose was observed by red-
coloured colonies. (B) Purification steps of MBP-Crp fusion protein in an amylose-resin 
column. The first lane (-IPTG) correspond to the un-induced control, while the protein 
extracts correspond to: T: total proteins (before lysis); S: soluble fraction; I: Insoluble 
fraction (cell debris); FT: flow-trough (unbound proteins) and W: Washes of the resin 
with equilibration buffer. Eluates were obtained with equilibration buffer plus 10 mM 
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Prior to proceed with any purification, we ensured that the resulting MBP-Crp protein was 
active, for which we transformed E. coli W3110 ∆crp with the plasmid pARCrp5 that 
encodes the fusion. As shown in Fig. 16A, such plasmid complemented the lack of crp in 
maltose MacConkey medium as well as the MBP-less counterpart. On these bases, we 
moved on to express and recover the MBP-CrpP. putida fusion as explained in the Materials 
and Methods section (Fig. 16B). The purification strategy employed, was suitable to obtain 
large amounts of a high-purity protein and to overcome the problem of the insolubility 
observed with the His-tagged version of CrpP. putida. 
 
 
Fig. 17. Cleavage of MBP-CrpP. putida and purification of MBP-less CrpP. putida. Samples 
from protein purification steps were analyzed by 12% denaturing PAGE stained with 
Coomassie blue (left panel, lanes 1-3) or subject to Western blot with rabbit anti-CrpE.coli 
serum (right panel, lanes 4-6). Lanes 1 and 4: MBP-Crp fusion protein. Lanes 2 and 5: 
thrombin cleavage of MBP-Crp. Lanes 3 and 6: purification of free Crp from digested 
MBP-Crp with phosphocellulose resin. 
 
Next, the fusion protein was submitted to digestion with thrombin (Fig. 17, lane 2) for 
releasing the CrpP.putida moiety of the fusion. This was then captured in a phosphocellulose 
column by the pseudo-affinity of some DNA binding proteins for this kind of resin (Ward 
et al., 1991) and recovered at high-salt as an apparently homogenous protein (Fig. 17, lane 
3). This passover could be identified as the Crp protein by Western blot of the denaturing 
gel with anti-CrpE. coli rabbit serum (Fig. 1B, lanes 3-6). However, the purified Crp run in 
the gel with an apparent molecular mass of ~32 kDa, which diverges from the 24.571 kDa 
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predicted for the protein on the basis of its amino acid sequence (ProtParam tool, ExPASy 
server; Gasteiger et al., 2005). To clarify this, we submitted the purified protein to SELDI 
TOF mass spectrometry, which non-only confirmed the virtual homogeneity of the CrpP. 
putida preparation, but also fixed its mass in 24.6 kDa. 
 
2 CrpP.putida is a dimeric protein that undergoes a conformational change upon 
cAMP binding 
The assays with pure CrpP. putida protein started by determining its oligomerization state and 
the potential effects of cAMP on it. To examine this issue, we resorted to analytical 
ultracentrifugation assays as described in the Materials and Methods section. As shown in 
Fig. 18, the sedimentation velocity experiments indicated that >90% of the native CrpP. putida 
has a sedimentation coefficient of 3.2 ± 0.1 S, which suggests a protein dimer to be the 
predominant protein form under the ultracentrifugation. On the other hand, 
sedimentation equilibrium assays predicted this major protein species to hold an apparent  
 
 
Fig. 18. Oligomerization state of P. putida Crp. Plotted data correspond to the 
sedimentation coefficient distribution obtained in sedimentation velocity experiments 
with purified Crp (Blue-continuous line) and Crp in complex with cAMP (Red-dotted 
line). A predominant fraction of Crp species (92.8%) presented a sedimentation 
coefficient of 3.2 ± 0.1 S. This value corresponds to a molecular mass of 51.6 kDa as 
confirmed by sedimentation equilibrium experiments, which is compatible with the 
dimeric form of the protein. Addition of cAMP to the samples increases the 
sedimentation coefficient value of Crp to 3.4 ± 0.1 S (93.6% of total species), 



















molecular mass of 51.6 kDa. This value is virtually twice the mass predicted for the Crp 
monomer (24.571 kDa) and verified by mass spectrometry to be 24.6 kDa (see above). The 
set of data thus establishes that CrpP. putida is a stable dimer regardless of any effector. Yet, 
this does not rule out the possibility that binding of cAMP cause a modification in the 
oligomerization state of the protein, as is the case of many other transcriptional regulators 
like FNR (Lazazzera et al., 1996), AraC (Soisson et al., 1997), Lrp (Chen & Calvo, 2002) 
or UlaR (Garces et al., 2008). To examine this possibility the same experiments were 
repeated but adding 1 mM cAMP to the centrifugation sample. As observed in Fig. 18, the 
sedimentation coefficient changed to 3.4 ± 0.1 S and the sedimentation equilibrium 
increased to an apparent molecular weight of 66.5 kDa, suggesting that the effector binding 
causes a different conformational change in the cAMP-CrpP. putida complex with respect to 
the effector-less protein.  
 
 
Fig. 19. Partial proteolysis of CrpP. putida. The purified protein was subject to digestion 
with trypsin in the absence (top panel) and presence (bottom panel) of 1.0 mM cAMP. 
Reactions were stopped at the times indicated and the samples were loaded in a 15% 
denaturing PAGE stained with Coomassie blue. First lane corresponds to the molecular 
weight marker. 
 
The analytical ultracentrifugation data before suggest that the hydrodynamic ratio of Crp 
dimer may somehow change upon cAMP binding. To ascertain this hypothesis, we 
implemented a simple test for detecting large conformational transitions based on partial 
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proteolysis of the purified protein with trypsin in the presence and absence of cAMP 
(Krakow & Pastan, 1973). Fig. 19 shows a Coomassie blue-stained gel displaying the 
peptides resulting from digestion of protein samples incubated or not with cAMP. 
Although the pattern of tryptic peptides is difficult to interpret in structural terms because 
of the anomalous migration of Crp discussed before, its seems that a large protein domain 
becomes released by the protease upon exposure to cAMP, a feature compatible with the 
conformational change exposed above. Furthermore, inspection of the gels of Fig. 19 
revealed no share of any of the proteolysis intermediates between the preparation devoid of 
cAMP and containing the effector. This strengthens the notion that the cAMP-unbound 
and cAMP-bound conformations of the factor represent two different forms of the protein. 
 
3 CrpP.putida displays an extraordinary high affinity for cAMP 
The results obtained from complementation assays and the detection of cAMP in P. putida 
cells disclosed in Chapter I, raised the hypothesis of a higher affinity CrpP.putida, which could 
be activated by the low intracellular levels of cyclic nucleotide produced by its native CyaA. 
Thus, to quantify the interplay between CrpP. putida and cAMP we set out to employ 
Isothermal Titration Calorimetry (ITC), one of the most reliable and accurate techniques 
to calculate a wide range of molecular interaction parameters (Krell, 2008). Since this 
procedure requires high protein concentrations, long handlings of > 2.5 h and the sample 
undergoes considerable changes in temperature, we first chose the MBP-CrpP.putida hybrid 
protein (see above) instead of the native-sized factor for such ITC assays. As mentioned 
above, the MBP domain does not change the characteristics of the protein in vivo while it 
helps its solubility both in vivo and in vitro (Fig. 16). 
Fig. 20A shows a typical titration curve of MBP-CrpP. putida with cAMP, which yields the 
thermodynamic parameters listed in Table 4. The fitting of the data with the One Binding 
Site model gave rise to a very satisfactory solution, indicative of a single event of molecular 
interaction. The results obtained reveal that binding is driven by favourable changes in the 
enthalpy (ΔH) and entropy (TΔS) of the system, the process resulting in an exothermic 
reaction. In contrast, non-cyclic AMP (Fig. 4B, upper profile) produced no interaction 




Fig. 20. Isothermal titration microcalorimetry of MBP-CrpP. putida interacting with 
putative effector molecules. Purified MBP-Crp fusion protein was titrated with dilutions 
of (A) cAMP (B) AMP, cGMP, as indicated. The upper panels plot the raw data obtained 
from titration of 10 µM of protein with aliquots of effector molecules at 350 µM (for 
further details see Materials and Methods). The lower panels represent the integrated and 
dilution-corrected curves fitted from raw data with the One Binding Site model of the 
MicroCal version of ORIGIN software. Thermodynamic parameters obtained from 
curves are summarized in Table 4. 
 
of data in Table 4 and Fig. 20A revealed also an outstanding high affinity of MBP-CrpP. 
putida for cAMP with a dissociation constant KD = 22.5 ± 2.8 nM, much lower than the 
figures for the homologous protein of E. coli (Gorshkova et al., 1995). This result reveals 
the biological reason of the low levels of cAMP found in this bacterium, i.e. as CrpP. putida 
displays its ultratight avidity for the cAMP, the intracellular concentration of the cyclic 
nucleotide necessary to activate this protein must be significantly lower.  
As stated above, the S128T substitution in the E. coli Crp protein is known to make the 
mutant responsive also to cGMP (see Chapter I). In P. putida the equivalent residue in this 
position is the T133, bringing about the possibility that CrpP.putida uses cGMP as an effector 
as well (see Fig. 8). Hence, a second set of ITC experiments were done with cGMP instead 
of cAMP. The experiment of Fig. 20B indicates that, similarly to the titration with cAMP, 






Table 4. Thermodynamic parameters obtained from titration of either MBP-CrpP. putida 
fusion protein or apo-CrpP. putida with putative effectors.  
 







MBP-CrpP. putida      
cAMP 0.65 ± 0.01 (4.4 ± 0.5) x 107 22.5 ± 2.8 nM -5.97 ± 0.03 4.47 ± 0.1 -10.44 ± 0.1 
cGMP 0.49 ± 0.02 (3.9 ± 0.4) x 105  2.6 ± 0.3 µM -4.16 ± 0.27 3.46 ± 0.3 -7.62 ± 0.06 
AMP  nda      
apo-CrpP. putida      
cAMP 0.498  ± 0.002 (2.2 ± 0.2) x 107 45.0 ± 3.4 nM -4.89 ± 0.03 5.11 ± 0.05 -10.0 ± 0.1 
cGMP 0.327  ± 0.084 (1.7 ± 0.2) x 105 5.7 ± 0.7 µM -15.24 ± 4.3 -8.09 ± 4.3 -7.15 ± 0.07 
a. No binding was observed for non-cyclic AMP 
 
changes in the enthalpy and entropy (Table 4). However the affinity of the cGMP for 
MBP-CrpP.putida is ~100 fold lower than that of cAMP under the same conditions 
(dissociation constant KD = 2.6 ± 0.3 µM). Despite the less defined shape of the ITC curve, 
the experimental results could be satisfactorily fit to the One Binding Site model (Table 4).  
 
4 CrpP.putida binds one cAMP molecule per protein dimer  
Regardless of the high quality of results obtained from MBP-CrpP.putida titrations with the 
data fitted in the One Binding Site model, the stoichiometry of the binding reaction 
remains ambiguous. For example, the stoichiometry of the cAMP-CrpP. putida complex 
deduced from Fig. 20A is approximately 0.65, which is close to 0.5 (it means 1 molecule of 
cAMP per dimer of Crp) and occurred in a single binding event, describing a monophasic 
curve. This is an important outcome to take into account, because all the Crp-like proteins 
described so far bind two or more cyclic nucleotides per protein dimer (Weber & Steitz, 
1987; Passner & Steitz, 1997; Stapleton et al., 2010; Tao et al., 2010; Cordes et al., 2011). 
However, the 0.65 n stoichiometry value obtained for cAMP binding to MBP-CrpP.putida is 
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not precise enough to determine truthfully the number of cyclic nucleotide molecules that 
activates this protein. Therefore, we decided to modify the purification protocol and 
overexpress the MBP-CrpP.putida fusion protein in E. coli W3110 Δcrp ΔcyaA grown on M9-
glucose medium, in order to obtain a CrpP.putida devoid of any source of cAMP (see 
Materials and Methods). The reason of this new approach is because, despite the extensive 
washing and dialysis steps during purification, it is likely that MBP-CrpP.putida is copurified 
with traces of cAMP due to its high affinity for the cyclic nucleotide. Also, we optimized 
the ITC reaction buffer conditions by increasing concentrations of KCl to 250 mM and by 
adding 1 mM DTT, in order to sustain a reducing milieu for the 6 cysteines of the protein. 
These minor changes allowed stabilizing the CrpP.putida and keeping it in the soluble form. 
Together, these set of modifications allowed us conducting the ITC experiments again with 
bona fide cAMP-less Crp of P. putida (apo-CrpP.putida) cleaved from MBP.  
 
 
Fig. 21. Isothermal titration microcalorimetry of apo-CrpP. putida interacting with (A) 
cAMP and (B) cGMP. The upper panels plot the raw data obtained from titrations with 
the cyclic nucleotides. The first titration in these panels exhibits the injection of the 
effector molecule into buffer without protein. The lower panels represent the integrated 
and dilution-corrected curves fitted from raw data with the One Binding Site model of the 
MicroCal version of ORIGIN software. Note that the titrations with cAMP were 
conducted in a buffer containing 250 mM KCl, against the 150 mM used for same 
experiments with cGMP. Thermodynamic parameters obtained from curves are 
summarized in Table 4. 
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The Fig 21A shows the titration of MBP-less apo-CrpP.putida with cAMP. The hyperbolic 
curve traced from plotting the titration data is virtually identical to the one observed for 
MBP-CrpP.putida, the binding being driven by favourable changes in the enthalpy (ΔH) and 
entropy (TΔS) of the system (Table 4). Likely, the interaction between both molecules 
yields once again a tight binding for the cyclic nucleotide (KD = 45 ± 3 nM). In spite of 
these similarities, the affinity for the cyclic nucleotide in the apo-protein is somewhat 
reduced as compared to the initial data set using the fusion protein (Table 4). However, 
this minor discrepancy is likely to be caused by the increased in the ionic strength to 250 
mM KCl and not by the absence of the MBP tag. Moreover, integration of data with the 
One Binding Site model results in a very satisfactory fit, which describes only one binding 
event and confirms without any doubt the stoichiometry of 1 molecule of cAMP per dimer 
of CrpP.putida. This reflects a scenario in which only one of the two cAMP binging sites 
available in the protein becomes occupied. 
Similarly, the titration of apo-CrpP.putida with cGMP plotted in Fig. 21B was very similar to 
the interaction of the cyclic nucleotide for the MBP fusion protein (Fig. 20B). Nevertheless, 
in this case the binding of cGMP is driven by negative entropy changes (Table 4). This 
unfavourable ΔS value can have different reasons and is not necessarily caused by an 
ordering of water molecules at the complex interface. Another important negative 
contribution to the entropy change is the loss of flexibility of the ligands during the 
binding process (Jelesarov & Bosshard, 1999). Thus, the cGMP-CrpP. putida complex could 
occur in a way where the interaction process does not alter the conformational architecture 
of the binding sites and therefore, the entropy of the system is negative. Once again, the 
affinity of the cGMP for apo-CrpP.putida is ~100 fold lower than the one observed for cAMP 
with the same protein, which confirms the results obtained with the MBP-CrpP.putida fusion 
protein. Furthermore, as was the case with cAMP interaction for apo-CrpP.putida, there is just 
one binding event for cGMP-CrpP.putida complex. Despite the less defined shape of the ITC 
plot, the One Binding Site model fitting of the data yields again a binding stoichiometry 
closer to 0.5 (0.327  ± 0.084, Table 4), which is consistent with the model proposed that 
only one molecule of the cyclic nucleotide (cAMP or cGMP) is interacting with the 




5 CrpP. putida activates the transcription machinery of P. putida in a class I Crp-
dependent promoter 
Since the specific target sequences of CrpP. putida in the native host genome are still uncertain 
but its gene complements the metabolic phenotypes of a Δcrp mutant of E. coli (Fig. 9), we 
assumed that the P. putida protein should bind and activate typical class I Crp-dependent 
promoters such as Plac (Busby & Ebright, 1999). Thus, a 330 bp DNA fragment 
containing the native Plac promoter was PCR amplified and either end-labelled for gel 
retardation (EMSA) assays or recloned in the pJCD01 specialized vector for creating a 
supercoiled template for in vitro transcription (see Materials and Methods for details).  
 
 
Fig. 22. DNA recognition and transcription activation of the Plac promoter mediated by 
CrpP. putida. (A) Electrophoretic mobility shift assay (EMSA) of a 330 bp fragment 
containing the Plac promoter with increasing concentrations of Crp and its effectors. 
Binding reactions contained 0.5 ng of end-labeled Plac probe, 0.1 mM of cyclic 
nucleotides (cAMP and cGMP) and increasing concentrations of CrpP. putida (lanes 2, 7 and 
12: 10 mM; lanes 3, 8 and 13: 50 nM; lanes 4, 9 and 14: 100 nM; lanes 5, 10 and 15: 
250 nM. (B) In vitro transcription of Plac promoter with purified Crp and σ70 RNAP of P. 
putida. Plac were PCR cloned into plasmid pJCD01 and the reactions were carried out 
with increasing concentrations of CrpP. putida in the presence and absence of either 0.5 mM 
of cGMP or 0.5 mM cAMP. Crp concentrations were as follows: lanes 2, 7 and 12: 10 
nM; lanes 3, 8 and 13: 20 nM; lanes 4, 9, and 14: 50 nM; lanes 5, 10 and 15: 100 nM. 
The specific 263 nt Plac transcript and the 104 nt internal control from plasmid vector 
pJCD01 are indicated at both sides of the film. 
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Fig. 22 shows the corresponding experiments, in which the activities of CrpP. putida were 
tested using an excess of either cAMP or cGMP as components of the reaction mixtures. 
Inspection of the EMSA data of Fig. 22A indicated that cAMP was necessary for binding 
CrpP. putida to the DNA fragment containing the lac promoter, the gross KD of the DNA-
protein interaction being in the range of 50 nM. In contrast, the effector-less protein failed 
to retard noticeably the labeled probe even at concentrations as high as ~ 0.3 µM (Fig. 22A, 
lane 5). On the other hand, cGMP appeared to increase minimally such a residual binding 
but only at the highest protein concentration –far above any biological sense. Since the 
levels of cGMP employed in the assay (100 µM) were nearly 20 times higher than the KD 
calculated with ITC using the apo-CrpP. putida (see above), we can assume that the same 
protein form that binds cGMP fails to bind DNA, at least the Crp recognition sequence 
employed present in the labeled DNA probe. 
 
Next, we set up the in vitro transcription experiment of Fig. 22B to corroborate whether 
results obtained in the EMSA experiments are correlated with the transcriptional activation 
of the Plac promoter. Hence, the same DNA fragment (cloned in an specialized vector) was 
incubated with RNA polymerase and CrpP. putida with identical effectors. Note that the 
enzyme employed was purified from P. putida (see Materials and Methods) and therefore 
the transcription assay recreates the conditions that RNAP and Crp experience in its native 
host. Inspection of Fig. 5B tells us that a weak lac transcript which is produced by the 
RNAP alone (lane 1) is not increased by either addition of the effector-less CrpP. putida (lanes 
2-5) or by its complex with cGMP (lanes 7-10). Yet, the same band intensifies in the 
samples with the cAMP-CrpP. putida complex, as would be expected of Class-I Crp-dependent 
promoters like Plac (Busby & Ebright, 1999). This set of data also confirms that only 
cAMP binding triggers the CrpP. putida protein for DNA binding and transcription activation, 





Detection of genes directly or indirectly regulated by the components of the cAMP-












1 RNA-seq transcriptome analysis of crp and cyaA mutants of P. putida  
The previous Chapters of the Thesis demonstrated, from phenotypically and 
mechanistically points of view, the mechanism by which Crp interacts with the allosteric 
effector cAMP in order to activate the transcription of some Crp-dependent promoters in E. 
coli. However, the data said nothing on the functional scope ruled by the crp and cyaA gene 
products in the native P. putida. The development of omics technologies (transcriptomics, 
proteomics, metabolomics, etc.) have emerged in recent years as powerful tools to address 
this important piece of information. Thus, we decided to perform a genome-scale 
transcriptome analysis of the Δcrp and ΔcyaA mutants of P. putida compared with the wild-
type KT2440 strain. For this purpose, we implemented the newly developed high-
throughput sequencing using the Illumina RNA-seq methodology, instead of classical 
microarray technologies. RNA-seq allows the sequencing of millions of short DNA 
fragments in a single run, which are derived from reverse transcription of bacterial RNA 
(previously fragmented and cleaned up from rRNA, see Materials and Methods). These 
fragments are then aligned with the entire P. putida genome and mapped with annotated 
genes. The information obtained by sequencing data enables the identification of 
differentially expressed genes, while allowing for additional analysis, such as detection of 
low-expressed genes, novel transcripts and identification of ncRNAs (Marioni et al., 2008). 
Following the procedures detailed in the Materials and Methods section, we analysed the 
transcriptome of P. putida strains KT2440, Δcrp and ΔcyaA previously grown until mid-
exponential phase in M9 medium supplemented with 0.2% glucose. We decided to use 
glucose as the only carbon source because the translational fusions of lacZ gene with both 
crp and cyaA promoters showed slightly higher β-galactosidase activity in cells growing in 
this carbon source, compared to others as succinate or fructose (see Fig. 14C and Fig. 15).  
The differential expression of genes in the P. putida Δcrp strain, compared with wild-type 
KT2440, is shown in Fig 23. We found many genes that were either upregulated or 
downregulated in the Δcrp mutant. Thus, it is plausible that CrpP. putida could act as a dual 
transcriptional regulator, either activating or repressing the expression of several 
transcriptional units. However, we also find that there are more genes overexpressed       
(65 genes) in the Δcrp strain than the ones whose expression is downregulated in the 




Fig. 23. Differential expression pattern of genes in the Δcrp mutant of P. putida 
compared with reference KT2440 wild-type strain. The RNA of cells cultured in M9-
glucose medium was isolated and analysed by Illumina high-throughput sequencing as 
explained in Materials and Methods section. Upregulated genes: Red; Downregulated 
genes: Green. Detail of the genes differentially expressed could be found in Table 5 and 6 
of the annexes section. 
 
is both preeliminary and limited and it does not certify whether the differences in gene 
expression are the effect of direct or indirect interactions between Crp and those genes. Yet, 
the abundance of upregulated versus the downregulated genes in the P. putida Δcrp mutant 
stated above suggests that Crp could behave mainly as a transcriptional repressor. Tables 5 
and 6 in the annexes describe respectively the upregulated and downregulated genes in the 
Δcrp mutant of P. putida, together with the predicted function and subcellular localization 
of their protein products. Unfortunately, many of these genes codify hypothetical proteins 
or proteins with a hypothetical function. Still, it is noteworthy that only few genes related 
with carbon source metabolism or transport were found to be regulated by CrpP. putida. These 
genes include an acetyl-CoA synthetase (acsA), a benzoate transporter (PP_1820) and the 
gene glcG, which form part of the glc operon for glycolate utilization in E. coli (Pellicer et 
al., 1996). In contrast, many of the proteins produced by genes regulated by CrpP. putida 
(overexpressed and also repressed) are related with cell membrane functions and therefore, 
are predicted to localize in the cell membrane. These proteins include some outer 




















and 6 in the annexes for details). This results agree with the observation made by Milanesio 
(2007) that cAMP-Crp system controls mainly cell surface-related functions. 
 
 
Fig. 24. Differential expression pattern of genes in the ΔcyaA mutant of P. putida 
compared with reference KT2440 wild-type strain. The RNA of cells cultured in M9-
glucose medium was isolated and analysed by Illumina high-throughput sequencing as 
explained in Materials and Methods section. Upregulated genes: Red; Downregulated 
genes: Green. Detail of the genes differentially expressed could be found in Tables 7 and 
8 of the annexes section. 
 
On the other hand, Fig. 24 shows the differential expression of genes in the ΔcyaA strain of 
P. putida, compared with wild-type KT2440. A detailed list of the upregulated and 
downregulated genes plotted in Fig. 24 can be found respectively in Tables 7 and 8 of the 
annexes. As in the case of Δcrp mutant of P. putida, in ΔcyaA strain we found more 
upregulated genes (81 genes) than downregulated ones (57 genes), with respect to wild-type 
strain. Remarkably, virtually none of them matches with previously annotated genes related 
to the metabolism of carbon sources. This ruled out, once again, the general assumption 
that cAMP is a key signal for metabolization of none-preferred carbon sources in bacteria as 
it does in E. coli. 
There were a larger number of genes that are controlled (either directly or indirectly) by the 





















that many genes that were up- or downregulated in the Δcrp mutant were also regulated in 
the same fashion in the ΔcyaA strain. This convergence is showed in the Venn diagrams of 
Fig. 25A (upregulated genes) and Fig. 25B (downregulated genes). We found some 
interesting transcriptional units (genes and operons) shared by both mutants. For example, 
the arcDAIC operon for the metabolism of arginine via the arginine deiminase pathway is 
upregulated in both the Δcrp and the ΔcyaA strains. Another small operon overexpressed in 
both mutants is conformed by the locus PP_0353 and PP_0354. The first gene encodes for 
a putative exonuclease, while the second gene is annotated as a CBS (cystathionine-β-
synthase) domain protein. The later gene is very relevant not only because it is the 
upregulated gene that exhibits the maximum fold change in both Δcrp and ΔcyaA strains, 
but also because it includes a predicted cyclic nucleotide binding domain. Additionally, 
some overexpressed operons include proteins related to cell membrane functions. This is 
the case of the ABC protein secretion efflux system (included in the operon formed by 
locus PP_0803 to PP_0806), the cfa cyclopropane-fatty-acyl-phospholipid synthase 
(included in the operon formed by locus PP_2733 to 2738) or the biosynthesis of 
lipopolysaccharides carried out by WecB protein. Furthermore, components of the type I 
pili (encoded in the operon formed by locus PP_2357-2363) were found to be upregulated 
in both mutants. Finally, we also found the genes encoding for cytochrome C oxidase 
subunits and the assembly protein (operon formed by locus PP_0103 to PP_0111) to be 
upregulated in both mutants of P. putida. 
 
  
Fig. 25. Venn diagrams illustrating the genes that are co-regulated by Crp and CyaA in P. 
putida. Figure shows the up-regulated (A) or down-regulated (B) genes shared in 
common in the Δcrp and ΔcyaA strains respective to wild-type KT2440. 
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We also detected an important set of genes that were downregulated in the Δcrp and the 
ΔcyaA strains. Interestingly, we found that some of these genes were involved in the 
protection of the bacterial cell against environmental stresses. These include the genes 
coding for the major chaperones in the microbial cell: GroES, GroEL and DnaK. 
Additionally, we found another two heat-shock proteins (ibpA and htpG) and a putative 
chaperone-associated ATPase (PP_3095). Thus, cAMP-Crp system could be involved in 
the activation of the cell response to heat or environmental stress. We observed three 
operons that include several genes encoding outer membrane receptors, like the outer 
membrane protein OprG, the outer membrane copper receptor OprC and the putative 
ferric siderophore receptor PP_3330. Finally, another genes downregulated in both Δcrp 
and ΔcyaA mutant strains of P. putida include a flavin mononucleotide (FMN) reductase 
(ssuE), the translation initiation factor IF1 (infA) and the ribosomal protein L31 (rpmE). 
Despite most of the genes that are upregulated or downregulated in the Δcrp mutant, are 
also affected in the ΔcyaA strain in a similar fashion, there are another set of genes that were 
only affected in one mutant or in the other, respective to the wild-type strain. This is 
especially true in the case of the ΔcyaA mutant of P. putida. Thus, it is tempting to suggest 
that there could be another partners and factors involved in the cAMP signalling pathway 
in P. putida. This fascinating issue is currently under examination. 
 
  

















1 The cAMP-Crp system of Pseudomonas putida 
P. putida bears in its chromosome an authentic cAMP-Crp gene regulation system similar 
to that of E. coli, encoding at least one copy of its three main components: the adenylate 
cyclase (cyaA, PP_5222), the cAMP-receptor protein (crp, PP_0424) and the cAMP 
phosphodiesterase (cpdA, PP_4917). The next question to address was whether this system 
also conserves the biological function and the gene regulation mechanism as its 
enterobacterial counterpart, where Crp is at the top of the hierarchy in the control of 
carbon metabolism (Kolb et al., 1993; Ishihama, 2010; Gama-Castro et al., 2011; Shimada 
et al., 2011). If this feature is also conserved in P. putida, then the metabolism of carbon 
sources in this bacterium would be tightly controlled by cAMP-Crp complex. However, the 
growth of crp and cyaA deficient strains of P. putida on succinate, glucose and fructose 
(each processed through different metabolic pathways) is mostly indistinguishable from the 
growth of wild-type KT2440. Recent works are consistent with this result and show that 
deletion of crp and cyaA genes in P. putida hardly alter the global metabolic features in this 
bacterium (Daniels et al., 2010; Milanesio et al., 2011). Moreover, the implication of P. 
putida cAMP-Crp could be related with cell surface functions, as resistance to toxic 
compounds, cell motility and biofilm formation (Milanesio, 2007). On this background, 
we implemented a simple but very informative assay in which we complement the loss of 
crp and cyaA genes in E. coli. The complementation of E. coli W3110 crp with the plasmid 
encoding crpP.putida, not only demonstrates that CrpP.putida is a functional transcriptional 
regulator, but also reveals three important pieces of information: first, CrpP.putida can 
recognize the E. coli Crp binding sequence of the maltose-consumption promoters 
regulated by this TF. As shown in Fig. 8, the HTH DNA binding domain of CrpP.putida is 
conserved with regards to its E. coli counterpart. This high level of homology, together with 
the results of maltose complementation in E. coli explained before, suggest that CrpP.putida 
recognizes similar (but perhaps non-identical) DNA target sequences in its native host. 
Second, CrpP.putida is able to contact the RNAPE. coli and to promote the transcription of Crp-
dependent promoters (Fig. 9). Third, Fig. 8 also shows the conservation in CrpP.putida of the 
residues encompassing these three activating regions responsible for the interaction with the 
RNA polymerase in E. coli. Just two of these activating regions (AR1 and AR2) seem to 
occur naturally in the CrpE. coli. The third non-native AR3 becomes artificially activated 
when the Lys52 of the protein surface is substituted by a residue with negative charge. 
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Interestingly, P. putida Crp has a negatively charged Glu in this position. This simple 
substitution could in turn activate the AR3 and therefore it can trigger the activation of 
class II Crp-dependent promoters by all AR1, AR2 and AR3. Finally, the lack of 
complementation in the E. coli ∆crp ∆cyaA double mutant only with the plasmid bearing 
the crpP. putida suggests that the encoded Crp is functional when the adenylate cyclase is also 
present (Fig. 9B). 
 
2 P. putida CyaA produces very low levels of cAMP 
The complementation of E. coli W3110 ∆cyaA suggests that cyaAP. putida expression gives rise 
to only small amounts of cAMP, just enough to complement the mutation in the 
hypersensitive TP610A strain. Moreover, this complementation was only achieved in this 
strain when the cyaAP. putida was overexpressed with high concentrations of IPTG (1 mM). 
This low concentration of the cyclic nucleotide was further confirmed qualitatively by the 
D. discoideum biosensor and quantitatively by HPLC-ESI-MS. While the intracellular and 
extracellular concentrations of cAMP detected in E. coli cultured on glycerol were within 
the range reported by others (Wayne & Rosen, 1974; Joseph et al., 1982), the levels of this 
metabolite in P. putida were below the quantification limit of the method employed (> 43 
pmol/OD600/ml). Former analysis of cyclic AMP concentration in related proteobacteria by 
Phillips & Mulfinger (1981), reported mean intracellular levels of this metabolite in the 
range of 0.19-0.30 pmol/OD600/ml for P. aeruginosa (the levels vary slightly depending on 
the carbon source in which cells are growing), 0.016 pmol/OD600/ml for Comamonas 
testosteroni (formerly Pseudomonas testosteroni) and 0.105 pmol/OD600/ml for Cupriavidus 
oxalaticus (formerly Pseudomonas oxalaticus). Moreover, the same authors report 
intracellular cAMP levels in P. putida ranging values of 0.038, 0.050 and 0.029 
pmol/OD600/ml in cells growing on glucose, histidine and succinate, respectively. Although 
these results were obtained with a different methodology to that used in this work (cAMP 
radio-immunoassay), they also reflect the very low concentrations of cyclic AMP produced 
by P. putida and P. aeruginosa regardless of the carbon source where the cells are cultured. 
But, what is the reason for such a low cAMP production in this bacterium? The simplest 
and more logic explanation is to attribute a lower catalytic activity to the corresponding 
cyclase.  In E. coli, the only known mechanism to influence CyaA performance (and thus 
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intracellular cAMP levels) involves direct contacts of the enzyme with an uncharacterized 
regulatory factor of the cell cytoplasm and with the phosphorylated forms of EIIA-type 
enzymes of the phosphoenolpyruvate-dependent carbohydrate transport system (Park et al., 
2006). Whether this mechanism is conserved in P. putida is unknown, but certainly, 
fructose is the only sugar that is transported through PTS in this microorganism (Velazquez 
et al., 2004; Chavarria et al., 2012). It would be surprising that the Crp–cAMP system were 
linked only to this sugar. Instead, it is likely that CyaAP. putida activity is controlled by other, 
so far unknown physiological or environmental signals. Another explanation to the low 
cAMP levels could be the action of one or more phosphodiesterases encoded in the P. 
putida genome. Here, we report a gene in this bacterium (PP_4917) encoding a protein 
with high homology to the P. aeruginosa and E. coli CpdA phosphodiesterases (Fig. 6D). 
Although there is not sufficient information about the functional duties of this protein, the 
high homology and the preservation of the 13 residues absolutely conserved amongst all the 
class III phosphodiesterases suggest that PP_4917 encodes a genuine 3’-5’ cyclic AMP 
phosphodiesterase. 
But besides the cAMP turnover played by the activity of the adenylate cyclase and the 
phosphodiesterase(s) enzymes, another factor that contributes to the low concentration of 
the cyclic nucleotide in P. putida is the expression of the corresponding cyclase itself. The 
transcriptional and translational fusions of the cyaAP. putida promoter show that while this 
gene is efficiently transcribed in a cell population, its translation is extremely low. This 
feature however is not alien to cyaAP. putida, as several important regulatory genes as malT 
(main regulator of maltose regulon), nagC (repressor/activator of the nag regulon, 
responsible for the metabolism of the amino sugars N-acetylglucosamine and glucosamine) 
and trpR (repressor of the tryptophan regulon) are also inefficiently translated in E. coli 
(Ozbudak et al., 2002). Moreover, the cyaA genes of a variety of Gram-negative bacteria 
(including enterobacteria) have also a slow translational rate, compared with higher levels of 
transcription (Trotot et al., 1996). Low translational rates in these important set of genes 
seems to be a mechanism to regulate the phenotypic variation generated by the noise 
(coefficient of variation) in the protein expression. This noise is often harmful, because it 
disrupts the fine-tuning regulation of cell signalling pathways (Ozbudak et al., 2002). Thus, 
a gene with low transcription, but high translation rates, produces a so-called translational 
burst, in which the gene with the higher translational efficiency vs. the lower mRNA 
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abundance displays protein bursts that are variable and infrequent, resulting in strong 
stochastic fluctuations in protein concentration. Conversely, a gene with high transcription 
and low translation rates produces burst that are small and frequent, causing only week 
fluctuations in protein concentration and producing a smaller phenotypic variation in the 
cell population (Kaern et al., 2005; Ozbudak et al., 2002). Therefore, the inefficient 
translation of cyaA along Gram-negative bacteria (including P. putida) is perhaps conserved 
because it supresses the harmful fluctuations in CyaA and thereby in the cAMP levels that 
could have pleiotropic effects for the cell. 
 
3 CyaA and Crp levels are slightly increased in cells growing on glucose and are not 
autoregulated by cAMP-Crp 
Interestingly, the translational activity of cyaA’-‘lacZ fusion results to be slightly higher in P. 
putida cells growing on glucose than in cells cultured in fructose or succinate (Fig. 14C). A 
similar result was observed for the translational levels of crp’-‘lacZ fusion of Fig. 15, in 
which the LacZ activity was slightly increased in glucose compared with the other carbon 
sources employed. If this assumption is true, then the cAMP-Crp system in P. putida could 
be active when the cells are growing on glucose, acting opposite to the same mechanism in 
E. coli, where glucose is a repressor of the adenylate cyclase activity. This speculation is not 
meaningless because in P. putida glucose is not transported by the classical PTS system as in 
E. coli, but it is metabolized via the Entner–Doudoroff pathway (del Castillo et al., 2007; 
Chavarria et al., 2012). However, the metabolic or environmental signals that control the 
activity of the CyaAP. putida are not known yet and they must be closely studied to ascertain 
the influence of glucose in the expression of the cAMP-Crp system in this bacterium. 
The expression of both PcyaA and Pcrp was not influenced by autoregulation of the cAMP-
Crp complex, because deletion of cyaA or crp hardly had any effect over the β-galactosidase 
activity of the translational or transcriptional fusions. This fact contrasts with E. coli, where 
the cyaA expression seems to be negatively regulated by cAMP-Crp complex (Mori & Aiba, 
1985; Aiba, 1985). Also expression of crpE.coli is controlled by a dual autoregulation 
mechanism in which cAMP-Crp exerts both positive and negative regulation depending on 
the cAMP concentration, by binding to two different Crp sites in the crp promoter 
(Ishizuka et al., 1994). Moreover, P. aeruginosa Vfr positively regulates its own expression 
Discussion 
 95 
in a cAMP dependent mechanism (Fuchs et al., 2010a). These dissimilar regulatory modes 
of crp and cyaA genes, due to the distinct promoter architecture amongst each bacterial 
species, reflects the different regulatory roles by which the cAMP-Crp system were 
evolutionary selected in these bacteria.  
 
4 CrpP.putida is a dimeric protein that undergoes a conformational change upon 
cAMP binding 
Analytical ultracentrifugation experiments with purified CrpP.putida were employed to assess 
its oligomerization state. This important issue cannot be predicted from protein 
homologies only, as often the same enzyme or regulator may adopt diverse oligomeric 
forms with different properties, kinetic or otherwise in different species (Chavarria et al., 
2011). The results show in Fig. 18 clearly established that this protein form dimers in 
solution regardless of any effector. Remarkably, the presence of cAMP causes an increase in 
the apparent size of the dimeric protein from of 51.6 kDa to 66.5 kDa, evidencing for the 
first time the molecular interaction between purified CrpP.putida and cAMP in vitro. Since the 
molecular weight contribution of the cAMP to the complex is not enough to explain this 
notable increment (the molecular weight of cAMP is ~329 Da) and the corresponding 
parameters are incompatible with formation of a higher-order oligomer (which should be at 
least ~75 kDa for a trimer and ~100 kDa for a tetramer), the data suggest that the 
hydrodynamic shape of the dimer change upon cAMP binding to produce a different 
protein form. This conformational change was further confirmed by partial proteolysis of 
CrpP.putida and cAMP- CrpP.putida complex with trypsin. Recently, Popovych et al. (2009) 
deciphered the structure of E. coli Crp in the absence of cAMP and proposed a mechanism 
of allosteric activation mediated by cAMP in which the binding of the cyclic nucleotide to 
the protein induces a coil-to-helix transition that extends the C-helix (responsible for Crp 
dimerization). This in turn places the F-helix (responsible for DNA recognition) in the 
correct orientation for DNA binding (Fig. 2). It is likely that a similar allosteric mechanism 
is occurring in the CrpP.putida upon cAMP binding, bringing about a strong conformational 
shift in the protein surface that changes the accessible sites for trypsin proteolysis as well 
and thus generates the different peptide digestion pattern observed in Fig. 19. 
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5 CrpP.putida displays an extraordinary high affinity for cAMP 
Throughout the Chapter I of this work, we have addressed the low levels of cAMP in P. 
putida and its implication in the cAMP-Crp mechanism of gene regulation. We argued that 
Crp could have evolved a higher sensitivity for cAMP as a consequence of the much lower 
intracellular levels of the cyclic nucleotide produced by its weak adenylate cyclase. This 
hypothesis was finally demonstrated by the ITC experiments with MBP-CrpP.putida (Fig. 
20A) and also with the apo-CrpP.putida (Fig. 21A). This binding is driven by an exothermic 
reaction with favourable (negative value) changes in the enthalpy (ΔH) and also favourable 
(positive value) entropy (TΔS) of the system. These negative enthalpy variations with 
cAMP (Table 4) can be explained by formation of non-covalent bonds between the cAMP 
molecule and the corresponding interaction pocket in CrpP. putida. On the other hand, 
positive entropy is systematically associated to expulsion of protein-bound water to the 
aqueous surrounding induced by ligand binding (Krell et al., 2007). Moreover, we found 
the affinity for cAMP as ultratight (KD = 22.5 ± 2.8 nM) and also much stronger than the 
average affinity of effector molecules for transcriptional regulators. Compared with 
reference E. coli’s Crp protein, we found that the window of responsiveness of CrpP.putida to 
cAMP levels might vary more than 100-fold. This sensitivity is also higher than the 
observed for the Vfr of P. aeruginosa (~45-fold; Cordes et al., 2011)) and surprisingly much 
higher than Crp of Mycobacterium tuberculosis (>2,000-fold; Stapleton et al., 2010)). Even 
more, it is noteworthy that the cAMP–Crp system of M. tuberculosis seems to have evolved 
exactly in the opposite direction than P. putida (Stapleton et al., 2010). In this case, the 
protein has decreased its affinity for cAMP to compensate for much higher physiological 
levels of the cyclic nucleotide produced by its numerous adenylate cyclases. 
The strength of the binding for the related cyclic guanosine monophosphate was also 
demonstrated by ITC experiments (Fig. 20B and Fig. 21B). Although this binding has near 
100-times lower affinity for CrpP.putida than the one reported for the cAMP, it is comparable 
with the values observed for cAMP binding to the Crp counterpart of E. coli, and thus it is 
still considerable in biological terms (Table 4). Yet, the corresponding affinities make a 
difference, because the strengths of the interaction of CrpP. putida with either cAMP or cGMP 
in P. putida differ two orders of magnitude. This stands in contrast with the smaller 
distance between the affinities of either effector in the E. coli scenario (Lin & Lee, 2002).  
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6 A negative cooperativity model of cyclic AMP binding explains the 1:1 CrpP. putida-
dimer:cAMP stoichiometry 
As explained in the Results section, we purified CrpP. putida in a cAMP-free environment in 
order to determine exactly the stoichiometry of the reaction between the protein and its 
effectors. As observed in Fig. 21A, titration of apo-CrpP. putida with cAMP was satisfactorily 
fitted with the One Binding Site model, yielding very similar thermodynamic parameters 
than the interaction of MBP-CrpP. putida fusion protein with the same effector. Moreover, we 
observed only one single event of binding (the curve shape is monophasic) with a 
stoichiometry of ~0.5, which would indicate a binding of a single molecule of ligand to a 
dimer. Surprisingly, the stoichiometry of cAMP–Crp binding in E. coli has not been to this 
day entirely solved. While the mainstream view adopts 1:1 effector/monomer ratios (Weber 
& Steitz, 1987), other structural studies with cAMP–Crp co-crystals suggest instead a 2:1 
proportion (Passner & Steitz, 1997). On the other hand, ITC experiments by Gorshkova 
and colleagues (1995) display heat changes compatible with an overall stoichiometry of two 
cAMP per protein monomer. Finally, Lin and Lee (2002) reported a biphasic curve by 
fluorescence titration and a clearly three-phasic ITC curve, indicative of two high-affinity 
sites and one low-affinity site. This indicates features of the protein-effector interplay in 
CrpP. putida that differ notably in respect of what is known about the Crp protein of E. coli. 
The fact that the ITC data show only one interaction event, reflects a scenario in which 
only one of the two cAMP binding sites available in the protein dimer becomes occupied. 
How this may happen? It is plausible that binding of one effector molecule to one of the 
subunits of the dimer decreases the affinity of the corresponding site in the other subunit 
(Milligan & Koshland, 1993) in a negative cooperativity effect. Hence, the bindings of the 
first cAMP molecule to one of the CrpP. putida monomers induce a conformational change 
(discussed above) that greatly lowers the affinity in the binding pocket of the remaining 
monomer. Counter-intuitive as it may look, this mechanism has been observed in other 
cases, such as the binding of aspartate to the Tar receptor of Salmonella typhimurium 
(Milligan & Koshland, 1993) or that of the flavonoid phloretin to the TtgR regulator of 
Pseudomonas (Teran et al., 2006). Similarly, the results of Fig. 21A most likely reflect that 
cAMP:Crp stoichiometry of the P. putida protein is 1 ligand : 1 dimer molecule, different 
from the variety of scenarios in E. coli where Crp dimer binds two or more cAMP 
molecules. In addition, the experiments were repeated with cGMP as effector of apo-CrpP. 
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putida (Fig. 21B). Once again, the experimental results could be satisfactorily fit to a One 
Binding Site model with a binding stoichiometry closer to 0.5 than 1 (0.327 ± 0.084, Table 
4), which would indicate a binding of a single molecule of ligand to a dimer. cGMP is thus 
likely to interact with CrpP. putida through the same negative cooperativity model discussed 
for cAMP. 
 
7 CrpP. putida activates the transcription machinery of P. putida and E. coli 
After documenting the binding of cAMP and cGMP to CrpP. putida we next examined 
whether this binding result triggers the two principal biological functions attributed to this 
factor in bacteria, i.e. DNA binding and transcriptional activation. Fig. 22A shows that 
CrpP. putida recognizes and binds the 22 bp Crp site of the lac promoter (3’-
TAATGTGAGTTAGCTCACTCAT-5’). Furthermore, consumption of maltose was also 
complemented when the E. coli crp mutant was transformed with the plasmid encoding the 
crpP. putida, as it is shown in Fig. 9. Thus, it is likely that CrpP. putida recognizes a sequence 
similar to the consensus of E. coli. On the other hand, in vitro transcription assays suggest 
that this protein do not just bind to the Crp site of the lac promoter, but it also bends the 
DNA and interact with the AR1 of the P. putida RNA polymerase in a similar fashion that 
occurs in E. coli. It is remarkable that DNA recognition and transcription activation occurs 
only when cAMP is present in the reaction, while addition of cGMP or absence of any 
effector does not promote binding and transcription reactions (see Fig. 22B). This set of 
data confirms [i] that only cAMP poises the CrpP. putida protein for binding DNA and 
activating transcription and [ii] that interaction with cGMP leads instead to a non-
productive protein form. 
 
8 RNA-seq transcriptome analysis of Δcrp and ΔcyaA mutants of P. putida  
The differential expression of genes in the Δcrp and ΔcyaA mutants of P. putida was 
examined by transcriptome analysis using high-throughput sequencing of the bacterial 
RNA (RNA-seq). This newly developed technology presents some advantages to the 
classical DNA microarrays, such as the detection of novel transcripts and ncRNAs that are 
transcribed from the intergenic regions. Also, this methodology allows to detect low-
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expressed genes and to identify alternative promoters within genes and operons (Marioni et 
al., 2008; Wilhelm & Landry, 2009). It is important to mention that a deep analysis of the 
putative novel transcripts and the ncRNAs obtained by RNA-seq of several P. putida strains 
are currently under extensive examination, and therefore, these results are not presented in 
this work. However, we decided to present in this Thesis a limited analysis of the 
differential expression pattern in the Δcrp and ΔcyaA strains compared to wild-type 
KT2440 to assess a preliminary landscape of the functional scope of Crp and CyaA 
proteins in P. putida. 
The first notable feature that emerged from our transcriptome analysis is the absence of 
metabolic genes related with consumption of carbon sources in the Δcrp and ΔcyaA 
mutants of P. putida. This stands in contrast with the situation in E. coli, where the 
shortfall of Crp results in appreciable gross changes in many operons encoding transporters 
and enzymes for carbon source utilization (Gosset et al., 2004). Conversely, our results 
suggest that the cAMP-Crp complex could be involved in the regulation of genes whose 
function is associated with the cell membrane. We found that deletion of crp and cyaA 
genes downregulated expression of several operons that codify for proteins involved in the 
response to environmental stress like GroEL, GroES, DnaK and several heat shock proteins. 
These mutants also repress the expression of outer membrane receptors and putative 
membrane associated proteins. On the contrary, Δcrp and ΔcyaA strains of P. putida 
overexpress several operons involved in the biosynthesis of cell membrane components, 
protein secretion systems, type I pili and also genes related to the assembly of cytochrome C 
components. Thus, we hypothesize that cAMP-CrpP. putida complex could regulate the 
response to environmental stress through the activation of cell chaperones and heat-shock 
proteins. Simultaneously, cAMP-CrpP. putida regulates the expression of membrane-related 
components to shape the cell envelope in response to the harmful condition. Additionally, 
we found that cAMP-CrpP. putida also controls one operon for the metabolism of arginine, 
and that mutation of cyaA upregulates the expression of an aldolase involved in the 
biosynthesis of phenylalanine, tyrosine and tryptophan. This is consistent with the 
observation made by Daniels et al. (2010) and Milanesio et al. (2011) in which deletion of 
crp or cyaA impaired the use of various amino acids and dipeptides as nitrogen sources. 
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It was surprising that despite most of the genes altered in the crp mutant were also affected 
in the cyaA-deleted strain, some other genes were not shared by both mutants. In P. 
aeruginosa it has been shown that cAMP was not required for Vfr binding to the lasR 
promoter in vitro or for activation of the lasR promoter activity in vivo (Fuchs et al., 2010a). 
Given the similarity between CrpP. putida and Vfr, it is possible that the P. putida regulatory 
protein also works in a cAMP-independent manner for the regulation of some promoters. 
Also, in P. aeruginosa it was recently discovered an additional cAMP-binding protein 
(CbpA) that seems to be more structurally similar to eukaryotic protein kinase A (PKA) 
regulatory subunits than to Crp-FNR family of transcriptional regulators. This protein is 
localized at the cell pole upon cAMP interaction, and this localization seems to be critical 
to its function (Endoh & Engel, 2009). Although we did not find homologues of CbpA in 
the genome of P. putida KT2440 (results not shown), this does not rule out the possibility 
to find another kind of proteins whose activity is controlled by cAMP. One strong 
candidate is the CBS-domain protein encoded by the locus PP_0354. We found in our 
transcriptome analysis that this protein not only was highly overexpressed in the Δcrp and 
ΔcyaA mutants of P. putida, but it also has a cAMP-binding domain similar to CBD of Crp 
that could be modulating its function. These possibilities, which are beyond the scope of 
this Thesis, will be the subject of future studies. 
 
9 cAMP-Crp system of gene regulation: an example of Regulatory exaptation 
One of the corollaries of the work described above is that -despite similar mechanistic 
performance- the cAMP-Crp regulatory device of P. putida seems to be mostly alien to the 
biological (metabolic) functions that shape its predominant duty in E. coli. It is perfectly 
possible that some metabolic promoters of P. putida are still under a degree of control by 
Crp, but either there is a physiological backup to them, or the effect is not strong enough to 
be detected through the growth phenotypes described above and reported by Milanesio et al. 
(2011) and Daniels et al. (2010). We conclude then that the very same cAMP-Crp 
component (along with one or more phosphodiesterases) has been recruited in different 
bacteria to control dissimilar sets of biological functions. It is difficult to trace the 
evolutionary history of such a device, but cAMP seems to be produced in virtually all 
biological systems (Botsford & Harman, 1992) and thus appears to be a versatile signal-
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carrier molecule between regulatory modules. Whether the metabolic control functions of 
the system appeared earlier or later, we argue that the cAMP-Crp arrangement constitutes 
an obvious occurrence of evolutionary exaptation at a molecular level. This concept, which 
originated in Darwinian Zoology (Gould & Vrba, 1982) refers to the process by which a 
fixed feature that was originally selected to perform a given function, may later execute 
another quite unlike role, i.e. is co-opted for its current function. The archetypical example 
of exaptation is the evolutionary history of feathers, which were probably selected first for 
thermal insulation, and only later they were co-opted for flight. The key angle here is that 
functional re-assignment happens with little or no concurrent structural modification. In 
this way, one specific trait that has evolved under one set of conditions can be co-opted to 
serve a different function under a second set of circumstances. In our case, it is most likely 
that an ancestral form of the cAMP-Crp system was selected for controlling expression of 
one or more distinct functions, but was then co-opted in subsequent hosts to regulate 
entirely different functional ensembles. Even different strains of the same species can select 
the same transcriptional factor for controlling dissimilar sets of functions. For instance, a 
crp mutant of the solvent-tolerant P. putida strain DOT-T1E was unable to employ 
ammonium salts as sole N source (Daniels et al., 2010) in contrast with the soil and 
rhizosphere-thriving P. putida KT2440 counterpart described in this work. That habitat-
dependent exaptation happens in transcriptional factors argues in favour of the idea that 
regulatory control systems can evolve in a fashion that is somewhat independent of the 
functions that they regulate (de Lorenzo & Perez-Martin, 1996). Perhaps this is not true for 
all types of proteins, but the basic function of the cAMP-Crp system seems to enjoy a 
considerable level of orthogonality (i.e. context-independence; Silva-Rocha & de Lorenzo, 
























The data presented in this Thesis grant the following conclusions: 
1. The cAMP-Crp system of gene regulation in P. putida is composed by at least three 
components: one cAMP-receptor protein (Crp), one adenylate cyclase (CyaA) and one 
(and maybe more) cAMP phosphodiesterase (CpdA). 
2. CrpP. putida is a functional transcriptional regulator that is allosterically regulated by 
cAMP to complement the maltose consumption phenotype in E. coli. 
3. The intracellular and extracellular levels of cAMP produced by the adenylate cyclase of 
P. putida are very low compared to enterobacterial organisms. The low levels of this 
second messenger stem from the fact that the adenylate cyclase gene is transcribed but 
it is not efficiently translated. 
4. CrpP. putida is a dimeric protein that undergoes a conformational change upon cAMP 
binding. This binding is proposed to place the protein in the correct orientation to 
facilitate DNA recognition and binding. 
5. CrpP. putida has an ultratight avidity for cAMP, which likely determines the window of 
functionality exerted by the protein in this bacterium. This hypersensitivity for cAMP 
helps to explain the low levels of this metabolite produced in P. putida. 
6. CrpP. putida binds cAMP with 1:1 Crp dimer:cAMP stoichiometry. This is explained 
because binding of cAMP to the first protein monomer induces a conformational 
change that greatly reduces the affinity in the binding pocket of the remaining 
monomer 
7. The cAMP-CrpP. putida complex binds and activates the transcription of the class I Crp-
dependent lac promoter. 
8. The regulatory tasks of the cAMP-Crp system in P. putida are related with the cellular 
response to environmental stress and the expression of cell membrane components to 
shape the cell envelope in response to such conditions. Additionally, this system could 
regulate the metabolism of amino acids as carbon and nitrogen sources. 
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El trabajo descrito en esta Tesis permite proponer las siguientes conclusiones: 
1. En P. putida, el sistema de regulación cAMP-Crp se compone de al menos tres 
componentes: una proteína de unión a cAMP (Crp), una adenilato ciclasa (CyaA) y 
una (y posiblemente más de una) fosfodiesterasa de cAMP (CpdA) 
2. La proteína CrpP. putida es un regulador transcripcional que se activa mediante regulación 
alostérica por el cAMP para complementar el fenotipo de metabolismo de maltosa en E. 
coli. 
3. La concentración intracelular y extracelular de cAMP producida por la adenilato ciclasa 
de P. putida es muy baja en comparación con las enterobacterias. Estos niveles tan 
bajos son en parte debido a que el gene que codifica la adenilato ciclasa en este 
organismo es transcrito eficientemente, pero su traducción es muy baja. 
4. La proteína CrpP. putida forma dímeros cuando se encuentra en solución. Estos dímeros 
sufren un cambio conformacional cuando interaccionan con el cAMP, lo que 
posiblemente posiciona la proteína en la orientación correcta para reconocer e 
interaccionar con las correspondientes secuencias de ADN. 
5. La proteína CrpP. putida tiene una afinidad extraordinaria por el cAMP, que a su vez 
determina en gran parte sus funciones en P. putida. Esta hipersensibilidad por el cAMP 
explica por qué las concentración de cAMP en esta bacteria son tan bajas. 
6. La proteína CrpP. putida se une al cAMP con una estequiometría de 1 dímero de Crp: 1 
molécula cAMP. Esto se explica mediante un modelo de cooperatividad  negativa en el 
cual la unión del cAMP en uno de los monómeros induce un cambio conformacional  
que reduce en gran medida la afinidad por el cAMP en el  bolsillo de unión de ésta 
molécula en el segundo monómero. 
7. El complejo formado por cAMP-CrpP. putida es capaz de unir y activar la transcripción 
del promotor lac (tipo I para Crp). 
8. La función reguladora del sistema cAMP-Crp de P. putida está relacionada con la 
respuesta celular al estrés ambiental y con la expresión de componentes de la 
membrana que modifican el envoltorio bacteriano en esas condiciones. Adicionalmente, 
este sistema puede regular el metabolismo de ciertos aminoácidos como fuentes de 
carbono y nitrógeno. 
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Table 5. List of upregulated genes in P. putida KT2440 Δcrp vs. wild-type KT2440 strain 
in M9-glucose cultures. 
Locus  Gene  Fold 
Change  
FDR  Product Subcellular 
localization 
PP_0354  ---  11.781 0 CBS domain protein  Cytoplasm 
PP_1742  ---  9.595 4.04E-53 conserved hypothetical protein  Cytoplasmic 
membrane 
PP_2734  cfa  6.805 2.93E-244 cyclopropane-fatty-acyl-
phospholipid synthase  
Cytoplasm 




PP_2733  ---  6.426 2.42E-57 hypothetical protein  - 
PP_1000  argI  6.269 0 ornithine carbamoyltransferase, 
catabolic  
Cytoplasm 
PP_1001  arcA  5.546 0 arginine deiminase  Cytoplasm 
PP_0999  arcC  5.38 0 carbamate kinase  Cytoplasm 
PP_0806  ---  5.287 0 surface adhesion protein, putative  Extracellular 
PP_2735  ---  5.275 6.57E-113 conserved hypothetical protein  Cytoplasmic 
membrane 
PP_1408  phaG  4.965 0 acyl-transferase  Cytoplasm 
PP_0711  ---  4.781 2.51E-258 hydrolase, isochorismatase family  - 
PP_2730  ---  4.711 1.14E-62 lipoprotein, putative  - 
PP_0353  ---  4.634 9.68E-49 exonuclease  Cytoplasm 
PP_1659  ---  4.574 1.92E-273 conserved hypothetical protein  Periplasmic 
PP_1002  arcD  4.458 0 arginine/ornithine antiporter  Cytoplasmic 
membrane 
PP_2732  ---  4.225 1.15E-131 conserved hypothetical protein  Cytoplasmic 
membrane 
PP_0805  ---  4.152 0 outer membrane efflux protein  Outer 
membrane 
PP_4487  acsA  4.109 0 acetyl-coA synthetase  Cytoplasm 
PP_1660  ---  3.94 1.31E-57 hypothetical protein  Cytoplasmic 
membrane 
PP_2736  ---  3.936 3.27E-156 conserved hypothetical protein  - 
PP_2361  csuC  3.896 0 type 1 pili usher pathway 
chaperone CsuC  
- 
PP_4851  ---  3.818 0 phosphate starvation-inducible 
protein, PSIF precursor  
- 
PP_0804  ---  3.757 0 protein secretion ABC efflux 
system, permease and ATP-
binding protein  
Cytoplasmic 
membrane 
PP_0803  ---  3.7 0 protein secretion ABC efflux 
system, membrane fusion protein  
Cytoplasmic 
membrane 
PP_2705  ---  3.669 2.20E-95 hypothetical protein  - 
PP_2731  ---  3.664 3.74E-27 conserved hypothetical protein  - 
PP_2359  ---  3.624 0 type 1 pili subunit CsuA/B 
protein, putative  
Extracellular 
PP_2360  ---  3.539 9.15E-245 type 1 pili subunit CsuA/B 
protein, putative  
Cytoplasmic 
membrane 
PP_0154  ---  3.516 8.85E-87 acetyl-CoA hydrolase/transferase Cytoplasm 
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family protein  
PP_2512  folE-2  3.51 3.02E-50 GTP cyclohydrolase I  Cytoplasm 
PP_0699  ---  3.467 3.96E-299 transporter, LysE family  Cytoplasmic 
membrane 
PP_2353  ---  3.425 2.22E-13 hypothetical protein  - 
PP_1144  ---  3.406 5.03E-262 GGDEF domain protein  Cytoplasmic 
membrane 
PP_1661  ---  3.398 1.03E-263 dehydrogenase subunit, putative  Extracellular 
PP_0103  ---  3.393 1.78E-146 cytochrome c oxidase, subunit II  Cytoplasmic 
membrane 
PP_0108  ---  3.377 2.27E-15 conserved hypothetical protein  Cytoplasm 
PP_1811  wecB  3.296 6.83E-50 UDP-N-acetylglucosamine 2-
epimerase  
Cytoplasm 
PP_3504  ---  3.282 0 conserved hypothetical protein  - 
PP_5008  ---  3.273 0 polyhydroxyalkanoate granule-
associated protein GA1  
Cytoplasm 
PP_2729  ---  3.259 9.65E-67 hypothetical protein  - 
PP_4061  ---  3.251 1.14E-16 hypothetical protein  - 
PP_4554  ---  3.217 9.62E-37 conserved hypothetical protein  - 
PP_4409  ---  3.188 1.73E-05 site-specific recombinase, phage 
integrase family  
Cytoplasm 
PP_4793  ---  3.133 1.06E-55 conserved hypothetical protein  - 
PP_0109  ---  3.096 2.53E-23 membrane protein, putative  Cytoplasm 
PP_0105  ---  3.092 1.83E-24 cytochrome c oxidase assembly 
protein  
Cytoplasm 
PP_3261  ---  3.081 0.000272 conserved hypothetical protein  Cytoplasm 
PP_2363  csuE  3.047 3.08E-62 type 1 pili protein CsuE  - 
PP_4555  ---  3.026 1.22E-28 conserved hypothetical protein  - 
PP_2358  ---  3.01 1.68E-209 type 1 pili subunit CsuA/B 
protein, putative  
- 
PP_0998  ---  3.001 0 conserved hypothetical protein  Cytoplasm 
PP_0104  ---  2.988 1.42E-65 cytochrome c oxidase, subunit I  Cytoplasmic 
membrane 
PP_2362  csuD  2.976 0 type 1 pili usher protein CsuD  Outer 
membrane 
PP_2751  ---  2.918 1.35E-05 conserved hypothetical protein  - 
PP_3574  ---  2.884 8.77E-16 YER057c/YjgF/UK114 family 
protein  
- 
PP_3145  ---  2.879 0 conserved hypothetical protein  - 
PP_4282  ---  2.844 5.90E-114 aquaporin Z  Cytoplasmic 
membrane 
PP_0679  ---  2.839 0 conserved hypothetical protein  Cytoplasmic 
membrane 
PP_3030  ---  2.835 4.75E-10 hypothetical protein  - 
PP_0107  ---  2.834 4.16E-61 conserved hypothetical protein  Periplasmic 
PP_4010  cspD  2.822 0 cold-shock protein CspD  Cytoplasm 
PP_0763  ---  2.813 0 medium-chain-fatty-acid CoA 
ligase  
Cytoplasm 
PP_2572  ---  2.81 9.57E-51 hypothetical protein  Cytoplasm 




Table 6. List of downregulated genes in P. putida KT2440 Δcrp vs. wild-type KT2440 
strain in M9-glucose cultures. 
Locus  Gene  Fold 
Change  
FDR  Product Subcellular 
localization 
PP_0424  crp  -196.42 0 catabolite gene activator Crp  Cytoplasm 
PP_1249  ---  -10.579 0 lipoprotein, putative  - 
PP_0236  ssuE  -8.895 7.23E-180 NADH-dependent FMN 
reductase  
- 
PP_0504  oprG  -8.305 7.41E-126 outer membrane protein OprG  Outer 
membrane 
PP_3482  ---  -5.858 1.93E-07 hypothetical protein  - 




PP_0153  ---  -5.547 0 conserved hypothetical protein  - 
PP_3330  ---  -5.482 1.28E-232 outer membrane ferric 
siderophore receptor, putative  
Outer 
membrane 
PP_3335  ---  -5.344 1.99E-172 conserved hypothetical protein  - 
PP_3522  ---  -5.284 8.50E-08 conserved hypothetical protein  - 
PP_5274  ---  -5.102 1.65E-90 hypothetical protein  - 
PP_1982  ibpA  -4.847 0 heat-shock protein IbpA  Cytoplasm 
PP_3336  ---  -4.76 1.79E-49 hypothetical protein  Cytoplasmic 
membrane 
PP_4837  ---  -4.677 0 conserved hypothetical protein  - 
PP_4007  infA  -4.542 0 translation initiation factor IF-1  Cytoplasm 
PP_4626  ---  -4.062 1.60E-12 LrgA family protein  Cytoplasmic 
membrane 
PP_3331  ---  -4.031 4.75E-79 conserved hypothetical protein  Cytoplasmic 
membrane 
PP_3095  ---  -4.016 4.75E-105 chaperone-associated ATPase, 
putative  
Cytoplasm 
PP_3100  ---  -3.975 2.83E-63 conserved hypothetical protein  Cytoplasm 
PP_3405  ---  -3.967 1.34E-153 conserved hypothetical protein  Cytoplasmic 
membrane 
PP_4839  ---  -3.957 0 membrane protein, putative  Cytoplasmic 
membrane 
PP_4836  ---  -3.647 2.10E-293 conserved hypothetical protein  Periplasmic 
PP_3748  glcG  -3.589 0.000289 glcG protein  - 
PP_3099  ---  -3.581 7.68E-121 conserved hypothetical protein  Cytoplasm 
PP_2655  ---  -3.474 1.18E-10 hypothetical protein  - 
PP_2070  ---  -3.444 0.000267 transcriptional regulator, AraC 
family  
Cytoplasm 
PP_5087  rpmE  -3.435 0 ribosomal protein L31  Cytoplasm 
PP_3091  ---  -3.364 3.01E-116 conserved hypothetical protein  Cytoplasmic 
membrane 
PP_3682  ---  -3.24 5.70E-15 hypothetical protein  - 
PP_1361  groEL  -3.234 0 chaperonin, 60 kDa  Cytoplasm 
PP_1360  groES  -3.223 0 chaperonin, 10 kDa  Cytoplasm 




PP_4179  htpG  -3.189 0 heat shock protein HtpG  Cytoplasm 
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PP_5392  ---  -3.157 9.06E-67 conserved hypothetical protein  Cytoplasm 
PP_3092  ---  -3.135 9.31E-22 conserved hypothetical protein  Cytoplasm 
PP_0318  ---  -3.113 2.16E-47 conserved hypothetical protein  - 
PP_3093  ---  -3.113 1.83E-39 conserved hypothetical protein  Cytoplasm 
PP_3332  ---  -3.111 1.85E-138 cytochrome c-type protein  - 
PP_4178  ---  -3.06 5.89E-237 dienelactone hydrolase family 
protein  
- 
PP_1820  ---  -2.995 4.71E-241 benzoate transport protein  Cytoplasmic 
membrane 
PP_4727  dnaK  -2.921 0 dnaK protein  Cytoplasm 
PP_2384  ---  -2.849 0.000968 conserved hypothetical protein  Cytoplasmic 
membrane 
PP_3088  ---  -2.802 2.07E-31 conserved hypothetical protein  - 
 
Table 7. List of upregulated genes in P. putida KT2440 ΔcyaA vs. wild-type KT2440 strain 
in M9-glucose cultures. 
Locus  Gene  Fold 
Change  
FDR  Product Subcellular 
localization 
PP_0354  ---  11.151 0 CBS domain protein  Cytoplasm 
PP_1742  ---  10.488 1.89E-57 conserved hypothetical protein  Cytoplasmic 
membrane 
PP_2734  cfa  8.537 0 cyclopropane-fatty-acyl-
phospholipid synthase  
Cytoplasm 




PP_1000  argI  7.51 0 ornithine carbamoyltransferase, 
catabolic  
Cytoplasm 
PP_0999  arcC  7.21 0 carbamate kinase  Cytoplasm 
PP_2733  ---  5.837 6.71E-47 hypothetical protein  - 
PP_1001  arcA  5.714 0 arginine deiminase  Cytoplasm 
PP_2735  ---  5.544 6.09E-117 conserved hypothetical protein  Cytoplasmic 
membrane 
PP_2730  ---  5.385 3.50E-75 lipoprotein, putative  - 
PP_0806  ---  4.806 0 surface adhesion protein, putative  Extracellular 
PP_2736  ---  4.803 2.85E-215 conserved hypothetical protein  - 
PP_4487  acsA  4.641 0 acetyl-coA synthetase  Cytoplasm 
PP_2189  ---  4.596 0 conserved hypothetical protein  - 
PP_2135  ---  4.551 1.34E-23 hypothetical protein  - 
PP_0711  ---  4.538 1.88E-223 hydrolase, isochorismatase family  - 
PP_0805  ---  4.532 0 outer membrane efflux protein  Outer 
membrane 
PP_4851  ---  4.493 0 phosphate starvation-inducible 
protein, PSIF precursor  
- 
PP_2512  folE-2  4.205 4.20E-68 GTP cyclohydrolase I  Cytoplasm 
PP_2726  ---  4.195 7.32E-05 conserved hypothetical protein  Cytoplasmic 
membrane 





PP_1408  phaG  4.087 0 acyl-transferase  Cytoplasm 
PP_1002  arcD  4.063 0 arginine/ornithine antiporter  Cytoplasmic 
membrane 
PP_0353  ---  4.024 9.69E-36 exonuclease  Cytoplasm 
PP_3030  ---  4.005 4.26E-19 hypothetical protein  - 
PP_3938  ---  4.005 6.28E-05 hypothetical protein  - 
PP_2705  ---  3.998 2.16E-107 hypothetical protein  - 
PP_1660  ---  3.996 2.90E-56 hypothetical protein  Cytoplasmic 
membrane 
PP_0103  ---  3.939 1.58E-188 cytochrome c oxidase, subunit II  Cytoplasmic 
membrane 
PP_1144  ---  3.931 0 GGDEF domain protein  Cytoplasmic 
membrane 
PP_4094  ---  3.909 4.84E-10 conserved hypothetical protein  Cytoplasm 
PP_3145  ---  3.872 0 conserved hypothetical protein  - 
PP_1811  wecB  3.773 1.32E-62 UDP-N-acetylglucosamine 2-
epimerase  
Cytoplasm 
PP_2732  ---  3.733 3.08E-98 conserved hypothetical protein  Cytoplasmic 
membrane 
PP_2729  ---  3.651 2.14E-80 hypothetical protein  - 
PP_4409  ---  3.636 1.61E-06 site-specific recombinase, phage 
integrase family  
Cytoplasm 
PP_0699  ---  3.609 0 transporter, LysE family  Cytoplasmic 
membrane 
PP_0998  ---  3.609 0 conserved hypothetical protein  Cytoplasm 
PP_2731  ---  3.57 1.82E-24 conserved hypothetical protein  - 
PP_2738  ---  3.546 3.48E-151 transcriptional regulator, putative  - 
PP_2353  ---  3.516 2.38E-13 hypothetical protein  - 
PP_0803  ---  3.511 6.07E-281 protein secretion ABC efflux 
system, membrane fusion protein  
Cytoplasmic 
membrane 
PP_5073  ---  3.472 4.56E-18 conserved hypothetical protein 
TIGR00156  
- 
PP_5008  ---  3.427 0 polyhydroxyalkanoate granule-
associated protein GA1  
Cytoplasm 
PP_4010  cspD  3.355 0 cold-shock protein CspD  Cytoplasm 
PP_0154  ---  3.334 1.40E-73 acetyl-CoA hydrolase/transferase 
family protein  
Cytoplasm 
PP_2572  ---  3.272 4.68E-68 hypothetical protein  Cytoplasm 
PP_1661  ---  3.261 1.59E-228 dehydrogenase subunit, putative  Extracellular 
PP_4793  ---  3.25 2.93E-57 conserved hypothetical protein  - 
PP_0028  ---  3.231 2.66E-05 conserved hypothetical protein  - 
PP_0107  ---  3.226 7.42E-78 conserved hypothetical protein  Periplasmic 
PP_2737  ---  3.216 1.90E-51 oxidoreductase, short-chain 
dehydrogenase/reductase family  
- 
PP_2006  ---  3.21 0 hypothetical protein  - 
PP_2511  ---  3.201 1.94E-46 conserved hypothetical protein  - 
PP_3676  ---  3.188 1.46E-80 hypothetical protein  - 
PP_2358  ---  3.154 9.40E-221 type 1 pili subunit CsuA/B 
protein, putative  
- 
PP_5319  ---  3.11 1.20E-185 conserved hypothetical protein  Periplasmic 
PP_3512  ---  3.089 2.31E-12 conserved hypothetical protein  Cytoplasmic 
membrane 
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PP_1609  ---  3.072 2.31E-132 hypothetical protein  - 
PP_1840  ---  3.064 3.93E-35 conserved hypothetical protein  Cytoplasm 
PP_4899  ---  3.05 1.94E-165 YjeF-related protein  Cytoplasm 
PP_0804  ---  3.02 0 protein secretion ABC efflux 
system, permease and ATP-
binding protein  
Cytoplasmic 
membrane 
PP_1196  ---  3.016 3.68E-94 hypothetical protein  - 
PP_0396  ---  3.011 0 conserved hypothetical protein  Cytoplasm 
PP_2853  ---  3.005 4.01E-277 conserved hypothetical protein  - 
PP_1033  ---  2.981 3.31E-225 sulfatase domain protein  Cytoplasmic 
membrane 
PP_4555  ---  2.965 6.21E-26 conserved hypothetical protein  - 
PP_1947  ---  2.961 0.000157 conserved hypothetical protein  - 
PP_3611  ---  2.954 7.46E-170 hypothetical protein  - 
PP_0397  ---  2.947 0 conserved hypothetical protein  Cytoplasm 
PP_2562  ---  2.942 3.30E-15 conserved hypothetical protein  - 
PP_0104  ---  2.924 4.31E-59 cytochrome c oxidase, subunit I  Cytoplasmic 
membrane 
PP_3223  ---  2.904 1.62E-24 ABC transporter, periplasmic 
binding protein  
Periplasmic 
PP_3080  aroF-2  2.901 3.06E-101 phospho-2-dehydro-3-
deoxyheptonate aldolase, class I  
Cytoplasm 
PP_0679  ---  2.888 0 conserved hypothetical protein  Cytoplasmic 
membrane 
PP_3668  ---  2.844 0 catalase/peroxidase HPI  Cytoplasm 
PP_3469  ---  2.838 1.08E-05 hypothetical protein  Extracellular 
PP_4240  ---  2.83 0.000151 microcin b17 processing protein 
mcbd, putative  
- 
PP_3677  ---  2.827 6.83E-115 hypothetical protein  Cytoplasm 
PP_3678  ---  2.82 9.68E-43 hypothetical protein  Cytoplasm 
PP_3449  ---  2.805 3.32E-29 hypothetical protein  - 
 
Table 8. List of downregulated genes in P. putida KT2440 ΔcyaA vs. wild-type KT2440 
strain in M9-glucose cultures. 
Locus  Gene  Fold 
Change  
FDR  Product Subcellular 
localization 
PP_5222  cyaA  -33.213 0.000252 adenylate cyclase  Cytoplasmic 
PP_1249  ---  -8.191 1.42E-12 lipoprotein, putative  - 
PP_4007  infA  -7.756 0 translation initiation factor IF-1  Cytoplasm 
PP_0153  ---  -7.125 2.79E-13 conserved hypothetical protein  - 
PP_1982  ibpA  -6.948 0 heat-shock protein IbpA  Cytoplasm 
PP_3482  ---  -6.283 9.10E-05 hypothetical protein  - 
PP_3682  ---  -6.154 1.98E-10 hypothetical protein  - 
PP_0236  ssuE  -6.088 0 NADH-dependent FMN 
reductase  
- 
PP_3335  ---  -5.557 3.02E-13 conserved hypothetical protein  - 




PP_0504  oprG  -5.383 0 outer membrane protein OprG  Outer 
membrane 
PP_5274  ---  -5.374 1.30E-13 hypothetical protein  - 
PP_5316  ---  -5.369 1.98E-05 hypothetical protein  - 
PP_3631  ---  -4.855 6.07E-06 conserved hypothetical protein  - 
PP_4837  ---  -4.76 1.53E-12 conserved hypothetical protein  - 
PP_3330  ---  -4.7 0 outer membrane ferric 
siderophore receptor, putative  
Outer 
membrane 
PP_3773  ---  -4.698 2.02E-05 hypothetical protein  Cytoplasm 




PP_4839  ---  -4.365 4.44E-12 membrane protein, putative  Cytoplasmic 
membrane 
PP_5254  ---  -4.224 0.000805 hypothetical protein  - 
PP_4836  ---  -4.214 0 conserved hypothetical protein  Periplasmic 
PP_3100  ---  -4.079 0 conserved hypothetical protein  Cytoplasm 
PP_3098  ---  -3.995 5.38E-13 conserved hypothetical protein  Cytoplasm 




PP_4179  htpG  -3.954 1.32E-10 heat shock protein HtpG  Cytoplasm 
PP_2655  ---  -3.933 2.34E-10 hypothetical protein  - 
PP_3331  ---  -3.894 5.77E-13 conserved hypothetical protein  Cytoplasmic 
membrane 
PP_3853  ---  -3.752 0 hypothetical protein  - 
PP_2064  ---  -3.627 3.85E-08 multidrug efflux RND membrane 
fusion protein  
Cytoplasmic 
membrane 
PP_4233  ---  -3.595 0 oxidoreductase, small subunit, 
putative  
Cytoplasm 
PP_3405  ---  -3.573 0 conserved hypothetical protein  Cytoplasmic 
membrane 
PP_3404  ---  -3.565 0 conserved hypothetical protein  Cytoplasm 
PP_3780  ---  -3.542 0 hypothetical protein  Cytoplasmic 
membrane 
PP_5087  rpmE  -3.505 0 ribosomal protein L31  Cytoplasm 
PP_1361  groEL  -3.504 2.61E-10 chaperonin, 60 kDa  Cytoplasm 
PP_3859  ---  -3.496 0.000275 conserved hypothetical protein  Cytoplasm 
PP_2178  ---  -3.454 8.41E-08 glutamine synthetase, putative  Cytoplasm 
PP_4626  ---  -3.434 5.68E-10 LrgA family protein  Cytoplasmic 
membrane 
PP_4725  dapB  -3.31 4.38E-12 dihydrodipicolinate reductase   
PP_4727  dnaK  -3.252 0 dnaK protein  Cytoplasm 




PP_4178  ---  -3.203 0 dienelactone hydrolase family 
protein  
- 
PP_1535  ---  -3.099 0.000875 methyltransferase, putative  Cytoplasm 
PP_0472  rpmD  -3.076 0 ribosomal protein L30  Cytoplasm 
PP_3465  ---  -3.067 0 hypothetical protein  - 
PP_3218  ---  -2.972 0.000179 monooxygenase, 
NtaA/SnaA/SoxA family  
Cytoplasm 
PP_2877  ---  -2.954 9.61E-13 transporter, bile acid/Na+ 




PP_4876  rpsR  -2.949 2.91E-11 ribosomal protein S18  Cytoplasm 
PP_3332  ---  -2.927 0 cytochrome c-type protein  - 
PP_5001  hslU  -2.917 0 heat shock protein HslVU, 
ATPase subunit HslU  
Cytoplasm 
PP_3091  ---  -2.905 0 conserved hypothetical protein  Cytoplasmic 
membrane 
PP_3092  ---  -2.887 0 conserved hypothetical protein  Cytoplasm 
PP_3339  ---  -2.874 0 conserved hypothetical protein  - 
PP_3095  ---  -2.87 2.79E-13 chaperone-associated ATPase, 
putative  
Cytoplasm 
PP_4728  grpE  -2.827 2.91E-11 heat shock protein GrpE  Cytoplasm 
PP_0627  ---  -2.816 1.55E-06 conserved hypothetical protein  Cytoplasmic 
membrane 





Summary of the Thesis in Spanish by sections 
I. Introducción 
La amplia diversidad de microorganismos que se encuentran en la naturaleza se enfrentan 
con mucha frecuencia a cambios drásticos en la disponibilidad de fuentes de carbono y de 
nitrógeno. Su supervivencia depende en gran medida de la habilidad con que se adaptan a 
estos cambios por medio de la regulación de la expresión de genes que codifican para las 
enzimas y transportadores necesarios para el crecimiento ante los cambios en su medio 
ambiente. El mecanismo por el cual se lleva a cabo esta expresión genética es muy complejo, 
y comprende muchas etapas, cada una con una minuciosa regulación. Sin embargo, en 
bacterias la iniciación de la transcripción es el paso más importante de este proceso. 
Los factores de transcripción son proteínas que cumplen un papel fundamental en la 
iniciación de la transcripción, ya que modulan su activación por medio de la ARN 
polimerasa, o bien la pueden reprimir al interferir con la actividad de esta enzima. El 
genoma del microorganismo modelo Escherichia coli codifica para alrededor de 300 factores 
de transcripción, de los cuales diez de ellos (Crp, FNR, IHF, Fis, ArcA, NarL, Lrp, RutR, 
Cra and Dan) se consideran reguladores globales, ya que controlan simultáneamente la 
transcripción de un gran número de genes. Uno de los más estudiados en procariotas es la 
proteína receptora de cAMP (Crp o CAP). En E. coli, este factor se encuentra formando 
dímeros que se activan mediante la interacción con el adenosín monofosfato cíclico o 
cAMP, el cual provoca un cambio estructural en la proteína que le permite interaccionar 
con secuencias específicas de ADN que se encuentran dentro de los promotores de los genes 
que ésta regula (esta secuencia es similar al motivo consenso 5’TGTGA-6N-TCACA3’). A 
pesar de que Crp es una proteína muy abundante en E. coli, se ha especializado en controlar 
las funciones metabólicas en esta bacteria, ya que muchos de los genes que regula codifican 
para enzimas y proteínas transportadoras de sustratos que son utilizados por la célula como 
fuentes de carbono. Esto convierte a Crp en uno de los factores principales que median el 
fenómeno de Represión Catabólica. Este proceso es sumamente importante para la 
adaptación de los microorganismos a las condiciones cambiantes del medio ambiente en el 
cual habitan, ya que les permite diferenciar entre fuentes de carbono preferidas (que son 
metabolizadas rápidamente o que son energéticamente favorables) cuando se encuentran 
expuestas a más de un nutriente. De esta forma, la regulación de la actividad de Crp en E. 
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coli por medio de la disponibilidad de su molécula efectora (cAMP) le permite activar o 
reprimir solamente los genes que codifican las enzimas necesarias para utilizar las fuentes de 
carbono preferenciales. 
Como se mencionó anteriormente, la actividad de Crp se encuentra altamente regulada por 
la concentración intracelular del cAMP, la cual se sintetiza a partir del ATP por la enzima 
adenilato ciclasa (AC). Existen varias clases de AC, las cuales están presentes en 
prácticamente todos los dominios de la vida. Entre estas, la CyaA de E. coli es 
probablemente la AC de clase I mejor caracterizada en procariotas. Según el modelo vigente, 
esta proteína es activada mediante el estado de fosforilación de la proteína EIIAGlc 
perteneciente al sistema de fosfotransferasa para azúcares dependiente de fosfoenolpiruvato 
o PTS. Así, cuando la enzima EIIAGlc se encuentra fosforilada, activa a la AC para sintetizar 
el cAMP. Otro factor importante que regula la concentración intracelular de este 
nucleótido cíclico es la actividad de las enzimas fosfodiesterasas de cAMP. Estas proteínas 
catalizan la hidrólisis del fosfato cíclico del cAMP, resultando en la producción del 
monofostato de adenosina inactivo.  
La bacteria del suelo Pseudomonas putida es el organismo oportunista por excelencia desde 
el punto de vista nutricional y además es un modelo de diversidad metabólica entre los 
organismos capaces de reciclar desechos orgánicos en el medio ambiente aeróbico. Sus 
muchas características, de las cuales destacan principalmente su gran diversidad metabólica, 
la capacidad para degradar compuestos xenobióticos y su gran robustez, la han convertido 
en un organismo modelo para la investigación en bacterias del suelo y para aplicaciones 
biotecnológicas como biorremediación y biocatálisis. A pesar de que han transcurrido más 
de 40 años desde el descubrimiento de Crp en E. coli, las funciones del dúo cAMP-Crp en 
P. putida no se han llegado a estudiar en profundidad. Su genoma codifica ortólogos 
singulares de los genes crp y cyaA de E. coli. Sin embargo, su función no parece estar 
relacionada con el metabolismo de fuentes de carbono, y por otra parte parece regular 
funciones relacionadas con la membrana celular, como la resistencia a antibióticos y 
antimetabolitos, la motilidad celular y la formación de biopelículas. Adicionalmente, 
existen evidencias de que el sistema cAMP-Crp puede estar involucrado en la utilización de 
aminoácidos como fuentes de carbono y nitrógeno en esta bacteria. De este modo, en la 
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presente Tesis tratamos de esclarecer cual es el mecanismo de activación y regulación de la 




Investigar los mecanismos de regulación en el sistema de expresión genética basado en el 
dúo cAMP-Crp, así como las funciones que lleva a cabo. 
Objetivos específicos 
1. Caracterizar genética y fenotípicamente los genes crp, cyaA y cpdA de P. putida, así 
como las proteínas que están codificadas por cada uno de ellos. 
2. Detectar y medir los niveles intracelulares del metabolito secundario cAMP en P. 
putida. 
3. Purificar y caracterizar bioquímicamente el regulador CrpP. putida, así como la 
regulación de su actividad por el cAMP. 
4. Detectar los genes que se encuentran regulados directa o indirectamente por el 
sistema cAMP-Crp de P. putida 
 
III. Resultados y Discusión 
Capítulo I 
En este capítulo se describen los genes que forman parte del sistema de regulación genética 
basado en el dúo cAMP-Crp en P. putida, así como su contexto genómico. Estos genes 
corresponden a crp (que codifica para la proteína de unión a cAMP o Crp), cyaA (adenilato 
ciclasa o CyaA) y cpdA (fosfodiesterasa de cAMP o CpdA). Mediante curvas de crecimiento, 
se muestra que la mutación tanto de crp como de cyaA en P. putida no tienen ningún efecto 
perceptible sobre el crecimiento de esta bacteria en varias fuentes de carbono. Por el 
contrario, la mutación del gene cpdA disminuye la tasa de crecimiento en los cultivos 
crecidos en succinato y glucosa, pero no así en fructosa. Mientras que la función de CpdA 
puede predecirse mediante homología con otras fosfodiesterasas descritas en la literatura, los 
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productos de los genes crp y cyaA de P. putida se analizaron funcionalmente mediante 
ensayos de complementación del consumo de maltosa  en cepas mutantes de los genes 
homólogos en E. coli. Estos experimentos muestran que la proteína CrpP. putida es realmente 
funcional y requiere del cAMP para ejercer su actividad regulatoria. Por otra parte, la 
enzima CyaAP. putida solo fue capaz de complementar la mutación del gene cyaA en una cepa 
de E. coli hipersensible a bajas concentraciones de cAMP, lo cual supone que la AC de P. 
putida produce niveles muy bajos de cAMP. Estos resultados se confirmaron 
posteriormente tanto cualitativamente con un biosensor basado en el protozoo 
Dictyostelium discoideum y cuantitativamente mediante HPLC-ESI-MS. Posteriormente, se 
utilizan fusiones transcripcionales y traduccionales del promotor del gene cyaAP. putida para 
demostrar que una de las razones de la baja actividad de la AC de P. putida radica en que 
este gene se transcribe eficientemente, pero su nivel de traducción es muy bajo. Finalmente, se 
muestra la fusión traduccional del promotor de crpP. putida para comprobar que la traducción de 
este gen se aumenta ligeramente cuando las células crecen en glucosa como única fuente de 
carbono. La actividad de estos promotores (cyaA y crp) parece ser independiente  del dúo 
regulador cAMP-Crp en P. putida. 
Capítulo II 
Con la finalidad de caracterizar bioquímicamente la proteína CrpP. putida, esta se purificó 
mediante una fusión con la proteína de unión a maltosa (MBP). En el capítulo II se 
describen los pasos para obtener grandes cantidades de MBP-CrpP. putida, que posteriormente 
se somete a un proceso de proteólisis con trombina y purificación en una resina de 
fosfocelulosa para obtener la CrpP. putida libre de la etiqueta de MBP. A continuación, se 
utilizan ensayos de ultracentrifugación analítica para determinar el estado de 
oligomerización de la CrpP. putida pura, que forma dímeros en solución con un tamaño 
molecular de 51,6 kDa. Estos dímeros sufren un aumento en su dimensión física cuando 
CrpP. putida interacciona con el cAMP, lo cual se debe a un cambio conformacional en la 
estructura de la proteína. Este cambio se demuestra asimismo utilizando ensayos de proteólisis 
parcial en ausencia o presencia de este efector. Con el propósito de calcular los parámetros 
termodinámicos de la interacción de CrpP. putida con el cAMP, se realizaron ensayos de 
microcalorimetría de titulación isotérmica. Estos experimentos revelaron que la unión entre el 
cAMP y CrpP. putida ocurre mediante un proceso exotérmico, con cambios favorables en la 
Annexes 
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entalpía y en la entropía del sistema. Más importante aún, los ensayos muestran que esta unión 
se lleva a cabo con una estequiometría de 1 molécula cAMP: 1 dímero CrpP. putida y es 
especialmente fuerte, con una KD de 45.0 ± 3.4 nM, es decir, una afinidad mucho mayor que la 
conocida para la proteína homóloga de E. coli. La estequiometría tan atípica para este tipo de 
reguladores transcripcionales se explica mediante un modelo de cooperatividad negativa en el 
cual, la unión del cAMP por uno de los monómeros de CrpP. putida disminuye en gran medida la 
afinidad del cAMP en el bolsillo de unión del monómero restante. CrpP. putida también muestra 
afinidad por el cGMP, pero esta es cerca de 100 veces menor. Finalmente, se utiliza un 
sistema de transcripción in vitro empleando la ARN polimerasa purificada de P. putida, junto 
con sus respectivos ensayos de retardo de la movilidad electroforética para mostrar que   
CrpP. putida es capaz de unir y activar la transcripción del promotor lac de E. coli únicamente 
en presencia de cAMP. Esto indica que todas las características básicas de la CrpE.coli necesarias 
para la iniciación de la transcripción también se encuentran presentes en la Crp de P. putida. 
Capítulo III 
En este capitulo se muestran resultados preeliminares de los experimentos de transcriptómica 
realizados en las cepas de P. putida KT2440, Δcrp y ΔcyaA mediante ultra-secuenciación 
profunda de ARN (ARN-seq). Estos análisis demuestran que tanto Crp como CyaA regulan 
muy pocos genes relacionados con funciones metabólicas en P. putida. Por el contrario, el dúo 
regulador cAMP-CrpP. putida parece controlar factores relacionados con la respuesta celular a 
estrés ambiental como por ejemplo GroEL, GroES, DnaK y varias proteínas de choque 
térmico. Así mismo cAMP-CrpP. putida controlaría la expresión de componentes de la envuelta 
celular, sistemas de secreción de proteínas, los pili tipo I y componentes del citocromo C como 
respuesta a condiciones estresantes. Es interesante el hecho de que los resultados muestran 
muchos genes que se ven afectados solamente en alguno de los dos mutantes. Esto abre la 
posibilidad de que CrpP. putida pueda estar actuando también de manera independiente del 
cAMP, como se ha demostrado para la proteína homóloga Vfr de P. aeruginosa o bien, que 






El trabajo descrito en esta Tesis permite proponer las siguientes conclusiones: 
1. En P. putida, el sistema de regulación cAMP-Crp se compone de al menos tres 
componentes: una proteína de unión a cAMP (Crp), una adenilato ciclasa (CyaA) y 
una (y posiblemente más de una) fosfodiesterasa de cAMP (CpdA) 
2. La proteína CrpP. putida es un regulador transcripcional que se activa mediante regulación 
alostérica por el cAMP para complementar el fenotipo de metabolismo de maltosa en E. 
coli. 
3. La concentración intracelular y extracelular de cAMP producida por la adenilato ciclasa 
de P. putida es muy baja en comparación con las enterobacterias. Estos niveles tan 
bajos son en parte debido a que el gene que codifica la adenilato ciclasa en este 
organismo es transcrito eficientemente, pero su traducción es muy baja. 
4. La proteína CrpP. putida forma dímeros cuando se encuentra en solución. Estos dímeros 
sufren un cambio conformacional cuando interaccionan con el cAMP, lo que 
posiblemente posiciona la proteína en la orientación correcta para reconocer e 
interaccionar con las correspondientes secuencias de ADN. 
5. La proteína CrpP. putida tiene una afinidad extraordinaria por el cAMP, que a su vez 
determina en gran parte sus funciones en P. putida. Esta hipersensibilidad por el cAMP 
explica por qué las concentración de cAMP en esta bacteria son tan bajas. 
6. La proteína CrpP. putida se une al cAMP con una estequiometría de 1 dímero de Crp: 1 
molécula cAMP. Esto se explica mediante un modelo de cooperatividad  negativa en el 
cual la unión del cAMP en uno de los monómeros induce un cambio conformacional  
que reduce en gran medida la afinidad por el cAMP en el  bolsillo de unión de ésta 
molécula en el segundo monómero. 
7. El complejo formado por cAMP-CrpP. putida es capaz de unir y activar la transcripción 
del promotor lac (tipo I para Crp). 
8. La función reguladora del sistema cAMP-Crp de P. putida está relacionada con la 
respuesta celular al estrés ambiental y con la expresión de componentes de la 
membrana que modifican el envoltorio bacteriano en esas condiciones. Adicionalmente, 
este sistema puede regular el metabolismo de ciertos aminoácidos como fuentes de 
carbono y nitrógeno. 
